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Abstract 
 
Field and experimental investigations were conducted to study the fatty liver haemorrhagic 
syndrome (FLHS) in caged laying hens. The main goal of the research was to gain a greater 
understanding of the aetiology and pathogenesis of this non-infectious disease. The disease is 
characterized by excessive accumulation of fat in the liver and abdominal cavity, subsequent liver 
rupture, haemorrhage and sudden death of hens. It has been shown that the balance between hepatic 
synthesis and secretion of lipids is the key point that regulates hepatic and extrahepatic fat 
deposition in hens. Liver fat accumulation can be increased by many factors, especially nutrition, 
housing conditions, and inflammatory challenges. A description of normal and abnormal lipid 
metabolism in the hen, and consequences for hen health and disease (including FLHS) is given in 
the literature review (Chapter 2).  
 
The initial study examined mortality of layer flocks kept in three different housing systems (cage, 
barn and free range) on the Gatton Campus, University of Queensland (Chapter 4). It was shown 
that there were no significant differences in mortality rates of hens (6.1%, 6.4% and 5.8%, for 
cages, barns and free range, respectively) between the housing systems but the causes of death were 
different. The most common cause of death in hens kept in cages was FLHS with 74% of dead hens 
dying from the condition. In contrast, FLHS only accounted for 0 to 5% of hen mortality in the 
other systems. Post-mortem of dead hens and body weight monitoring of flocks throughout the 
laying cycle were recommended as tools to predict FLHS.  
 
An epidemiological survey (Chapter 5) of caged flocks in South-Eastern Queensland was 
undertaken to explore the prevalence of FLHS in commercial layer flocks. From necropsies of dead 
birds from 7 flocks of different ages, it was found that approximately 40% of hens died due to 
FLHS. This result indicated that FLHS continues to be the major cause of mortality in commercial 
caged laying hens kept in either controlled environment sheds or naturally ventilated sheds. As part 
of the epidemiological study, a questionnaire was circulated among farms and the responses 
revealed that there is a general lack of knowledge of FLHS in the industry. 
 
The study of the pathogenesis of FLHS is very difficult as it occurs sporadically and over an 
extended period of time in the field. In the studies in Chapter 6, an oestradiol (E2) hen model was 
used to study the condition. The administration of exogenous E2 reproduced the disease in 30 wk 
old laying hens, and was associated with significant changes in E2 plasma levels and metabolic 
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profiles, increased liver weights, and macroscopic (fat depositions, haemorrhages and haematomas) 
and microscopic alterations. Hens exposed to E2 and fed ad libitum diet experienced severe FLHS 
and had a higher incidence of FLHS than hens that had their feed intake restricted by 10%. One 
interesting observation from this study (not reported from other investigators) was the alteration of 
total leukocyte numbers and plasma fibrinogen concentrations after E2 exposure, suggesting that 
inflammation (as a part of the acute phase response) contributed to the development of FLHS. 
Further investigations were conducted using E2 hens injected with lipopolysaccharide (LPS) to 
simulate an immunological challenge in Chapter 7. This challenge increased the incidence of 
FLHS. Gene expression levels of important inflammatory cytokines (IL-1β, IL-6, and IL-18 
involved in the generation of systemic and local responses to infection and injury) were evaluated. 
The mRNA expression of both IL-1β, IL-6 was greatly up-regulated in E2 and LPS treated hens, 
with IL-6 giving the greatest increase  in the acute phase response (3 h post-treatments), while  IL-
1β gave the greatest response  in a later stages (at 24 h) of the response. It was confirmed that the 
stimulation of fibrinogen synthesis during acute-phase response was mediated by leukocytes and 
cytokines, and the IL-6 had a prominent role.  
 
Studies conducted in this thesis indicate that FLHS is a significant disease of caged layer hens and 
impacts on hen health and welfare. The finding of the role of inflammation during elevated 
circulating levels of oestradiol in inducing FLHS is a useful step in understanding the pathogenesis 
of this condition. Further studies of these factors and the pathogenesis of FLHS are required. 
Finally, it will not be possible to develop strategies to reduce the incidence of FLHS until the 
factors that predispose birds to the condition are fully understood.   
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1.1  Preface 
 
Fatty liver haemorrhagic syndrome (FLHS) is a non-infectious (metabolic) disease of laying hens 
characterized by excessive accumulation of fat in the liver and abdominal cavity, liver rupture and 
haemorrhage, and sudden death (Crespo and Shivaprasad, 2003). It is a major cause of mortality in 
caged commercial laying hens, resulting in great economic losses to the poultry industry, not only 
from bird mortality but also from decreased egg production in affected flocks (Squires and Leeson, 
1988). Birds affected by FLHS are difficult to distinguish from healthy birds; however decreased 
egg production, increased body weights (BW) and flock mortality can be ―signals‖ of the presence 
of this metabolic condition in a layer flock (Julian, 2005; Leeson, 2007).  
 
First described by Couch (1956) in heavy breeds of laying hens during hot weather conditions in the 
USA, this syndrome created much interest. There were a number of studies conducted by 
researchers between 1950s and 80s (Akiba et al., 1983; Balnave, 1971; Butler, 1975; Haghighi-Rad 
and Polin, 1982b; Harms et al., 1982; Harms et al., 1977; Ivy and Nesheim, 1973; Pearson et al., 
1978a; Pearson and Butler, 1978b; Pearson et al., 1978b; Polin and Wolford, 1973, 1976, 1977; 
Ringer and Sheppard, 1963; Wolford and Polin, 1972, 1975), with no success in clarifying the 
aetiology and pathogenesis or reducing the occurrence of this disorder in commercial flocks. It was 
an unresolved metabolic disease of laying hens (Hansen and Walzem, 1993). It should be noted that 
during the 1950s intensive housing system (i.e., battery cages) and high-energy diets were 
increasingly introduced to the poultry industry worldwide (Couch, 1956), suggesting that these 
factors may have contributed to the increased prevalence of this disease.  
 
18 
 
Globally, between 55 to 90% of laying hens are housed in conventional cages (Shields and Duncan, 
2008), making FLHS a disease of potential importance in terms of hen welfare and farm 
profitability. Any progress in preventing this condition will benefit bird health and productivity and 
lead to increased economic returns for the poultry industry (Cherian, 2007). Since the 1990s, little 
research has been conducted into the aetiology and pathogenesis of FLHS. Given that over 50% of 
Australia‘s layer flock is housed in cages (AECL, 2011), studies on the FLHS are of current 
importance.  
 
1.2      The Origin of the Study 
 
1.2.1 FLHS – a disease “rediscovered”  
 
The idea to conduct studies on FLHS in caged hens came from the field. There were several reports 
from egg producers about increased mortalities in their flocks. The author subsequently undertook 
random necropsies and observed that most hens had large amounts of coagulated blood in the 
abdominal cavity and pale livers and the diagnosis was FLHS. As described below, FLHS had been 
investigated in Queensland some 30 years previously. However, in the intervening period it had 
either been forgotten or considered as a normal consequence in hens producing eggs. 
 
1.2.2 An “old” disease in Queensland flocks 
 
There had been prior reports of the occurrence of FLHS in commercial laying flocks in Queensland 
(Neill et al., 1975) suggesting that Queensland probably presents ―ideal‖ climatic conditions that 
favour the outbreak of this metabolic disorder in egg producing flocks.  
 
Neill et al. (1975) showed that for several years (1970 to 1975) there were a number of outbreaks of 
FLHS in laying hens in South Eastern Queensland. They pointed out that the sporadic nature of this 
disease, and the lack of established diagnostic tests contributed to the lack of systematic studies on 
FLHS. In an attempt to explain the pathological alterations of the liver during FLHS, Neill et al. 
(1975) used histopathology to determine if liver reticulolysis was specific for FLHS. This was of 
some significance because previous investigators (Butler, 1975; Hall, 1974) had shown that lysed 
reticulin was unique among fatty liver syndrome in birds, but in some cases this was associated 
with a toxicosis (e.g. feeding rapeseed). Nevertheless, in their study, Neill et al. (1975) confirmed 
that the reticulosis was a definitive lesion of FLHS in Queensland, where the outbreaks were 
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considered not to be associated with any known toxic principle. It is known that reticulosis 
produces a structural weakness of the liver which will rupture when under stress (nutritional/toxic, 
infectious, or environmental) (Neill et al., 1977). However, any correlation between liver fat content 
and degree of lysis of the reticulin was not found, although the presence of heavy fat infiltration in a 
structurally weakened liver was thought to have been the reason for massive haemorrhage and death 
of hens (Neill et al., 1975).  
 
An epidemiological study published in the same year by Grimes (1975), examined two Queensland 
commercial caged flocks with hens of different strains over a period of eight months. This study 
used necropsies and laboratory examinations of dead or euthanised sick birds to obtain information 
on the causes of mortality. Results of this survey revealed a high incidence of FLHS in both flocks 
(approx. 4% of the flocks) and recognized that affected hens were obese, but still producing eggs at 
the time of death.  
 
The studies conducted by both Neill et al. (1975) and (Grimes, 1975) were conducted in the 1970s 
and there is a lack of information on the current situation of FLHS in caged birds in Queensland and 
in Australia. 
 
1.2.3 Past research and the current industry  
 
Most previous investigators have reported that FLHS is a condition with significantly higher 
incidence in caged hens than in hens kept in other systems (Butler, 1976; Couch, 1956; Meijering, 
1979; Peckham, 1984; Shini et al., 2006; Squires and Leeson, 1988; Ugochukwu, 1983; 
Weitzenburger et al., 2005). However, a few studies have suggested that FLHS occurs equally in 
both caged and floor birds (Couch, 1956; Crespo and Shivaprasad, 2003; Harms et al., 1972; Trott 
et al., 2013). Moreover, past research found increased mortality due to FLHS at temperature 
extremes (Couch, 1956; Greuel and Hartfiel, 1968; Pearson and Butler, 1978a; Polin and Wolford, 
1973; Schexnailder and Griffith, 1973). 
 
Most of the previous studies were conducted many years ago and although they may have general 
applicability to the current industry, much has changed in the intervening period. The genotype of 
the modern layer is very different to the bird of 30 years ago as are the diets fed. It is less likely that 
todays caged birds will experience temperature extremes as most cages are located in thermo-
neutral temperatures. Interestingly, birds in controlled environment sheds have lower energy 
requirements for maintaining body temperature. The unused energy might be the factor that 
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contributes to a higher positive energy balance and the likely occurrence of FLHS. All these factors 
indicate that studies of FLHS must examine modern housing systems and current management 
practices. 
 
1.3  Aims and Objectives of the Study 
 
The overarching hypothesis of this thesis is that ―FLHS is a major cause of mortality in Queensland 
laying flocks‖. Following the initial study which demonstrated that FLHS was the major cause of 
mortality in caged layer flocks but not in other housing systems, further research questions were 
formulated and experiments designed. These were to: 
 Determine the occurrence of FLHS in commercial caged layer flocks; 
 Identify environmental factors influencing the incidence of the disease;  
 Identify management factors influencing the incidence of the disease.  
 
While conducting these studies it became apparent that to unravel the aetiology and pathogenesis of 
this disease, a model was needed that would allow the disease to be induced routinely. This became 
the object of the later studies reported in this thesis.  
 
Ultimately, it was hoped that the work in this thesis would assist the poultry industry to improve the 
health, welfare and profitability of commercial laying hens. 
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2.1  Scope of Review 
 
Metabolic disorders have been recognised for 50 years, yet most still affect the poultry industry 
(Leeson, 2007). 
 
Metabolic disorders in poultry are those conditions associated with increased metabolism, rapid 
growth rate or high egg production, that result in the failure of a body system due to an increased 
work-load on that organ or system (Julian, 2005). Fatty liver haemorrhagic syndrome is classified in 
that group of metabolic disorders that ―result from the failure or deficiency in the production, 
synthesis or transport of an enzyme, hormone or secretory mechanism‖ (Julian, 2005).  
 
Fatty liver haemorrhagic syndrome is a disorder of current concern and a major cause of mortality 
in high producing commercial laying flocks (Leeson, 2007). Although, the liver is the main site of 
fat synthesis in the chicken, in laying hens fatty liver (FL) is normal (Butler, 1975, 1976). Under the 
influence of various factors, excessive fat can accumulate in the liver, and the liver capsule can 
rupture so that haemorrhage occurs and causes death of the bird, and this condition is diagnosed as 
FLHS. The exact cause of FLHS is still unknown (Julian, 2005; Leeson, 2007; Squires and Leeson, 
1988) and the pathophysiological background of this complex metabolic condition is still to be 
outlined.  
 
For the purpose of this review a broad description of lipogenesis and lipid storage in the chicken is 
presented, to increase the understanding and help distinguishing the normal pathways of lipid 
metabolism from ―non-normal‖ (i.e. ―disordered‖) pathways. Chicken liver structure and function 
are introduced to provide a logical foundation for the understanding of physiological and 
pathophysiological events that can occur under the influence of various factors (nutritional and non-
nutritional). This review recognises the involvement of liver and non-liver components in the 
pathogenesis of FLHS. A series of earlier studies are presented here, in particular those focusing on 
the diagnosis and control of FLHS in laying flocks. Finally, important concluding remarks are given 
to support studies that follow in the next chapters of this thesis. 
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2.2  Metabolism of lipids and lipid disorders in laying hens 
 
2.2.1 Introduction         
 
Lipids (i.e. fats) are water-insoluble hydrocarbon derivatives that serve as structural components of 
membranes, energy-rich fuel stores, pigments, and intracellular signals (Nelson and Cox, 2008). 
Fats and oils are the principal forms of stored energy in many organisms. Phospholipids and sterols 
present the major structural components of biological membranes. Other lipids are present in 
relatively small amounts, but play crucial roles as electron carriers (in mitochondrial membranes, 
electron transport system), enzyme cofactors (fat-soluble vitamins or their metabolic products), 
light-absorbing pigments, hydrophobic anchors for proteins, ―chaperones‖ to help membrane 
proteins fold, hormones, intracellular messengers, emulsifying agents in the digestive tract (Gurr et 
al., 2002). Last but not least, lipids (i.e. adipose tissue) have insulating properties, important in 
thermoregulation and protection of internal organs.  
 
Like a mammal, the chicken utilises lipids as its main energy source (Butler, 1975). Dietary lipids 
are the only dietary component that is deposited intact into tissues with little or no modification 
(Klasing, 1998). Consequently, the fatty acid composition of the diet primarily determines the fatty 
acid composition of fat stores in birds, although some conversion of dietary fatty acids occurs 
creating some differences between fatty acid composition of diet and body fat (Klasing, 1998). 
Unlike in mammals, lipogenesis in birds is very limited in the adipose tissue and the production of 
lipids is greater in the hepatic tissue (Hermier, 1997). In laying hens, the liver plays a dominant role 
in the synthesis and metabolism of lipids. Lipids metabolised in the liver are derived from three 
main sources: feed fat, depot fat, and from de novo fatty acid synthesis (from feed carbohydrates). 
Briefly, the digestion and absorption of dietary lipids occurs in small intestine, lipogenesis occurs 
mainly in the liver, and the transport of triglycerides from liver into the adipose tissue or the oviduct 
is facilitated by various classes of lipoproteins.  
 
2.2.2  Digestion and absorption of lipids     
 
Birds are very efficient animals at absorbing and utilising fat. Chickens are able to utilize fat at 
more than 50% of dietary dry mass (Place, 1996).  Dietary fatty acids are absorbed mainly in the 
duodenum and jejunum after being emulsified by lipase and bile salt. Digestion of dietary lipids 
(basically of triglycerides) in the intestine involves their partial hydrolysis and absorption.  
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Plasma lipid transport in birds is similar to that in mammals, however due to a poorly developed 
intestinal lymphatic system in birds, dietary fatty acids are secreted directly into the portal blood 
system as very low density lipoproteins and are termed portomicrons (Bensadoun and Rothfeld, 
1972). The size (mean diameter of about 150 nm) and composition (about 90% triglycerides) of 
portomicrons are very similar to those of mammalian chylomicrons (Griffin et al., 1982), but their 
mode of transport differs; portomicrons enter the intestinal blood vessels through endothelial 
intracytoplasmic vesicles, whereas chylomicrons enter the intestinal lymphatics through gaps 
between endothelial cells (Fraser et al., 1986). Due to entry into the portal blood system, 
portomicrons pass through the liver before they reach the rest of the circulation (Figure 2.1). Such a 
feature predisposes birds to fat deposition in the liver (Cherian et al., 2002). Apparently, these 
particles are too large to go through the sieve plate-like pores in the sinusoidal capillary bed and 
cannot be also metabolized by the liver (Fraser et al., 1986); eventually they will be deposited in the 
liver tissue. Such particles are absent from the plasma of unfed birds and are in very low 
concentration in fed immature birds (Hermier et al., 1996). However, this situation may also reflect 
the very rapid catabolism of portomicrons in extrahepatic tissues (e.g. adipose and muscle tissue).  
 
Studies have shown that the ovarian follicle of the laying-hen makes little contribution to 
catabolism of circulating portomicrons, as it specifically excludes lipoproteins of intestinal origin 
from yolk, most probably because they are too large to pass through the connective tissue matrix of 
the basal lamina (Griffin and Perry, 1985).  
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Figure 2.1 Plasma lipid absorption and transport in birds and mammals (Griffin and Hermier, 
1988). 
NEFA=non-esterified fatty acids; VLDL=very low density lipoproteins; HDL=high density 
lipoproteins 
*Chylomicrons and lymph in mammals; 
Picture adapted from: www2.estrellamountain.edu/faculty/farabee/BIOBK/biobookdigest.html  
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2.2.3 Lipid metabolism in the laying hen  
 
Lipogenesis      
 
As mentioned above, in birds lipogenesis (i.e., the conversion of glucose to triglycerides) takes 
place primarily in the liver and involves a series of linked, enzyme-catalysed reactions including 
glycolysis, the citric acid cycle and fatty acid synthesis (Richards et al., 2003). Because commercial 
avian breeds are usually fed lipid-poor diets (less than 10%), the liver plays a key role in 
lipogenesis, providing lipids destined to be used by all tissues, including the liver itself (Hermier, 
1997). Dietary fatty acids in poultry are provided by animal- or vegetable- blend oils that are high 
in saturated and n-6 fatty acids.  However, avian hepatic cells are able to synthetise saturated fatty 
acids from non-lipid substrates (i.e. de novo synthesis) (Klasing, 1998) and to oxidize them to 
mono- and di-unsaturated fatty acids. The biochemical details of this synthesis are similar to those 
in mammals (Donaldson, 1990). Birds, however, cannot use stearic acid to synthetise linoleic and 
linolenic acids therefore they have a dietary requirement for them. Both dietary and endogenously 
produced fatty acids are metabolised by enzymes within chicken hepatocytes from arachidonic acid, 
which is further de-saturated by hepatocytes to produce prostaglandins and eicosapentanoic acid, 
respectively (Klasing, 1998).  
 
It should be stressed that lipogenesis in the chicken liver is high, and particularly active in females 
producing eggs. In laying hens, hepatic lipogenesis is dramatically enhanced by oestrogens in order 
to meet the demand for vitellogenesis (Hermier, 1997). De novo hepatic fatty acid synthesis in a 
female hen is essential to meet the lipid requirement of producing an egg every day which contains 
6 g of triacylglycerols transported to the oocyte from the liver (Walzem et al., 1999). Fatty acid 
synthesis depends on the availability of dietary carbohydrate to ultimately provide acetyl-CoA 
(Figure 2.2). Although, the main products of de novo hepatic lipogenesis are triglycerides, the liver 
is also the major site of cholesterol and phospholipid synthesis. These lipids, along with proteins, 
are the main components of lipoproteins. In chickens, very low density lipoprotein (VLDL), low 
density lipoprotein (LDL), and high density lipoproteins (HDL) are the three classes of lipoprotein 
particles that are also synthesized and secreted by the liver (Walzem et al., 1994).  
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Figure 2.2 The lipogenic pathways responsible for the production of triglycerides (Richards et 
al., 2003). 
It starts from glucose, including the export of triglycerides from the liver to other tissues such as 
adipose tissue and muscle tissue; specific enzymes are shown next to the steps in the reaction that 
they catalyse.  
 
Lipid transport and lipoprotein catabolism  
 
Fatty acids, triglycerides, and other lipids are almost completely insoluble in blood plasma and 
tissue fluids. Fatty acids bind to fatty acid-binding proteins (within the cells) and albumin (in body 
fluids) to be solubilised (Nelson and Cox, 2008). Triglycerides are transported in the blood as 
components of lipoproteins (Figure 2.3). The liver repackages dietary lipids and endogenous 
synthesised lipids in the hepatocytes to give VLDL, which is secreted into the circulation. The 
transfer of triglycerides from VLDL into the adipose tissue involves their catabolism by lipoprotein 
lipase (LPL) (Hermier, 1997). This enzyme catalyses the hydrolysis of triglycerides into free fatty 
acids and glycerol molecules, which diffuse into the cells. The fatty acids then enter the 
surrounding tissues and, in the case of the adipose tissue, they are reesterified and stored as 
triglycerides. The LPL is synthesized in adipocytes as well as in muscle and other cell types, but 
only the fraction of the enzyme that has been secreted and anchored to the surface of the capillary 
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wall is functionally active. In mammals, LPL must be activated by an apolipoprotein (apo) of low 
molecular weight that is secreted with HDL and then transferred to VLDL prior to their hydrolysis 
(Griffin and Hermier, 1988).  
 
 
Figure 2.3  Lipoprotein structure (Alvarenga et al., 2011). 
 
The VLDL is the major lipoprotein responsible for the transport of lipids from the hen‘s liver to the 
oocyte and accounts for 60% of the dry yolk mass (Speake et al., 1998). At the onset of lay, VLDL 
concentrations rise, while those of HDL are approximately halved (Griffin and Hermier, 1988). The 
specific protein moieties, apo of these lipoprotein particles are also synthesized in the liver (Siuta-
Mangano et al., 1982). Synthesis and secretion pathways of chicken HDL are believed to be similar 
to those of VLDL. However, it is not known why triglycerides are preferentially associated with 
apo B into VLDL particles, whereas most of the phospholipids and cholesterol are associated with 
apo A-I in HDL. Vitellogenin is another lipoprotein synthesized in the liver and functions in the 
transport of lipids from liver to the oocyte and accounts for about 24% of the dry mass of egg yolk 
(Speake et al., 1998). 
 
In laying hens, the plasma catabolism of VLDL is very limited (Griffin et al., 1982), which allows 
the transport of lipids to oocytes, where VLDL are endocytosed, rather than to other tissues. Indeed, 
laying hen apo VLDL contain large amounts of an apo that is synthesized only under the influence 
of oestrogen (Nikolay et al., 2013). The intensive synthesis of yolk lipoproteins by the livers occurs 
faster than their mobilisation from the hepatocytes resulting in a transient increase in liver size and 
lipid content. Additionally, the rate of clearance of VLDL by the ovarian follicles is not as rapid as 
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hepatic release, therefore circulating triglycerides increase from 2-10 fold during egg production 
(Klasing, 1998).   
 
Lipid Storage 
 
In chickens, lipids and especially triglycerides are stored in hepatocytes, adipocytes, and growing 
oocytes (Alvarenga et al., 2011). Triglyceride storage in these compartments depends on the 
availability of a plasma lipid substrate originating from either the diet or lipogenesis in the liver. 
Intestinal and hepatic lipids are assembled and secreted as lipoprotein particles. Lipid storage in the 
oocytes is associated with vitellogenesis (Walzem et al., 1994), while excessive fat accumulation in 
the liver causes hepatic steatosis and FLHS, which are of much concern. In broilers, excessive 
accumulation of lipids in the adipose tissue is also a major concern, because most fat depots are lost 
during meat processing incurring losses for meat producers (Alvarenga et al., 2011).  
 
Endocrine function of adipose tissue and its implications for metabolism and 
inflammation  
 
Adipose tissue (or fat) is a form of loose connective tissue composed of adipocytes. Birds have the 
ability to store large quantities of excess triglycerides (energy) in the liver, adipose tissue 
(predominately abdominal fat) and in the yolk of developing oocytes. In mammals, there are two 
major types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue (BAT) with 
different structural and physiological roles (i.e. endocrine, and energy-storage and thermogenesis, 
respectively) (Cypess and Kahn, 2010). Brown adipose tissue has never been described in birds or 
other non-mammalian vertebrates (Mezentseva et al., 2008).  
 
A more modern view would categorize WAT as a complex, essential, and highly active metabolic 
and endocrine organ (Kershaw and Flier, 2004; Ottaviani et al., 2011). Besides adipocytes, adipose 
tissue contains connective tissue matrix, nerve tissue, stromovascular cells, and immune cells. 
Together these components function as an integrated unit. Recent research shows that WAT plays a 
dynamic role in numerous physiological processes (Figure 2.4) through its secretory and endocrine 
functions (Coelho et al., 2013; Krug and Ehrhart-Bornstein, 2005). Although storage and release of 
lipids are major functions of adipocytes, they also use specific lipid and protein molecules for 
intracellular signalling and communicate with essentially every organ system in the body (Kershaw 
and Flier, 2004). These include leptin, other cytokines, adiponectin, complement components, 
plasminogen activator inhibitor-1, proteins of the renin-angiotensin system, and resistin (Coelho et 
al., 2013; Scherer, 2006).  
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(a) 
 
 
 
(b) 
 
Figure 2.4 White adipose tissue (WAT) as an endocrine organ and its involvement in 
physiological and metabolic processes of the body (Coelho et al., 2013). 
The most significant physiological functions of WAT (a) and some of the factors secreted by WAT 
(b). 
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Leptin was one of the first peptide hormone discovered to be primarily secreted by mature 
adipocytes, and it has various biological activities, including effects on appetite, food intake and 
body weight regulation, fertility, reproduction and haematopoiesis (Chan et al., 2006). In addition, 
adipose tissue secretes a variety of peptides, cytokines and complement factors, which act in an 
autocrine and paracrine manner to regulate adipocyte metabolism and growth, as well as endocrine 
signals to regulate energy homeostasis. Adipose tissue is an important site for oestrogen 
biosynthesis and steroid hormone storage. Adipose tissue is also a major site for metabolism of sex 
steroids and glucocorticoid steroids (Mohamed-Ali et al., 1998). Alteration of WAT function with 
subsequent dysfunctional expression and secretion of adipokines plays a key role in the 
pathogenesis of obesity, diabetes, and other metabolic diseases (Armani et al., 2010). 
 
Avian WAT differ from those of mammals since it has only a limited capacity for lipogenesis. 
Avian white adipocytes depend on the capture of circulating lipids synthesized in the liver or 
released by digestion in the gut (Stettenheim, 2000). Moreover, growth of the abdominal WAT in 
chickens is from a combination of adipose cell hyperplasia (increase in adipocyte number) and 
hypertrophy (increase in adipocyte volume) up to about 12 to 14 weeks, then it continues mainly by 
hypertrophy (Ji et al., 2012). The endocrine role of avian WAT remains enigmatic as many of the 
classical hormones found in mammalian adipose tissue have not been found in avians 
(Ramachandran et al., 2013). 
 
2.2.4  Regulation of lipid metabolism in the laying hen    
 
In animals and humans, appetitive drive and food intake are affected by signals from inside the 
body and the environment and are under hormonal control together with sympathetic and 
parasympathetic nervous system inputs (Berthoud, 2008).  Environmental signals affecting food 
intake interact almost exclusively with corticolimbic brain areas (especially with hypothalamic and 
brainstem structures involved in the control of food intake and energy balance) and are modulated 
by metabolic signals (Berthoud, 2012). In this way, metabolic pathways and metabolites produced 
by them are integrated into the regulation of feed intake and energy metabolism. Regulation of fatty 
acid metabolism depends on energy status and changes in various hormones such as insulin, 
glucagon and catecholamines (Berthoud, 2012).  
Relatively little is known about regulation of adipose tissue deposition and metabolism in chickens 
(Ji et al., 2012). Most studies have focused on broilers, and have shown that adipose tissue 
metabolism in the chicken is regulated by energy status and, to a lesser extent by insulin. Unlike in 
mammals, insulin has minimal effect on glucose uptake in chicken adipose tissue (Tokushima et al., 
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2005). Insulin does, however, stimulate uptake of acetate, which is the preferred substrate for de 
novo lipogenesis in chicken adipocytes, although the magnitude of the effect is relatively modest 
(Montes et al., 1981). Insulin also does not inhibit lipolysis in chicken adipose tissue; glucagon is 
the primary lipolytic hormone (Scanes, 2009). 
 
Very little is also known about the regulation of lipoprotein synthesis and secretion in avian liver, at 
least in growing birds. Tarlow et al. (1977) used chicken hepatocytes and demonstrated that insulin 
enhances both de novo lipogenesis and VLDL synthesis, whereas thyroxine and glucagon have 
opposite effects. However, lipid secretion as lipoproteins may be not tightly coordinated with lipid 
synthesis. There is a lack of information on the hormonal regulation of LPL in birds. In fed 
mammals, LPL activity is enhanced in adipose tissue but is low in muscle, which results in fat 
storage. The opposite is seen in unfed animals. In birds, LPL regulation in adipose tissue seems to 
be less sensitive to the nutritional state (Hermier, 1997). Very high concentrations of insulin, fat 
feeding and refeeding  stimulate LPL activity in chicken adipose tissue; however it has been shown 
that differences in LPL activity are not related to differences in rate of body fat deposition (Borron 
et al., 1979). 
 
2.2.5  Disorders of lipid metabolism in the laying hen     
 
Disorders of lipid metabolism are a group of metabolic diseases that occur in a variety of species 
including chickens. Disturbance in lipid and lipoprotein metabolism are associated with 
abnormalities of lipid storage and lipid mobilization. Hyperlipidemias are of clinical relevance not 
only in humans but also in chickens, since they constitute an important risk factor for the 
development of hepatic lipidosis and subsequent diseases, such as vascular and heart disease or 
FLHS, respectively. Specific lipids accumulate due to the lack of corresponding degradative 
enzymes (Schulze et al., 2009). Since enzymes also require vitamins and co-factors to properly 
function, nutritional deficiencies can also be a factor that influences lipid metabolism.  
 
Lipid metabolic disorders affect the hepatocyte‘s ability to digest, process, and synthesize essential 
compounds. Although, there are many factors (i.e. nutritional, genetic, and environmental) that 
initiate the accumulation of fat in the liver, in many cases the increase in liver lipid synthesis is not 
accompanied by equivalent increases in lipid outflow, resulting in lipid accumulation. Fatty liver 
disorder is a reversible condition where large vacuoles of triglyceride fat accumulate in liver cells 
via the process of steatosis (Brunt, 2010). Fatty liver syndromes in birds (i.e. hepatic steatosis or 
hepatic lipidosis) have all been used to describe the condition of fatty infiltration of the liver 
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(Crespo and Shivaprasad, 2003). It occurs in laying hens when the increase in lipogenesis exceeds 
the capacity of synthesis and secretion of lipoproteins, especially when hens are fed a low protein 
and high calorie diet. In this case a dramatic enhancement of lipogenesis by oestrogen is responsible 
for an increase in VLDL secretion (Squires and Leeson, 1988).  
 
Hepatic steatosis is frequently confused with FLHS however the two conditions are quite different 
(Diaz et al., 1994). Hepatic steatosis causes a drop in egg production but little increase in mortality; 
FLHS causes increased mortality due to liver haemorrhage and hypovolemic shock. Moreover, 
hepatic steatosis is caused due to a specific accumulation of triglyceride within the parenchymal 
cells. The reason why neo-synthesised triglycerides are channeled towards intracytoplasmic storage 
rather than secretion remains unclear (Hermier, 1997). It is possible that, because the overfed 
chickens are never deprived of food, hormonal regulation does not allow the liver to secrete the 
excess of triglycerides, which continue to accumulate (Hermier et al., 1989). The degree of steatosis 
might vary being an apparent predisposing factor for FLHS (Polin and Wolford, 1977). Excessive 
hepatic lipid in certain instances leads to the development of fatty liver which is accompanied by 
liver haemorrhage.   
 
For more details on FLHS see Chapter 2.4.  
 
2.3  A review of the liver and liver diseases in the laying hen 
 
2.3.1 Introduction         
 
As in mammals, in birds the liver is the biochemical factory responsible for most of the synthesis, 
metabolism, excretion, and detoxification processes, and is involved with many metabolic and 
homeostatic functions. It plays an important role in digestion and metabolism, regulating the 
production, storage, and release of carbohydrates, lipids and proteins (Denbow, 2000). The liver 
produces a variety of proteins, including enzymes, hormones, blood proteins, clotting factors, and 
immune factors. Because it participates in so many vital functions, the liver in birds is frequently 
involved in many infectious and non-infectious diseases. 
 
2.3.2  The structure and function of the avian liver   
 
The liver in chickens is the largest internal organ, is firm, and has prominent sharply defined edges. 
In birds, as in mammals, the liver is a bilobed organ (Figure 2.5). The right lobe is larger, but both 
are joined cranially at the midline (Lumeij, 1994). Generally, the caudal border of the right lobe 
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extends to the edge of the sternum. In chickens, bile is transported to the duodenum via two ducts. 
The right hepatic duct and left hepatic duct combine to form the common hepatoenteric duct which 
then goes to the distal ascending loop of duodenum (Denbow, 2000). The avian liver has much less 
connective tissue than the mammalian liver, and it is larger than in mammals when compared to 
body size (Lumeij, 1994). The liver lobule is formed by parenchymal cells (hepatocytes) and non-
parenchymal cells. Hepatocytes occupy almost 80% of the total liver volume and perform numerous 
liver functions. Non-parenchymal liver cells are localised in the sinusoidal wall and consists of 
different cells: endothelial cells, immune cells and fat storing cells (Kmiec, 2001). The size and 
colour of the liver depends on age and body weight. The liver performs numerous physical, 
physiological and immunologic functions in birds (Figure 2.6). It functions as both an endocrine 
and exocrine gland (Denbow, 2000). 
 
           
(a)                                                            (b) 
Figure 2.5  Normal liver in the chicken 16 wk of age (a) and 30 wk of age (b). 
 
Bile acids secreted by liver function to emulsify fats and activate pancreatic lipase and amylase, all 
of each aid in digestion (Lumeij, 1994). Apart from metabolism of fats carbohydrates, proteins, and 
detoxification of drugs and toxins, the liver synthesises blood clotting proteins and proteins 
involved in immunity (acute-phase proteins and globulins). The significant involvement of the liver 
in controlling systemic innate immunity in avians is due to the fact that birds do not possess definite 
lymph nodes, rather they possess patches of lymphoid tissue, so that the role of the liver is crucial 
(Lumeij, 1994). Liver disease or damage, including hepatic lipidosis, may make a bird 
exceptionally susceptible to agents normally dealt with by the liver. In the case of hepatic lipidosis, 
normal liver cells are gradually being filled with fat, and these damaged cells can no longer function 
to perform the liver's work efficiently. As liver cells die, they are replaced with scar tissue or 
fibrous connective tissue (Hoerr, 1996).  
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Figure 2.6  The metabolic functions of the liver and the flow of products through the portal vein, hepatic artery, inferior vena cava and  
common bile duct, the location of central veins and portal tracts, as well as the direction of blood flow (Thomson and Knolle, 2010). 
36 
 
2.3.3 Liver diseases in laying hens     
 
Liver diseases (or hepatopathies) occur sporadically in laying hens. According to the aetiology 
some of the liver disorders (i.e. hepatitis) have been associated with infectious disease (bacteria, 
chlamydiosis, viruses, helminths and protozoa), non-infectious disease (such as heart disease 
complex and other metabolic disorders), gastrointestinal problems and toxins (mycotoxins, 
rapeseed, cotton seed and other toxic substances) and neoplasis (Lumeij, 1994). Many bacteria can 
cause hepatitis in birds including Borrelia, Escherichia coli, Salmonella typhimurium, 
Staphylococcus, Campylobacter, Pasteurella (Gerlach, 1994). Clinical signs may indicate liver 
disease which can be confirmed by liver functional tests and histologic examination of a liver 
biopsy (Grunkemeyer, 2010). However, the aetiology for many liver diseases cannot be determined. 
The distinction between primary and secondary hepatic disease is difficult but very important for 
the treatment (Jaensch, 2000). 
 
2.3.4 Clinical examination and functional tests of the liver   
 
Clinical signs of hepatopathies in birds are variable and can range from mild inappetence and 
inactivity to acute haemorrhage and death. The liver has a large functional reserve; therefore 
clinical signs can be observed only if a large proportion of liver tissue is affected (Hochleithner et 
al., 2006). Hepatic failure is associated with yellow or green faeces, poor feathering or colour 
changes (dark), diarrhoea and weight loss (Lumeij, 1994). Comparative studies have shown that the 
regenerative processes of the liver tissue in birds, as in the other vertebrates, are remarkable and are 
accomplished by regenerative hypertrophy; however, the original shape of the traumatized part is 
not restored (Sidorova, 1962). The destruction and regeneration of hepatic parenchyma results in 
fibrosis; therefore hepatic dysfunction can occur after severe injury or repeated significant damages 
(Hochleithner et al., 2006; Hoerr, 1996). At necropsy, the liver is the first and largest organ seen 
when the body cavity is opened. Many lesions in the liver might not be specific to the diagnosis, but 
provide important information about the general disease process. Changes in shape and colour can 
help to identify the cause of death (Jaensch, 2000). 
 
Microscopically, the unit of the liver is the lobule (Figure 2.7). Each lobule (or portal lobule) is 
bounded by four to five portal triads (supplied from the portal vein and hepatic artery) and has a 
central terminal hepatic venule (central vein). From a functional point of view the basic unit of the 
liver is the acinus (or zones of hepatocytes between central veins) (Malarkey et al., 2005). The 
acinus model (Figure 2.8) has at the centre the blood supply to liver parenchyma (portal triad), 
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rather than the venous drainage (central vein) (Godoy et al., 2013). Hepatocytes make up the bulk 
of the organ (80%). They are arranged in plates that radiate out from each portal triad toward 
adjacent central veins. The bile canaliculus is formed by grooves on the contact surface of adjacent 
liver cells. Bile forms in these canaliculi and progressively flows into ductules, interlobular bile 
ducts and then larger hepatic ducts (Denbow, 2000). 
 
 
 
 
 
 
 
Figure 2.7 The lobule model shown in a normal microscopic view of laying hen liver. 
Hepatocytes (H), central vein (CV), hepatic venule (HV), and bile ductile (BD). 
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Figure 2.8 The acinus model shown in a normal microscopic view of avian liver. 
The basic functional unit of the liver, the hepatic acinus with hepatocytes (H), portal/hepatic triad 
(HT), and central veins (CV).  
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Endothelial cells of the liver lack a basement membrane and contain numerous fenestrae that permit 
hepatocytes to have ready access to nutrients and macromolecules in plasma. Endothelial cells are 
also responsible for endocytosis of molecules and particles, and play a role in lipoprotein 
metabolism (Hochleithner et al., 2006). Microvacuoles of fat in the hepatocytes of chicks in the first 
week of life, and in laying hens are normal (Cherian, 2007). It is arguable what can be considered as 
a normal or excessive (pathologic) amount of fat in the liver of a laying hen (Butler, 1976). 
 
Percutaneous liver biopsy provides important diagnostic information at relatively low risk, but is 
needed in only a minority of cases of hepatic dysfunction. A small core of liver tissue can be 
obtained by needle aspiration under local anaesthesia (Lumeij, 2008). This usually provides a 
reliable reflection of the underlying disorder, although it is only a cytologic sample, and it is usually 
inadequate for full histological assessment (Jaensch, 2000). 
 
Determination of a panel of plasma enzymes is often referred to as liver function testing. This is a 
misleading use of this term, because plasma enzyme concentrations primarily reflect the degree of 
hepatocellular damage and leakage, not hepatic function, and in many cases may indicate damage 
to, or dysfunction of, other organs or tissues (Jaensch, 2000). Enzyme panels may include any of 
alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), 
alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), glutamyl dehydrogenase (GLDH) 
and creatinine kinase (CK) (Lumeij, 2008). The level of serum ALT activity reflects damage to 
hepatocytes and is considered to be a highly sensitive and fairly specific preclinical and clinical 
biomarker of hepatopathology (Ozer et al., 2008). Serum AST and CK activity is considered a less 
specific biomarker of liver function compared to ALT activity. Serum GLDH activity increases 
with hepatocellular damage.  
 
Liver function tests provide information on clearance and metabolizing ability or synthesizing 
ability of the liver (Jaensch, 2000). Synthesizing ability can be assessed by bile acids, plasma 
albumin concentrations or assay of clotting factors (Hochleithner et al., 2006). In conclusion, no 
single test can assess overall hepatic function, as the liver is a complex organ with interdependent 
metabolic, excretory and defence functions. A number of laboratory tests are usually combined to 
detect hepatic abnormalities, assess their severity, follow the course of the disease, and help 
establish an aetiology and treatment. 
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2.4  Fatty liver haemorrhagic syndrome in the laying hen 
 
2.4.1 The aetiology of FLHS  
 
Many studies have tried to identify the aetiology of FLHS; however it is still poorly understood. 
Important factors that have been considered as contributors into the aetiology of the FLHS are 
discussed below.  
 
Nutritional factors 
 
It has been previously recognised that feeding high producing hens (whose exercise is restricted) 
high-energy diets will result in the development of fatty livers and potentially FLHS (Akiba et al., 
1982; Butler, 1976). However, excessive consumption of feed in hens does not always result in a 
positive energy balance and increased fat deposition in the liver. The fact that FLHS can be 
experimentally induced through force-feeding and or oestrogen administration indicates that the 
condition might be caused by an excess of energy rather than being specific to an excess of any 
nutrient such as fat or carbohydrate (Squires and Leeson, 1988). Butler (1975) suggested that excess 
fat in the liver arises mainly from increased lipogenesis rather than from dietary lipids. Other 
studies have indicated that high energy diets, especially maize or wheat diets produce higher 
incidences of FLHS (Haghighi-Rad and Polin, 1982b; Pearson et al., 1978a; Polin and Wolford, 
1976).   
      
Other dietary factors 
 
Dietary factors other than excessive caloric intake, such as toxins and rapeseed products have been 
shown to stimulate lipogenesis  (Pearson et al., 1978b). There is evidence that mycotoxins 
(aflatoxin in particular) which may contaminate cereals induce liver lipid accumulation (Bryden et 
al., 1979). Rapeseed meal in the diet increases the incidence of FLHS because erucic acid or other 
toxic metabolites affect the strength of the connective tissue in the liver (Bhatnagar et al., 1980; 
Martland et al., 1984). Hens overfed a purified diet had a 33% incidence of FLHS (Walzem et al., 
1993). Branton et al. (1995) observed a high incidence of FLHS in hens that consumed diets 
containing chelated minerals. 
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Hormonal factors 
 
It has been shown that high oestrogen levels result in increased feed intake and subsequently in a 
positive energy balance.  High producing birds within a flock are most often affected by FLHS 
(Scheele, 1997), most probably due to a relationship between energy metabolism and hormone 
levels during egg production. Oestrogens influence lipid synthesis which is required for the yolk 
(Walzem et al., 1999). Polin and Wolford (1977) indicated that the haemorrhage score in liver was 
markedly increased when excess energy intake was combined with exogenous oestrogen treatment. 
The possibility of a hormonal imbalance has been suggested by the observation of greatly elevated 
serum calcium and cholesterol in chickens from flocks with FLHS (Branton et al., 1995; Harms and 
Simpson, 1979; Miles et al., 1983). 
 
Genetic factors 
 
There is little proof of the genetic strain influencing the occurrence of FLHS in a layer flock. 
Experimental studies have indicated that Rhode Island Red hens are more sensitive to experimental 
induction of FLHS than White Leghorn hens (Stake et al., 1981). It has also been suggested that 
some strains of laying hens are naturally more susceptible to FLHS (heavy and higher producing 
breeder hens) (Couch, 1956). Moreover, a strain of single comb white leghorn laying hens (UCD-
003) has been shown to be highly susceptible to FLHS (Abplanalp and Napolitano, 1987). 
Differences between genetically lean and fat chickens are by nature polygenic, and it is obvious that 
tendency to leanness or fatness in poultry relies on fundamental metabolic differences in the 
partitioning of nutrients, in which hormones are likely to play a major role (Squires and Leeson, 
1988). 
 
Housing and environmental temperature 
 
A high prevalence of FLHS in caged birds is thought to be related to the lack of exercise combined 
with a high feed intake in this housing system (Jensen et al., 1976a; Shini et al., 2006; 
Weitzenburger et al., 2005). There are other factors that have been considered to influence the 
prevalence of FLHS in caged birds, especially temperature. Most investigators have shown that 
increased lipogenesis occurs partly due to an excessive intake of carbohydrate brought about by hot 
weather (Couch, 1956; Pearson and Butler, 1978a). Jensen et al. (1976b) observed more FLHS in 
warmer vs. cooler regions of Georgia, whereas it is known that feed intake is attenuated at high 
temperature, and increased in cold temperatures. It should be noted that exposure to cold or heat 
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(stress) stimulates lipolysis in the domestic fowl (Annison, 1983). There is evidence that the 
injection of adrenocorticotropic hormone (ACTH) also produces a similar response (Jaussi et al., 
1962).  
 
Stress 
 
As mentioned above, stressful conditions (physical, chemical and biological stresses) activate a 
coordinated neuroendocrine response associated with increased levels of stress hormones, including 
catcholamines and ACTH; ACTH is controlled mainly by corticotropin release hormone (CRH). 
When the 4-wk-old and 8-wk-old chickens were treated with one administration of ACTH 
(Breitenbach, 1962), the secretion of corticosteroids increased. The glucocorticoid levels were 
increased from 17 to 22 μg % 1h after ACTH injection. The studies of Hillman et al. (1985) 
confirmed that experimental stress affected the secretion of corticosterone and its concentrations in 
the plasma.  
 
When administered with corticosterone, the hepatic lipids increased (Bartov, 1982). Clark and Das 
(1974) reported that the hepatic tissue of heat stressed chickens had a fatty, pale appearance, with 
small areas of haemorrhage similar to the appearance the FLHS. However, while the birds were 
kept at 21 to 38ºC, the liver weight did not change. There are other investigators that have 
demonstrated that the stress associated with high temperature and humidity of the environment 
affect the liver of hens and predisposes them to FLHS (Akiba et al., 1983; Ayo et al., 2011; Pearson 
and Butler, 1978a)  
 
Bacterial endotoxins 
 
The possibility of implication of bacterial endotoxins in the pathogenesis of fatty liver 
haemorrhagic syndrome in the laying hen was investigated by Curtis et al. (1980); Pearson et al. 
(1981), who showed that the haemorrhage was not ameliorated by suppressing enteric bacteria with 
neomycin or exacerbated by the repeated injection of Escherichia coli O111 endotoxin. It was also 
decided that the steatosis does not impair the ability of the liver to inactivate endotoxins of enteric 
bacteria and that these toxins were not involved in the pathogenesis of the syndrome. More recent 
data from humans and rodents indicate involvement of inflammation in the pathogenesis of fatty 
liver disorders and a contribution of the gut microbiota to the development of non-alcoholic fatty 
liver disease (NAFLD) (Alisi et al., 2012; Le Roy et al., 2013).  
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2.4.2 New insights into the aetiopathophysiology of NAFLD in humans 
 
Recent evidence indicates that the integration of metabolic, immune and inflammatory pathways is 
crucial, and dysfunction may underlie many chronic metabolic diseases, including NAFLD, which 
is the major cause of abnormal liver function in humans, and often associated with obesity and 
diabetes (Qureshi and Abrams, 2007; Tilg and Moschen, 2008).  
 
Adipose tissue and the liver constitute an interesting organ pair that is in constant communication 
with each other via adipokines, lipid factors, and lipoprotein particles. One of the first organs to be 
affected when adipose tissue becomes dysfunctional and inflamed is the liver (Attie and Scherer, 
2009). A great majority of NAFLD cases occur in patients who are obese, and have enhanced 
dietary fat delivery and physical inactivity. Altered physiology of adipose tissue is seen as central to 
development of insulin resistance, metabolic syndrome and NAFLD (Attie and Scherer, 2009; 
Qureshi and Abrams, 2007). Similar metabolic disorders (hepatic lipidosis and FLHS) that occur in 
caged laying hens are also associated with diet, increased feed intake, high egg production and lack 
of exercise.  
 
Lipid accumulation in the liver is the early and relevant pathophysiological step of the development 
of NAFLD, which remains a benign condition in most affected individuals (Kirovski et al., 2010). 
The proinflammatory state in the liver observed in NAFLD is regulated by an imbalance of various 
cytokines, transcription factors and adipocytokines (Tilg and Moschen, 2008). A hallmark of 
NAFLD is that fat accumulation and inflammatory processes are taking place in parallel and, 
therefore, a better understanding of such pathways is crucial. Another mystery in human studies is 
why simple steatosis remains a benign condition in most affected individuals, and why transition to 
an inflammatory condition, such as NASH, takes place. 
 
2.4.3  Clinical and pathological aspects of FLHS in laying hens  
 
First changes in the liver can be observed at the onset of the reproductive period, and are related to 
the increase in synthesis of lipids and proteins destined for the egg-yolk. However, no clinical signs 
are detected at this stage. The most profound changes occur at or after the peak of lay (from 35 to 
40 wk of age) most probably induced by oestrogen persistence throughout the laying period; at this 
stage clinical signs like increased BW, reduced egg production, sudden deaths, or hens with pale 
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combs and becoming lethargic can be recorded in a flock (Grimes et al., 1991; Harms et al., 1972; 
Julian, 2005; Squires and Leeson, 1988; Walzem et al., 1993). 
 
On post-mortem examination, attention is initially focussed on the extreme accumulation of fat in 
the abdominal cavity and the visceral regions (Butler, 1976; Scheele, 1997). The liver is enlarged, 
rounded and very fragile; its colour varies from light brown to yellow (Crespo and Shivaprasad, 
2003; Hoerr, 1996). In the liver parenchyme numerous capillary bleedings (haemorrhages), varying 
in size, can be observed (Couch, 1956; Hoerr, 1996). These haemorrhages may extend to the 
surface, or can form hematomas under the liver capsule. Mortality occurs when the degeneration of 
the liver tissue results in a rupture of the liver capsule, causing a fatal internal bleeding.  
 
Microscopic examination of the livers from hens with FLHS may show liver cells containing 
diffuse small fat droplets. More often, liver cells contain large droplets or one large fat vacuole that 
almost completely covers the cytoplasm and causes a change of cell colour and a displacement and 
deformation of the nucleus (Cherian and Goeger, 2004; Hoerr, 1996; Jaensch, 2000; Walzem et al., 
1993). 
 
2.4.4  Experimental approaches to studying FLHS in a chicken model 
 
There have been a number of attempts to reproduce FLHS in chickens and study the involvement of 
oestrogen and feed intake in the pathogenesis of FLHS. Polin and Wolford (1977) induced FLHS in 
immature male and female chickens, 11 weeks of age, of broiler and egg-laying breeds by force-
feeding birds three times a day for 21 days, amounts of feed equal to 125% and 150% of ad libitum 
intake, and produced a gradient response in hepatic steatosis (as measured by percentage of fat in 
the liver, and the ratio of fat to the fat-free dry weight of the liver). However, they were not able to 
reproduce FLHS. Intramuscular injections of β-estradiol-17-dipropionate (E2) at 2 mg/kg body 
weight, three times weekly for 21 days, produced a gradient response in haemorrhagic score, and an 
increase in ad libitum feed intake. Polin and Wolford (1977) did not find any significant difference 
between sex or breed in the score values used to evaluate FLHS, but females of both breeds 
accumulated significantly more fat in the liver than males. Their studies showed that oestrogen is 
implicated in the production of FLHS, along with the necessity for the chicken to be in a positive 
energy balance induced FLHS to occur.  
 
Stake et al. (1981) used i.m.  administration of E2 every 4 or 5 days (5.0 or 7.5 mg E2/kg body 
weight) to induce FLHS in both Rhode Island Red (RIR), and White Leghorn (WL) hens. RIR hens 
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exhibited ataxia and opisthotonus, and 30% died from hepatic haemorrhage within 14 days. No WL 
birds similarly treated for 32 days died or showed neurologic disorder, thereby indicating a major 
breed difference in response to exogenous E2. 
 
Other investigators have shown that exogenous E2 combined or not with an increase in feed intake 
or use of high energy diets can induce fatty liver in immature, mature or older birds (Akiba et al., 
1983; Balnave, 1971; Chawak et al., 1997; Haghighi-Rad and Polin, 1981, 1982a; Harms et al., 
1977; Martland et al., 1984; Pearson and Butler, 1978b; Schumann et al., 2003; Walzem et al., 
1993; Yamashiro et al., 1975). It is thought that the induction of FLHS in mature layers may be a 
better model to study the pathogenesis as FLHS is more often observed in high producing layers. 
 
2.4.5 Monitoring and control of FLHS in laying flocks 
 
Since the first descriptions of the FLHS in 50s, monitoring and preventive strategies have been 
searched. Various aspects of nutrition have been regarded in terms of diet restrictions and diet 
manipulations, with little or no success. 
 
There is no evidence about any attempt to conduct regular monitoring of laying flocks for FLHS. 
Most of the investigators suggest regular monitoring of BW, egg production and mortality rates, as 
these records may indicate the presence of FLHS in a flock. While mortality may be low, the 
number of subclinical cases of FLHS could be much higher. Many hens experience excessive fatty 
liver or liver haemorrhages but not all die from FLHS. Hens that survive from moderate hepatic 
haemorrhages or haematomas located within the subcapsular membrane of liver continue to live 
with or without a decline in egg production. Overweight hens are predisposed to FLHS (Couch, 
1956), in particular hens  with body weights heavier than the breeder‘s recommendation for their 
age and phase of production are more susceptible to FLHS (Meijering, 1979). In the case of natural 
outbreaks of FLHS, hens that do not die suddenly exhibit pale combs (Grimes et al., 1991; Harms et 
al., 1972). However, it has been shown that hens with normal comb colour still had liver 
haemorrhage, indicating that comb appearance alone is not completely indicative of FLHS. No 
definitive diagnostic criterion has been determined for FLHS in live birds, so the diagnosis is 
usually made at necropsy (Couch, 1956; Grimes et al., 1991; Meijering, 1979; Squires and Leeson, 
1988; Thomson et al., 2003). 
 
If lipogenesis exceeds the capacity of VLDL secretion, triglycerides accumulate in the liver. One 
way to reduce FLHS could be the control of VLDL production. Previous investigators have 
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undertaken nutritional trials to reduce lipogenesis (e.g. a partial replacement of dietary energy by 
protein) and subsequent fattening, which have been shown to be effective, but high-priced 
(Hermier, 1997). Other attempts have been made to restrict the energy intake (i.e. restricting feed 
intake). A severe feed restriction (80 % of the intake of the control group) during six weeks resulted 
in a drop in body weight, weight of the abdominal fat pad, liver weight and mean liver fat content 
(Polin and Wolford, 1976; Wolford and Murphy, 1972; Wolford and Polin, 1974). Despite the 
positive effect of restricted feed intake on reducing FLHS, this preventive measure was found less 
suited, due to difficulties in setting the level of restriction in practical situations. Reduction of the 
energy content of the feed from 2900 to 2400 kcal ME/kg reduced liver fat content (Wolford and 
Murphy, 1972). Adding a variety of lipotropic compounds, fatty liver supplements or antioxidants 
to the diet for their protective effects on the liver has been shown to be effective in controlling 
FLHS in hens (Diaz et al., 1994; Harms et al., 1982; Spurlock and Savage, 1993; Wolford and 
Polin, 1975; Yeh et al., 2009). 
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2.5  Concluding remarks         
 
Although each metabolic disorder has unique predisposing factors, increased productivity, either 
as egg output or growth, is a common factor (Leeson, 2007). 
 
Due to advances in genetic selection, nutrition, and other management practices, the ―modern 
laying hen‖ demonstrating improved metabolic and egg production phenotypes might experience 
failure of a body system because of the increased work-load on an organ or system such as the liver 
(Julian, 2005). The liver is the major site of synthesis of lipids and the majority of proteins, 
including enzymes, hormones, blood proteins, clotting factors, and immune factors are synthetised 
in the hepatocytes. When hepatic lipogenesis exceeds the capacity of VLDL secretion, triglycerides 
accumulate in the liver, causing steatosis. The balance between synthesis and secretion of VLDL is 
therefore a key point that may regulate hepatic and extrahepatic fat in poultry (Hermier, 1997).  
 
As described in this review, the laying hen appears to develop fatty liver under conditions of excess 
energy intake. Additionally, other environmental factors provide a possible influence in terms of 
alteration of liver function and lipid utilisation, and therefore mediate the accumulation of fat in the 
liver predisposing laying hens to FLHS. Despite its obvious importance, the aetiology of FLHS is 
not been clearly defined and the pathogenesis is poorly understood. Moreover, no definitive 
diagnosis criteria have been determined for live birds.  
 
Previous studies (Polin and Wolford, 1977; Stake et al., 1981) implicate oestrogen as a factor in the 
production of FLHS along with the necessity for the chicken to be in a positive energy balance 
creating sufficient hepatic fat for FLHS to occur. These studies used immature chicken as a model 
to induce FLHS. The induction of FLHS in mature hens may prove to be more useful than younger 
hens, since FLHS is commonly observed in high producing layers. Recent studies in humans have 
provided new information regarding communication between adipose tissue and the liver via 
adipokines and other molecular factors. The liver is the first organ to be affected when adipose 
tissue becomes dysfunctional and inflamed, initially undergoing a proinflammatory state followed 
by inflammatory processes. With respect to this in chickens, it will be important to study the 
pathogenesis of FLHS in a reproduced laying hen model to see if certain molecular factors 
influence fat accumulation and inflammatory processes in the liver of affected hens. Moreover, it 
will be intriguing to understand why only some laying hens develop FLHS, while all of them have 
fatty livers. 
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3.1  Birds and bird care  
 
3.1.1 Laying hens and housing conditions 
 
For the first study, hens (Hy-Line Brown layers) were housed in three different housing systems: 
conventional cages (in a controlled environment shed), free range and barn systems. Detailed 
information on the housing conditions is given in Chapter 4. Production and health parameters were 
recorded for 52 weeks. Husbandry procedures were similar for all birds, and the same personnel 
were responsible for handling birds in all housing systems.  
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For the second study, the questionnaire was sent out to 20 registered farms in Queensland, and data 
were collected from birds used and kept in these farms. For the epidemiological study, birds of 
three farms involved in the monitoring were kept at their respective farms. Samples were collected 
on site while data on performance were provided by producers (see Chapter 5 for more details).   
 
For experiments 3 and 4 (Chapters, 6 and 7, respectively), Hy-Line Brown laying hens were used. 
Pullets, 17 wk old birds, were housed in a controlled shed (at the Layer Facility, Poultry Unit at the 
Gatton Campus, University of Queensland). Hens were housed individually in stainless steel cages 
and kept in a climate controlled environment. The temperature of the shed ranged from 22ºC to 
24ºC, and hens were exposed to a photoperiodic lighting 16 hours of light: 8 hours of dark. Hens 
were kept in the shed until they were 30 wk of age and then used to reproduce FLHS.  
 
In all experiments, husbandry and care were in accordance with the animal welfare guidelines 
established at University of Queensland, and with ethical clearance obtained by the University 
Animal Ethics Committee, approval numbers SAS/871/07, and SAS/842/08.  
 
3.1.2 Diets 
 
Commercial layer diets and water were available ad libitum in all experiments. Details of the diet 
used in 3 farms during the epidemiological survey (Chapter 5) appear in Appendix 1, and for all 
other experiments carried out at Gatton in Appendix 2. For the investigations of FLHS in different 
housing systems, layers in all systems were fed the same commercial diet (Appendix 2). In all 
systems, feed and water were available ad libitum for consumption. 
 
3.2 Collection of samples  
 
3.2.1 Blood 
 
For all experiments blood samples were taken in the morning between 8:00 and 10:00 a.m., 
immediately after each hen had been removed from its cage. Each bird was appropriately restrained 
to ensure as little stress as possible on the bird; the entire procedure did not take longer than 45 to 
50 s.  
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For haematological analyses whole blood was used and samples were taken from the wing vein 
using individual EDTA vacutainers and individual blood tubes. For the oestradiol assay and 
metabolite profile, blood samples were centrifuged at 1500X g for 10 min and plasma was divided 
into three aliquots and stored at -20°C until subsequently analysed.  
 
3.2.2 Organs 
 
For studies in Chapter 6 and 7, hens were euthanised by cervical dislocation and subjected to post-
mortem examination. After dissection, liver, ovary, and oviduct were removed and weighed. The 
absolute and relative weights (organ weight to body weight ratio) of organs were calculated. Liver 
samples were used to prepare slides for histology examinations. 
 
3.2.3 Eggs 
 
Eggs were collected daily. Egg production was calculated per day as hen-day production (HDP) or 
number of eggs produced per day and expressed as percentage. The following measures of egg 
quality were determined: egg weight, shell thickness, shell weight, albumen height (from which 
Haugh Units were calculated), and yolk colour score (Roche Egg Yolk Colour Fan, Switzerland).  
 
 
3.3 Methods  
 
3.3.1 Oestradiol determination   
 
Principle of the test 
 
The procedure follows the basic principle of radioimmunoassay (RIA) where there is competition 
between a radioactive and a non-radioactive antigen for a fixed number of antibody binding sites. 
The amount of [I-125]-labelled oestradiol bound to the antibody is inversely proportional to the 
concentration of the oestradiol present in the sample. The separation of free and bound antigen is 
easily and rapidly achieved by using a double antibody system. 
 
Plasma 17-β oestradiol concentration was determined by RIA kit using coated tube technology 
(Spectria, Orion Diagnostica Oy, Finland). The RIA was conducted according to the manufacturer‘s 
instructions using duplicate 200 μL samples in assays. Samples were counted on a Gamma Counter 
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(Wallac 1470 Wizard Automatic). At 394 and 9,520 pmol/L the inter-assay variations were 5.1 and 
8 % respectively, and the intra-assay coefficient of variation was 4.33%. The assay sensitivity 
ranged between 30-15,000 pmol/L. The antiserum was highly specific for 17-β oestradiol with a 
relatively low cross reactivity to other naturally occurring steroids in the plasma sample as stated by 
the manufacturer. 
 
Assay procedure 
 
All (samples standards, controls and unknowns were assayed in duplicates).  
 
1. 200 μL of the standards, controls or unknowns were added to appropriate tubes. 300 μL of the 0 
pg/mL oestradiol standard was added to Non-Specific Binding (NSB) tubes. 
2. 100 μL of oestradiol antiserum was added to all tubes except NSB and total count tubes. 
3. All tubes were vortexed, covered and incubated at room temperature (25°C) for 1 hour. 
4. 100 μL of oestradiol [I-125] reagent was added to each tube. 
5. All tubes were vortexed, covered and incubated at room temperature (25°C) for 2 hours. 
6. 1 mL of precipitating reagent was added to all tubes except total count tubes. Tubes were 
vortexed and allowed to stand at room temperature (25°C) for 15-20 minutes. 
7. All tubes were centrifuged (refrigerated), for 15-20 minutes at 1500 x g, except the total count 
tubes.  
8. The content was decanted from all tubes (except total count tubes) by simultaneous inversion 
with a sponge rack into a radioactive waste receptacle.  
9. Tubes were allowed to drain on absorbent material for 15-30 seconds and gently blotted to 
remove any droplets adhering to the rim before returning them to the upright position.  
10. All tubes were counted in a gamma counter for one minute. 
 
Calculation of results 
 
The mean of duplicate determinations were calculated for all calibrators, samples and controls, and 
then the bound radioactivity (%B/B0) was calculated from the following formula: 
 
count calibrator 0
 x100count) sampleor r (calibrato
%B/B0   
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A calibration curve was constructed and the oestradiol concentrations of the unknowns were 
determined from the standard curve (Figure 3.1) and expressed as pmol/L and then converted in 
pg/mL plasma. 
 
 
 
Figure 3.1  Oestradiol calibration curve  
 
3.3.2 Measurement of metabolic parameters 
In order to fully assess the condition of a liver, one must consider four groups of plasma 
metabolites: lipids, carbohydrates, proteins, and enzymes. Hence, plasma metabolites, such as 
cholesterol (CHOL), triglycerides (TG), total protein (TP), glucose (GLU), gamma glutamyl 
transferase (GGT), aspartate aminotransferase (AST) were determined. Not all metabolites were 
measured in all experiments; for each experiment important metabolites were targeted and 
measured in samples. To measure these metabolites in plasma, commercial kits and a chemistry 
system (VetTest chemistry analyser, IDEXX Laboratories, Inc. USA) were used. The instrument is 
based on dry chemical technology and colorimetric reaction. Dry-slide technology ensures that even 
compromised samples produce accurate results. Unique layers provide accurate results even on 
samples compromised by haemolysis or lipaemia (as it is the case of high levels of TG in avian 
female samples). 
 
Plasma fibrinogen content was determined by heat precipitation method (Schalm, 1980) using an 
automatic temperature compensated refractometer with protein scale. This test was performed only 
on EDTA samples. The fibrinogen concentration was calculated by the difference between two 
plasma protein measurements (total plasma protein and plasma protein concentration after 
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heating/incubating at 50°C which precipitates the fibrinogen). The difference is equivalent to the 
fibrinogen that was removed from the plasma in the second tube by heating and centrifuging. Data 
collected from the refractometer were determined in g/dl then results were multiplied by 1000 to 
obtain the fibrinogen measurement in mg/dl. 
 
3.3.3 Liver macroscopic evaluation 
 
The liver was removed and individually examined for the presence of haemorrhagic lesions. 
Haemorrhages were counted on both the dorsal and ventral surfaces of the liver. Liver 
haemorrhages were graded on a scale from 0 to 5, with 0 indicating no haemorrhages; 1, up to 10 
subcapsular petechial or ecchymotic haemorrhages; 2, more than 10 subcapsular petechial or 
ecchymotic haemorrhages; and 5, massive liver haemorrhage accompanied by rupture of the 
Glisson's capsule (Diaz et al., 1994). A haemorrhagic score of three to five was considered highly 
characteristic of FLHS (for details see Chapter 5.3.3). Two sections from the liver of each bird were 
dissected and used for histological tests. The remaining liver tissue was kept frozen (−20°C) for 
further lipid analysis. 
 
3.3.4 Liver histology  
 
Two slices of liver about 1 × 1 × 0.3 cm thick were taken from the right lobe of each hen, fixed in 
10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with haematoxylin and 
eosin (H&E) stain prior to microscopic examination. For each section of liver, randomly located 
areas were assessed using a light microscope (40x and 100x). A digital camera connected to the 
microscope was used to take pictures. Fat content was assessed by evaluating the incidence of fat 
vacuoles inside and between hepatocytes. A fat vacuole was considered to be any non-staining area 
of cytoplasm with a sharply defined border. Inflammation was determined as the occurrence of 
focal infiltration with leukocytes and haemorrhage was determined according to the dilatation of 
arteries and veins, and focal infiltration of liver tissue with RBC.   
 
3.3.5 Liver lipid content 
 
The lipid content of liver was determined by the method of Folch et al. (1957). One gram of sample 
was weighed into a screw-capped test tube with 20 mL of chloroform/methanol (2:1, vol/vol), and 
homogenized with a polytron (Type PT 10/35) for 5 to 10 s at high speed. After an overnight 
incubation at 4°C, the homogenate was filtered through Whatman #1 filter paper into a 100-mL 
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graduated cylinder, and 5 mL of 0.88% sodium chloride solution was added and mixed. After phase 
separation, the volume of lipid layer was recorded, and the top layer was completely drained off. 
Total lipids were determined gravimetrically after evaporating the solvent. The sample was then 
dried and weighed, and the total lipid weight was calculated, and expressed as the percentage of 
liver fat against the total liver weight. 
 
3.3.6 Quantitative analysis of cytokine gene expression in the liver 
 
The levels of cytokine gene expression in the liver were analysed, focusing on mRNA expression 
levels of Interleukin (IL)-1β, IL-6, and IL-18. The mRNA determination was carried out using real-
time qRT-PCR assays. Total RNA was extracted from samples using an RNeasy plus mini kit 
(Qiagen, Doncaster, VIC Australia), following the manufacturer‘s directions. Liver samples were 
stored at –80°C prior to mRNA measurements. For details on the protocol and mRNA fold-change 
calculation see Chapter 7.2.3. 
 
3.3.7 Haematological tests 
 
Whole blood was used to measure haematological parameters in an automated analyser (CELL-
DYN® System 3700CS, Abbott Park, IL 60064). Results obtained from the haematology analyser 
were used for the total number of red blood cells (RBC), white blood cells (WBC), packed cell 
volume or haematocrit (HCT) and haemoglobin (HGB) concentration. It was thought that these 
parameters would help to identify the presence of haemorrhage/haematoma in the liver or 
abdominal cavity. The RBC, HCT and HBG are decreased in haemorrhages and haematomas. The 
HCT is one of the most precise methods of determining the degree of dehydration and acute 
bleeding anaemia. The HGB should be evaluated with HCT and RBC to determine the type of 
anaemia. 
 
3.3.8 Examination of the ovary and oviduct 
 
At necropsy birds were examined for internal ovulations, internal oviposition, ovarian enlargement 
or regression and follicular atresia.  
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3.4 Data processing and statistical analysis  
 
In this section, only a brief overview of the used statistical methods is described. A more specific 
description of the statistical analysis can be found in each chapter. Statistical analyses were 
processed using SAS/STAT software, Version 8 of the SAS System for Windows (SAS Institute 
Inc, 2001). For experiment 4 statistical analyses on cytokine gene expression measurement were 
performed using the two tailed Student‘s t-test at the 99% confidence level (Microsoft Office Excel 
2010 v14.0). A degree of significance of 5% was used in all experiments and data are shown as 
mean ± SEM, or SD as specified in the tables and figures. Significant differences among 
treatments/groups are mainly determined using Duncan‘s multiple comparison tests, and 
correlations between different significant measures are determined using Pearson's correlation 
coefficient. For parameters measured repeatedly in time from the same chickens, a statistical model 
for repeated measurements in time was used. Other specific statistical tests are described in the 
respective chapter. 
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4.1  Introduction 
 
Worldwide, around 85% of the laying hens are housed in the conventional cage system (Windhorst, 
2011). In Australia, approximately 55% of eggs are produced in cage layer farms, with the balance 
coming from barn (9%) and free-range (34%) farms (AECL, 2011). It has been recognised that, 
typically, metabolic disorders such as FLHS cause loss to the industry through reduced productivity 
and increased mortality (Julian, 2005; Leeson, 2007; Scheele, 1997). Taking in consideration that 
more than 50% of Australia‘s layer flocks are caged, the investigation of the effect of housing 
system on causes of mortality in laying hens is of economic and ethical importance for Australian 
poultry industry. In particular, reviewing an ―old problem‖ for Queensland flocks such as FLHS 
was seen as a necessity.  
 
It should be mentioned that nutritional factors (i.e., total M.E intake per day) and non-nutritional 
factors such as genetics (with some strains being more susceptible) have been seen as primary 
factors implicated in the aetiology of FLHS (Squires and Leeson, 1988).  Nevertheless, in terms of 
space and microclimate conditions, housing system could be considered a very important factor, 
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because it may predispose hens to this metabolic disorder. It should be noted that the egg industry 
has progressively evolved from ―as a side-line or by-product in small family farms‖ (Poultry 
Tribune, 1900) to modern egg farming when hens are kept in battery cage systems. Before 1940, 
small backyard flocks of chickens made up the majority of the egg producing industry worldwide, 
and the cage system began to spread in the mid-to-late 1940s (United Egg Producers, 2014).  
 
As the poultry industry expanded in the 1950s, conventional cage egg production systems appeared 
to reduce disease and provided cleaner eggs. They proved to be more economically efficient as 
previous systems; the new systems were automated and more laying hens could be managed in less 
space (Mench et al., 2011). Over time, conventional cage systems have been heavily criticized for 
providing poor welfare for laying hens (Lay et al., 2011). Later on, many investigators started to 
demonstrate effects of cage housing of laying hens on bird health, and cage system housing was 
criticized as being a significant contributor to major metabolic diseases (Baxter, 1994; Craig and 
Swanson, 1994; Julian, 2005; Leeson, 2007; Scheele, 1997; Webster, 2004).  
 
The first classical description of a metabolic disorder was that of cage layer fatigue, recognized in 
1955 (Leeson, 2007; Webster, 2004). Over the past three decades, alternative housing, also known 
as the ―free range, barn raised, or perchery‖ has been introduced to the egg industry and a 
progressive shift, from conventional to alternative housing, has been seen in the last 20 years 
(Appleby et al., 2002; Elson, 2010; Hester, 2005; Lay et al., 2011; Tauson, 1998). However, to a 
certain degree it appears that no single housing system is ideal from a hen welfare perspective (Lay 
et al., 2011). Currently modern poultry industry is represented by both conventional and alternative 
intensive housing, which can be responsible for different health problems that are characteristic for 
hens kept in cages or floor, respectively (Rodenburg et al., 2005; Shimmura et al., 2010; Shini et al., 
2006; Weitzenburger et al., 2005).  
 
The aim of this study was to collect data on mortality and mortality causes of hens kept in cages 
and alternative housing systems, and evaluate the impact of different layer housing conditions on 
the occurrence of FLHS, and general health and welfare of hens.  
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4.2  Materials and methods 
 
4.2.1 Birds and bird husbandry 
 
The investigation was carried out at the Gatton layer facility, University of Queensland. This 
facility provides a unique resource for investigations in terms of management practices used in 
different housing systems (conventional cages, barn, and free-range) on laying hen production, 
health, welfare and profitability.  
 
Hy-Line Brown layers of the same hatch were housed under three different housing systems. Birds 
were reared on the same farm and under the same conditions as they were placed during the laying 
cycle (i.e. free-range birds were reared on range, barn birds reared in barns etc.), and subjected to 
the same diet, light and vaccination programs. Pullets were placed in the trial facilities at 17 weeks 
of age and fed a diet with the following specifications: CP - 17.5%; ME - 11.5 MJ/kg; Ca - 4.1%; 
Avail. P - 0.40%; Na - 0.18%; Lysine - 0.85%, Meth. + Cys.-0.77%. For details on diet see 
Appendix 2. Water and feed were provided ad libidum. Beak trimming was done at day old for all 
the caged layer hens and barn hens. In accordance with RSPCA recommendations, no beak 
trimming was done on the free range. Pullets had a constant 16:8 hour lighting program. 
 
4.2.2 Housing systems 
 
The free range system comprised three separated units located adjacent to each other which allowed 
a density of 5 hens/m2 of floor space or 600 hens per shed, 5 hens per nest boxes, 120mm of perch 
per hen, nipple drinkers and automatic feed chain feeders; hens had access to a grassed outdoor 
free-range area suitable for 1500 hens/hectare. The barn consisted of 3 pens each housing 600 hens 
at approximately 7 hens/m2 with 1/3 litter and 2/3 slatted floor with perches, automated nest box 
system, nipple drinkers and automatic feed chain feeders. Cages (Euro-vent, Big Dutchman, 6 
hen/cage) were located in an environmentally controlled shed with tunnel ventilation and a pad 
system for summer cooling and fan assisted heaters for winter. Cages were in three tiers (3 
replicates), with 48 units per tier, and in two rows back to back, holding 580 hens per replicate, and 
providing 550cm
2
/hen, and 2 x nipple drinkers/cage. 
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4.2.3 Determination of the mortality rate and mortality causes 
 
Data on cumulative mortality were collected from 19 to 70 wk of age. Mortality rate was calculated 
as a percentage of the initial number of hens in a flock using the formula: 
 
 
Mortality causes were determined from gross necropsy of birds that died between 30 to 62 weeks of 
age. Histological, bacteriological, parasitological and other laboratory examinations were not 
performed in this study. Only gross pathological findings were used to determine the cause of 
death. All dead birds were necropsied according to a routine protocol (see Appendix 3). Birds that 
died (or appeared sick and were euthanised) were collected daily, refrigerated and necropsied 
weekly. The results given here are only for necropsied bird (240); not all dead birds recorded during 
this period were necropsied (in total 263). Some dead birds were not found (missed) or their body 
was highly decomposed therefore the necropsy was not conducted. The findings at necropsy were 
recorded individually for every hen and assigned to the appropriate housing system. Other problems 
such as parasites and other pathologies that did not lead to death of hens (or did not present any 
reason to euthanise hens) are not included or discussed in this study.  
 
4.2.4 Performance parameters   
 
Data on egg production and body weights (BW) were collected from 19 to 70 wk of age. Body 
weight was measured monthly. Fifty birds from each pen in the free-range and barn systems, and all 
birds in each cage (6 hens) from 9 cages (54 birds per replicate) were weighed at each time point. 
The average for each replicate was calculated and presented as the mean ± SD.  
 
Eggs were collected daily between 09:30 and 12:30. The number of eggs laid in a flock is given as a 
percentage of hen-day production (%HDP) parameter, where hen-day is the number of hens alive in 
a house at a specific day over the whole observation period. Data on feed consumption were 
recorded inconsistently for all systems, and therefore not used in this study. 
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4.3  Statistics 
 
Data were subjected to one-way ANOVA for repeated measure tests (with housing system as the 
main factor), and SAS program (SAS Institute Inc, 2001) was used to test for null hypothesis that 
the housing system does not have any effect on hen performance and mortality. For further 
interpretation of data, General Linear Model (GLM) procedures were used. When significant 
differences were found, comparisons among systems were conducted by Duncan‘s multiple 
comparison tests. Statements of significance are based on P<0.05. Correlations between BW and 
mortality rate, and BW and %HDP for birds housed in cages were determined using Pearson 
correlation coefficients. The means (n=3) were calculated for each system and presented in Figures 
and Tables.   
 
 
4.4  Results 
 
4.4.1 Mortality rates and necropsy findings 
 
The average of mortality rate from 19 to 70 wk of age for hens housed in three different systems is 
presented in Table 4.1. The cumulative mortality at 70 wk of age and data on necropsy findings (i.e. 
causes of mortality) in conventional and alternative housing systems are presented in Table 4.2. At 
70 wk of age no significant differences (P=0.70) were found in mortality rates between different 
housing systems. The mean of cumulative mortality rate from the start of lay until 70 wk of age was 
6.1 %, 6.4 %, 5.8 %, respectively, for cages, barn and free range hens.  
 
However, the gross pathology findings showed that causes of mortality for birds in different 
systems were different. More interestingly, the necropsy results indicated that, from birds that died 
and were necropsied in the cage system, 74% died due to FLHS. The condition was recognised 
from internal haemorrhage or haematoma due to liver capsule rupture. An excessive amount of fat 
was found in the abdominal cavity and surrounding the liver of these birds. There were several 
birds from the cage system (7% of all dead necropsied birds) that showed prolapse (but not signs of 
cannibalism), while 5% of examined birds were pecked and died due to cannibalism. One bird, 
which appeared sick was euthanised and had blocked eggs in the abdomen (egg binding), while in 6 
cadavers the cause of death was unclear.  
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Table 4.1 Mortality rate and causes of death from necropsy findings in hens in different 
housing systems. 
Most common causes of death Conventional Barn Free range 
Mortality rate (%)
1 6.1 6.4 5.8 
N of birds examined 60 101 79 
1. Cannibalism in total (%) 
 -Vent 
- Body 
- Head 
5 
75 
25 
0 
59 
23 
66 
11 
77 
27 
70 
3 
2. Inflammation (%) 
- Salpingitis 
- Enteritis 
7 
7 
0 
11 
10 
1 
0 
0 
0 
3. Rupture of liver and fatty liver (%) 74 5 0 
4. Cachexia (%) 
 -Cachexia associated with ovarian inactivity 
0 
0 
8 
20 
14 
80 
5. Unclear cases (%) 11 17 9 
1
Cummulative mortality at 70 wk of age 
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Table 4.2  Egg production (%HDP) and mortality (%) in laying hens from 19 to 70 wk of  
age. 
Age (wk) %HDP
1 
Mortality (%)
1 
 CE FR BR CE FR BR 
19 16.5 3.6 3.6 0.00 0.00 0.14 
24 94.6 90.3 89.4 0.74 0.36 1.00 
28 92.9 88.6 89.8 0.88 0.57 1.24 
33 93.2 90.6 91.6 1.48 1.09 1.60 
37 91.7 87.0 90.9 1.93 1.51 1.70 
42 90.2 88.4 89.2 2.30 2.46 2.12 
46 87.3 86.3 87.1 2.83 2.83 2.72 
51 80.2 80.0 82.2 3.06 3.25 3.43 
55 80.7 75.0 76.7 3.82 3.78 3.86 
60 78.4 73.6 75.1 4.43 4.37 4.66 
65 75.5 65.6 71.5 5.20 4.86 5.33 
70 76.4 65.0 69.3 6.14 5.83 6.44 
1
Each value represents the average of data recorded from each unit (replicates, n=3) calculated on the basis of number 
of hens at each unit at each time point.  
 
 
In the barn system, the examination of dead hens showed that the cause of death in 59% of all cases 
was due to cannibalism. There were 16 birds (or 17% of birds examined) in which the cause of 
death was unclear. Abdominal haemorrhage was present in 5% of examined birds. Ten examined 
birds showed inflammation of the ovary, oviduct and cloacae (salpingitis), and one bird showed 
necrotic alterations of the intestine. In the free range, 77% of birds examined showed fresh 
lesions/wounds, and in some cases eaten parts of the muscles or cloaca and intestine, providing 
evidence of cannibalism. There were 11 birds (or 14% of examined birds) that died due to cachexia 
(no signs of cannibalism were found). Examination of the reproductive tract of cachectic birds 
showed the presence of an undeveloped ovary and lack of large yellow follicles. The cause of death 
was unclear in 7 cadavers from free range housing.  
 
4.4.2 Performance parameters   
 
Data on egg production (%HDP) are presented in Table 4.2, and data on BW for all systems are 
presented in Figure 4.1. Data are compared at 70 wk of age. 
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Egg production 
 
As shown in Table 4.2, hens in cage system started laying eggs earlier than hens in alternative 
system, although their egg production peaked at a similar age. Most of hens achieved their peak of 
production at 33 wk of age (with %HDP over 90%), thereafter the egg production decreased. At the 
end of the laying period there were no significant differences in %HDP (P>0.05) among systems. 
Hens in all systems had a comparable %HDP ranging from 65% to 75 % at 70 wk of age. 
 
Body weights  
 
Data on BW are presented in Figure 4.1. As shown from the line chart, all birds started the laying 
cycle with a similar BW (>1700g per bird). From the start to the peak of the laying period, BW was 
increased significantly (P<0.01) in all systems. All birds were heavier around 53 weeks of age; 
however at the end of 69 wk birds in cages continued to have BW over 2100g, while birds in barns 
and free-range dropped their BW approx. 100 to 200g/bird, respectively. For birds kept in the cage 
system, the highest body weight was achieved at 49 wk ca. 2200g/bird. At the end of 69 wk of age, 
the BW for hens in cages was significantly higher (P<0.001) than hens in free range and barns. 
 
Correlation analysis were conducted to see if there were any relationships between variables 
measured, explicitly between the BW (which was the variable that showed a significant difference), 
and mortality rate or %HDP, and to measure the strength of this relationship. There was a positive 
and strong significant correlation between BW and mortality rate, and BW and %HDP in cage system 
(r=0.78, P=0.00014). There was a weak correlation between mortality rate and %HDP in this system 
(Table 4.3). 
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Figure 4.1  Monthly average of BW
1
(g) in laying hens from 21 to 70 wk of age. 
1
Each value represents the average (n=3) of each unit (replicate) calculated on the basis of number of 
hens that were weighed at each unit at each time point. 
 
 
Table 4.3 Pearson‘s Correlation of BW, mortality rate and %HDP for hens kept in cage 
system.  
Cage System  Mortality BW %HDP 
Mortality rate 1     
BW 0.78 (P<0.01) 1   
%HDP 0.15 0.46 (P<0.01) 1 
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4.5  Discussion 
 
This study was undertaken to collect data on mortality and determine causes of death of hens kept 
in three different housing systems in a layer flock facility at Gatton Campus, University of 
Queensland. It was thought that recording data on mortality in three different housing systems 
along with data on egg production and body weights, it would help to not only assess the mortality 
in each system but also determine if the mortality rate is related to other performance parameters or 
any other problem associated with the housing system (i.e. husbandry practices and or 
environmental conditions associated with each system). Causes of mortality were determined 
through the necropsy of dead birds.  
 
The results of this study showed that at the end of the lay period, there were no significant 
differences (P>0.05) in mortality rate among housing systems, and the mortality rate was 
comparable between all housing systems. In this case, the null-hypothesis that housing system does 
not affect mortality rate was confirmed. However data on causes of mortality showed that housing 
system had a major influence on the causes of hen death. The most common cause of death in hens 
kept in cages was FLHS with 74% of hens dying from this condition. The majority of hens kept in 
free range died from cannibalism (77%) and cachexia (14%), while hens in barns had problems 
such as cannibalism (59%), reproductive tract infections (10%) and cachexia from stress and 
malnutrition.   
 
At 70 wk of age, %HDP was also comparable among the three systems, with hens in cages 
achieving the highest level of egg production at the peak (ca. 33 wk) and at the end of egg 
production (at 70 wk). However these differences were not statistically significant, confirming 
again the null-hypothesis, that there is no effect of the type of housing system on hen egg 
production. 
 
Data on BW showed that, as hens got older, the average BW increased in all systems. Close to the 
end of egg production (at 65 and 69 wk of age) BW of hens in free range and barn system started to 
decrease; this wasn‘t true for hen in cages, whose BW did not change or was slightly increased. It 
was concluded that housing system did affect the BW therefore the null-hypothesis was rejected.  
 
Data on necropsy showed that the housing system influenced the causes of mortality, including the 
prevalence of FLHS. These data demonstrated that the highest incidence of FLHS happened in hens 
kept in cages. Previous investigators have suggested that FLHS is a metabolic disease of hens 
housed in conventional cages (Butler, 1976; Couch, 1956; Hansen and Walzem, 1993; Julian, 2005; 
66 
 
Leeson, 2007; Neill et al., 1975; Peckham, 1984; Ringer and Sheppard, 1963; Simonsen, 1978; 
Weitzenburger et al., 2005), and this statement was confirmed in this study. It was previously 
suggested that increased BW has a great impact on hen mortality and in most of cases is associated 
with fatty livers and FLHS (Harms et al., 1972; Pearson and Butler, 1978c; Schumann et al., 2003; 
Walzem et al., 1993). Moreover, one of the most obvious clinical signs of FLHS is overweight of 
hens (typically 25%) and, if associated with sudden death of hens, sudden drop in egg production 
and pale comb and wattles (Couch, 1956; Crespo and Shivaprasad, 2003; Ivy and Nesheim, 1973; 
Julian, 2005; Lumeij, 1994; Thomson et al., 2003), could be warning signs of the presence of FLHS 
in a flock.  
 
As mentioned above, in this study, a high occurrence of FLHS in the cage system was related to an 
increased BW of hens. There was a high correlation between BW and mortality prevalence. It is 
possible that birds that died due to FLHS were heavier than other birds in the same cage/system, 
although data were not collected/not shown for BW of dead birds in this study. However, higher 
BW was associated with increased mortality in this system. As regards HDP, correlation data 
showed that this variable was also related to BW. Previous studies have demonstrated an increased 
incidence of FLHS in high producing flocks (Couch, 1956; Harms et al., 1972; Julian, 2005; Lee et 
al., 1975; Leeson, 2007; Squires and Leeson, 1988).   
 
As shown by correlation analysis, there was a positive and highly significant correlation between 
BW and mortality rate, and BW and %HDP in the cage system. In contrast, there was a weak 
correlation between mortality rate and egg production indicating that the level of production was a 
lower contributor to the mortality rate, and subsequently the occurrence of FLHS in the cage 
system. At peak production (ca. 33 wk of age), the mortality rate was under 2%. Apparently due to 
an excess in energy balance, birds in the cage system accumulated more fat than birds in other 
systems, resulting in an increased BW in these birds. An increased BW is also related to the lack of 
physical activity of birds, which were unable to burn off the extra dietary energy. The haemorrhage 
presumably occurred due to fat accumulation in the liver and liver capsule rupture when hens 
straining to lay the egg. As a result, death occurred unexpectedly. The reasons and detailed events 
of liver rupture have been so far unknown, and will be investigated and discussed in this thesis. 
 
From this preliminary investigation, it was suggested that there is a high incidence of FLHS in the 
cage system and BW of hens is an important factor that contributes to this incidence. Monitoring 
BW throughout the laying cycle appears to be a helpful diagnostic tool to predict FLHS occurrence 
in a laying flock. Meanwhile, it is suggested that, in the case of increased BW in a flock, attempts 
should be made to control and regulate the total energy intake of hens.  
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5.1  Introduction 
 
Fatty liver haemorrhagic syndrome is a production disorder and an important cause of mortality in 
caged commercial layer flocks, with obvious welfare and economic implications (Craig and 
Swanson, 1994; Diaz et al., 1999; Leeson, 2007). Since the 1950s, a number of investigations have 
been conducted into the aetiology and prevention of this disease, but the aetiopathogenesis is still 
not completely understood. Currently it is seen as an unresolved problem in laying hens, and 
anecdotally is called the ―silent killer.― There are no recent data available on the incidence of FLHS 
in Australia. Neill et al. (1975) were the first to report outbreaks of FLHS in laying hen flocks in 
South East Queensland, Australia. Thirty years later, Shini et al. (2006) examined the causes of 
mortality of laying hens in a flock from the same region, and showed that hens kept in battery cages 
had a higher occurrence of FLHS. More specifically in the case of a mortality rate of 5%, more than 
70% of deaths were due to FLHS.  
68 
 
As FLHS is often asymptomatic, most producers are unaware of its occurrence in their flocks. The 
first sign of the syndrome is a sudden drop in egg production and an increase in mortality, with 
birds in full production being found dead. In many cases, affected hens are overweight with pale 
combs and wattles; however diagnosis of FLHS can only be confirmed at necropsy (Grimes et al., 
1991; Squires and Leeson, 1988). Haemorrhage occurs when the hen strains to lay an egg or from 
trauma resulting in the liver blood vessels rupturing (Crespo and Shivaprasad, 2003). The liver at 
necropsy appears enlarged, yellowish, and friable. In some cases subscapular haemorrhage and 
several hematomas are found inside or on the surface of the liver with or without internal blood 
clotting (Crespo and Shivaprasad, 2003). Large blood clots and excessive fat deposits are found in 
the abdominal cavity. 
 
Outbreaks of FLHS occur sporadically in commercial flocks (Hoerr, 1996; Squires and Leeson, 
1988), with a mortality rate of 3-5% (Dimitrov et al., 1980; Hansen and Walzem, 1993; Pearson and 
Butler, 1978c; Valkonen et al., 2008) although higher mortality rates have been reported (Shini et 
al., 2006; Ugochukwu, 1983; Weitzenburger et al., 2005). Industry estimates suggest that between 
one third to two thirds of caged layer mortality can be attributed to FLHS. However, to date there is 
no husbandry strategy applied in laying flocks that can prevent FLHS, most probably due to the fact 
that the aetiology of this syndrome is poorly understood and the occurrence probably 
underappreciated. It should be stressed that both decreases in egg production and increases in 
mortality associated with FLHS have implications for hen welfare and cause considerable economic 
loss to the egg industry in Australia. Since about 55% of Australia‘s commercial layer flocks are 
housed in cages, FLHS is a disorder of major importance.  
 
From the results of the first study in this thesis, it was suggested that there is a need to survey more 
flocks in Queensland and re-evaluate the situation after 30 years; this is required due to changes in 
many husbandry procedures and especially developments in terms of laying hen breed, nutrition 
and housing. 
 
5.2  Objectives 
 
The objectives of this study were to: 
 
(i) Determine the occurrence of FLHS in commercial caged layer flocks located in the 
South East Queensland of Australia, and 
(ii) Ascertain the importance of some husbandry factors in predisposing hens to this 
condition.  
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5.3  Survey design 
This region of Queensland had approximately 2.933 million laying hens (AECL, 2011). The 
epidemiological study involved both a questionnaire sent to 20 registered cage layer operations in 
Queensland, and a four-month survey to monitor health and production of selected farms or flocks 
from these operations. Of the farms that responded to the questionnaire, three farms (designated 
farms 1, 2 and 3) were selected for an on-farm flock epidemiological survey (Table 5.1). All of the 
procedures undertaken in this study were approved by the University of Queensland Animal Ethics 
Committee (SAS/871/07).  
 
 5.3.1 Questionnaire  
The aim of the questionnaire was to collect data on layer bird management, health and productivity. 
The questionnaire contained questions on breed and flock age, feed source, lighting program, egg 
production, body weight (BW) monitoring, health (including vaccination), mortality, and the use of 
laboratory tests and necropsy for determining causes of mortality. Producers were also asked if they 
were able to recognize deaths FLHS, and if they could estimate its occurrence in their flocks (for 
more details se Appendix 4).  
 
5.3.2 Epidemiological studies on selected flocks   
 
Farms 1, 2 and 3 were chosen for the epidemiological study because they were representative of the 
egg industry in Queensland, with respect to bird strain in use, size and age of flocks (start, middle, 
or end of laying cycle), and feed management (commercial vs. farm-mixed feed). For more details 
on feed and feed ingredients used in each Farm see Appendix 1 (Tables 1, 2 and 3).  Data 
comparing laying hen nutrient levels as recommended by breeders until 44 wk of age (Australian 
ingredients) and provided in the diets used in farms surveyed are presented in Appendix 1 Table 4. 
Selection of the farms was stratified across geographic location (East and West from University of 
Queensland, Gatton Campus). A description of the farms is given in Table 5.1. It should be noted 
that only 7 flocks from these farms were surveyed in all; 3 flocks from each in Farms 1 and 3, and 1 
flock in Farm 2. These flocks had a combined total of 21,903 laying hens. The farms were visited 
on three occasions over a 4-month period. Necropsies were conducted on farm and blood samples 
were collected for haematology and biochemistry. Data on mortality and mortality causes, egg 
production and BW were recorded over the monitoring period (4 months). Cases of FLHS were 
confirmed by lesions found at necropsy.  
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Table 5.1  Description of farms that participated in the epidemiological survey. 
Farm ID Location 
from 
Gatton 
Breed and 
strain 
Age
1 
(wk) 
Type of feed in 
use 
Lighting 
(h)  
BW 
monitoring 
System,  
number of  birds/cage 
Farm 1 South-west Hy-Line 
Brown 
17 
42 
61 
Farm-mixed 16  Yes, 
monthly 
Environmentally controlled shed; multi-
tier cages;              
6 birds/cage at 550 cm
2
 
Farm 2 West Hy-Line 
Brown 
60 Farm-mixed 16  Yes, 
monthly 
Naturally controlled shed; single-tier 
cages; 
3 birds/cage at 650 cm
2
 
Farm 3 East ISA Brown 19  
27  
52   
Commercial 17  No Naturally controlled shed; single-tier 
cages; 
3 birds/cage at 550 cm
2
 
1
Age at the start of monitoring 
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5.3.3 Sampling 
 
Performance parameters 
 
Production and mortality data were provided by farmers and used to calculate percentage hen-day 
egg production (%HDP), and percentage mortality rates expressed as cumulative mortality from the 
start of lay.  
 
Body Weights  
 
Each farm was visited once a month for 2-3 days to conduct necropsies, monitor BWs and collect 
blood samples. The same birds, taken at 3 different spots in the shed, were weighed on 3 separate 
occasions. For an accurate BW monitoring in layers, most breeder companies recommend 
individually weighing 3 to 5% of the flock at each weighing point. Others suggest that 2% of the 
flock is sufficient, provided that a minimum of 50 birds are weighed irrespective of flock size 
(Leeson and Summers, 2000). For Farm 1, with ca. 5,000 birds per flock, individual birds in 40 
cage units (240 birds or 4.8 % of birds per flock) were weighed; for Farm 2, with ca. 3240 birds per 
flock, birds in 48 cage units (144 birds or 4.4% of birds) were weighed; for Farm 3, with ca. 1500 
birds per flock, birds in 24 cage units (72 birds or 4.8% of birds per flock) were weighed. Individual 
birds were weighed and the results are expressed as an average BW (g) per bird. 
 
Post-mortem examinations 
 
All dead birds from farms that participated in the survey were collected and mortality recorded. Due 
to insufficient freezer storing space, post-mortem was only carried out on birds that died during the 
first 10 days of each month for 4 months (from January to May). Dead birds were weighed and a 
thorough necropsy was carried out on each bird (for details on necropsy examination see Appendix 
3). Particular attention was paid to the presence of excess amount of fat and blood clots or 
coagulations in the coelomic cavity. The liver was carefully removed, examined for haemorrhages 
and haematomas, and weighed. Haemorrhage was assessed on both the dorsal and ventral surfaces 
of the liver and was graded on a scale from 0 to 5, with score 0 indicating no haemorrhages; score 
1, up to 10 subcapsular petechial or ecchymotic haemorrhages; score 2, more than 10 subcapsular 
petechial or ecchymotic haemorrhages; and scores 3-5, large haematomas and massive liver 
haemorrhage accompanied by rupture of liver capsule. A haemorrhagic score of 3-5 was considered 
highly characteristic of FLHS and was diagnosed as the cause of death (Figure 5. 1a, b, c, d, and e).  
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Figure 5.1  Pictures from post-mortem examinations of hens showing various stages of  
haematomas and haemorrhages scored 1 to 5 (a, b, c, d and e).  
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Blood parameters 
 
The number of birds used for blood tests was calculated according to epidemiological formulas and 
recommendations by Australian Animal Health Laboratory (AAHL, CSIRO). 
A minimum of 10 birds and a maximum of 50 birds per flock in a flock with 1,000 to 5,000 birds 
(or 1% of the flocks) were sampled, respectively. Random samples of birds were selected, and the 
results from the sample then provided an estimate of the status of the whole flock. The same bird 
was sampled for repeated measurements.  
 
Blood samples for haematology and biochemistry were collected from the brachial vein on all 
occasions (see Chapter 3.3.1 and 3.3.6 for more details). Haematological parameters, such as total 
red blood cell (RBC) numbers, haematocrit (HCT) and haemoglobin (Hb) concentration were 
measured using an automated analyser (CELL-DYN® System 3700CS, Abbott Park, IL 60064). 
Blood for biochemistry was centrifuged (1500 rpm for 10 min), the plasma stored at -20ºC and 
subsequently analysed for CHOL, TG, TP, GLU, and GGT using commercial kits and a chemistry 
system (Vet Test chemistry analyser, IDEXX Laboratories, Inc. USA). 
 
5.4  Statistical analysis        
 
Valid responses from the questionnaires were used to record data on bird and farm management and 
evaluate the frequencies and percentages of all observations. They provided an estimate, but they 
were not suited to statistical analysis. For the flock epidemiological survey, it was acknowledged 
that a direct comparison of the data of 7 flocks from different farms would not be valid due to 
specific conditions and variables associated with one management system compared to another. 
Results from each farm were summarized into three periods (for each point of sampling) and used 
to evaluate trends in mortality and egg production, and compare BW, and blood health profiles 
within the flock for the period of study. Farms or flocks were not statistically compared with each 
other in any of the analyses. Recorded data were subjected to one-way ANOVA. All analyses were 
performed using the GLM procedure of the SAS version 8.0 software (SAS Institute Inc, 2001). 
Significant differences among sampling points were determined using the Tukey‘s HSD (Honestly 
Significant Difference) test. Statements of significance were based on P<0.05. For data on BW and 
blood profile, the mean, standard error, and P values are presented.   
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5.5  Results  
         
5.5.1 Questionnaire 
 
Eleven of the cage egg producers in Queensland (or 55%) replied to the survey, and their total 
number of flocks and hens was 40 and 1,384,500 respectively. They represented different 
geographic locations and had been operational for more than 20 years, with four farms for more 
than 50 years. Tables 5.2 and 5.3 present data on-farm and bird management recorded from the 
questionnaires. The average number of birds per farm per year ranged from less than 10,000 (2 
producers), 20,000 to 190,000 (8 producers), and 900,000 birds (1 producer), with the number of 
sheds ranging from 1 to 16 per farm. Only two producers housed birds in environmentally 
controlled sheds, while the remainder of birds were maintained in naturally ventilated sheds. Seven 
of the producers (or 64%) used a cage system housing 5 or 6 birds/cage, and 4 producers used cages 
holding 3 birds/cage. All cages from surveyed farms complied with the Australian Model Codes of 
Practice for the Welfare of Animals (ARMCANZ and PISC, 2002).  
 
Five producers (or 45.5%) had Hy-Line Brown egg hens, two (18.2%) had Isa Brown hens, three 
(27.3%) had Hisex brown hens, and one (9%) had both Hy-Line and Isa Brown strain hens. Seven 
of the producers mixed feed on farm, and only four purchased commercial feed. The mortality rate 
of flocks ranged from 2% to 11% and the average rate of production for laying cycle ranged from 
70 to 89% (Table 5.3). Most of the producers did not know the causes of mortalities in their flocks, 
and only three of them used veterinary laboratories to determine the cause of mortality. Six (54.5%) 
producers monitored BW of their flocks, while all used lighting programs for flocks. Only one 
producer was aware of FLHS being present in their flock from necropsies conducted sporadically 
by a health adviser. 
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Table 5.2  Questionnaire data summary (farm data).   
Farm  N of 
sheds/ 
birds
1
 
System, cage type & number 
of hens/cage 
Shed temperature 
(ºC)
 2
 
Type of feed in 
use 
1 4/120K Controlled environment/ 
Valli/6 
23-25 Farm-mixed 
2 3/10K Natural/ Chainex/3 25-33 Farm-mixed 
3 1/9,5K Natural/Single tier/3 NA Commercial/ 
Darwalla 
4 7/190K Natural/Multi-tier/4&6 25 Farm-mixed 
5 1/10K Natural/old cages/3 NA Commercial 
6 1/8K Natural/Tier-Sylvan/5 15-34 Commercial 
7 2/20K Natural/multi-tier/6 25-30 Farm-mixed 
8 2/18K Natural/square old colonial 
wire/3 
28-30 Commercial/ 
Riverina 
9 16/900K Controlled-environment/Big 
Dutchman/6 
21-28 Farm-mixed 
10 2/74K Natural/Techno & Harrison/5 NA Farm-mixed 
11 1/25K New cage system/6 22-23 Farm-mixed 
1
Number of sheds and birds at the time of survey (1000=1K) 
2
During summer months 
NA = data not available
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Table 5.3  Questionnaire data summary (bird data).  
 
Farm  Breed Age of 
flocks
1
  
(wk) 
Average 
mortality 
(%)  
Causes of 
mortality 
who determines 
Average 
production 
(%)  
Weighing 
program 
1 Hy-Line 
Brown 
17 to 61 4 unknown/ 
manager 
85 no 
2 Hy-Line 
Brown  
60  2 unknown/ 
manager  90% 
laboratory 10% 
70 yes/ 
monthly 
3 ISA 
Brown 
19 to 52 7 unknown/ 
owner 
70 no 
4 Hy-Line 
Brown 
47 2 unknown/ 
manager  95% 
laboratory 5% 
85 yes 
5 ISA 
Brown 
various 6 unknown/ 
owner 
80 no 
6 HI-SEX 
Brown 
various 8 unknown/ 
owner 
76 no 
7 HI-SEX  
Brown 
various 5 unknown/ 
manager 
85 no 
8 Hy-Line 
Brown 
NA 11 unknown/ 
manager 
80 no 
9 Hy-Line 
& ISA 
Brown 
various 2.1 unknown/ 
manager 
80 yes/ 
monthly 
10 Hy-Line 
Brown 
various 10 unknown/ 
manager 
82 no 
11 HI-SEX 
Brown 
various 2 unknown/ 
manager  50% 
laboratory 50% 
89 yes/ 
quarterly 
1
Age of birds at the time of survey 
NA = data not available 
77 
 
5.5.2 Results from the epidemiological study  
 
Data are presented from samples and records collected in 3 designated farms (Farm 1, 2, and 3). 
 
Mortality and necropsy findings  
 
Table 5.4 shows cumulative mortality (as monitored by producers) and the number of dead birds 
and necropsies conducted on all three farms during the study. The mortality rate of flocks ranged 
from 0.8 % (the youngest flock) to 11.6 % the oldest one. The mortality rates increased with age 
(P<0.001). The age trend in mortality rates for three flocks in Farm 1 is presented in Figure 5.2. 
Each part of the graph represents one flock, and the entire graph represents three flocks from the 
same farm jointly. The graph indicates that at 29, 54 and 73 wk of age the % cumulative mortality 
of flocks (1, 2 and 3) was 2, 4.8 and 11.6%, respectively. There was a higher mortality rate than 
expected for flock 1 at 73 wk of age, reflecting mortality at the beginning of laying period 
(according to the producer‘s records and comments). The monthly mortality rate for these flocks 
during the study ranged from 1 to 1.2% per month. At 72 wk, for Farm 2 (flock 1) the mortality was 
calculated at 7.4% of the initial flock, and for Farm 3 at 31, 49 and 64 wk of age (flocks 1, 2, and 3) 
the mortality rate was 0.8, 2.5 and 4.8 %, respectively (Table 5.4). 
 
As indicated in the methodology, only 30-50 % of dead birds were necropsied. At Farm 1, 42% of 
birds necropsied showed large subcapsular haemorrhage of liver and blood clotting in the 
abdominal cavity indicative of FLHS, while in Farm 2 and 3, 28 % and 34% of dead birds had signs 
of FLHS, respectively (Table 5.4). From birds that died in Farm 1, and were aged between 42 to 54 
wk of age, about 63% demonstrated FLHS. For this study BW of all necropsied hens were 
recorded, hens with parts of the body missing were excluded from the calculations of BW average 
and statistical analyses. The BW average of dead birds in Farm 1 was 2008±107g. The average BW 
of birds that died in Farm 2 and 3 was 1821±78 and 1954±92g, respectively. 
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Table 5.4  Mortality (%), number of post-mortems conducted, and frequency of FLHS  
in three surveyed farms.  
Farm/ 
flocks 
surveyed 
Flock size and 
age
1
 
Mortality 
(cumulative 
from 18 wk) 
(%) 
Number of 
dead birds 
during 
study 
Number of 
post-mortems 
conducted 
during the 
study 
Incidence of 
FLHS 
(number of 
birds and %) 
Number 
of birds 
Age 
(wk) 
1 
(3 flocks) 
 
5022 
4776 
4347 
=14145 
29 
54 
73 
2.0 
4.8 
11.6 
619 
579 
407 
=1605 
166 
182 
134 
=482  
(30% of dead 
birds) 
46 
115 
41 
=202 
(42% of 
necropsied 
birds) 
2 
(1 flock) 
3240 
 
72 7.4 121 64  
(ca. 50% of 
dead birds) 
18 
(28% of 
necropsied 
birds) 
3 
(3 flocks) 
 
1635 
1539 
1344 
=4518 
31 
39 
64 
0.8 
2.5 
4.8 
22 
75 
118 
=215 
18 
22 
65 
=105  
(50% of dead 
birds) 
6 
13 
17 
 =36  
(34% of 
necropsied 
birds) 
1
Age at the end of survey 
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Figure 5.2  Data on mortality for Farm 1: flock 1 (a), flock 2 (b) and flock 3 (c).  
Mortality is presented only for the period of study as a percentage (cumulative) mortality of birds 
housed in the shed at start of lay. 
 
Performance parameters 
 
Table 5.5 shows data on hen performance (%HDP, BW and cumulative mortality) from three 
farms, and for comparison, data from respective layer breeding companies as recommended in 
their management guides (HY-Line, 2008; ISA, 2000). Body weight increased with age especially 
for birds in Farm 2 and 3 (Figure 5.3; data shown only for one flock per Farm at age ranging from 
56 to 73 wk of age). However, this increase was not statistically significant (P >0.05) for the 
sampling period in three flocks. At 73 wk of age, there was a decrease in BW of birds from Farm 
1, but again this difference was not statistically significant. At 29 and 69 wk of age, birds in Farm 
1, and at 32 and 72 wk of age, birds in Farm 2, had a BW comparable or lower than that 
recommended by breeders (Table 5.5). There was a significant increase (P < 0.05) in BW recorded 
for hens in Farm 3 flock 3 from 56 to 64 wk of age. At 31 and 64 wk of age, birds in Farm 3 
weighed more than breeder‘s recommendations for this age (Table 5.5), data shown only for 64 wk 
of age.   
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Table 5.5 Comparative data on performance parameters as recommended by breeders in the 
management guides (HY-Line, 2008; ISA, 2000) and data monitored in three 
farms.  
Parameter HY-Line 
Brown
1
  
Farm 1
2
  Farm 2  ISA Brown
1
  Farm 3 
3
 
BW (g) 
32 wk 
72 wk 
 
1980 
2250 
 
1872 
2128 
 
- 
2117 
 
1885 
1985 (1975 
at 64 wk) 
 
1985 
2163 
HDP (%) 
32 wk 
72 wk 
 
94 
72 
 
94.3 
77.4 
 
- 
74 
 
94.3 
75 (79.7 at 
64 wk) 
 
91 
85 
Mortality 
cumulative (%) 
32 wk 
72 wk 
 
 
0.8 
4.0 
 
 
2.0 
11.0 
 
 
- 
7.4 
 
 
1.2 
5.8  (4.9 at 
64 wk) 
 
 
0.8 
4.8 
1
At peaking (32 wk) and end of lay (72 wk); 
2
At 29 and 69 wk of age;  
3
At 31 and 64 wk of age 
 
 
The age trend in %HDP for three flocks in Farm 1 is presented in Figure 5.4. From the start of lay 
until the peak the %HDP increased (P < 0.001) with age. From 26 wk of age birds had a %HDP 
close to 90% and this continued at this level or above until 42 wk of age. At 64 wk of age, %HDP 
was between 82-85% in all farms. In general, the %HDP was comparable with the breeder‘s 
recommendations for the respective age (Table 5.5), while at 64 wk of age birds in Farm 3 had a 
higher %HDP than that recommended by the breeder (85% vs. 79.7%) at this age. 
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Figure 5.3 Average body weight measurements for Farms 1, 2 and 3.  
Data are shown here are only from 1 flock per farm and are presented as mean ±SD of hens weighed 
at each sampling point (every 4 weeks). Data were compared only within the same flock. Number of 
birds weighed at each sampling point was: Farm 1 (n=240), Farm 2 (n=144) and Farm 3 (n=72). 
 
 
 
Figure 5.4  Data on egg production for Farm 1, flock 1 (a), flock 2 (b) and flock 3 (c). 
Hen day production = HDP; 
Data shown only for the period of study for each flock.  
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Blood parameters 
 
Haematology and biochemistry parameters of hens from Farm 1 (flock 1 and 3), Farm 2 (flock 1) 
and Farm 3 (flock 1) are presented in Table 5.6, respectively. Data presented show measurements at 
3 sampling points and are tabulated according to the age for visual comparisons. However, as 
mentioned in section 5.4 of this Chapter (statistical analysis) there were no statistical comparisons 
between the farms or flocks of different farms. Only data from repeated measurements of the same 
flock of each farm were used for statistical analysis.  
 
From 21 to 29 wk of age, birds in Farm 1, flock 1, showed a significant increase in TG (P<0.005) 
and GLU (P<0.001) concentrations. Plasma concentration values peaked at 29 wk (17.9 mmol/L 
and 15.1 mmol/L for TG and GLU, respectively). These values were similar to plasma 
concentrations of birds in Farm 2, flock 1 at 31 wk of age (18.1 mmol/L and 15.1 mmol/L for TG 
and GLU, respectively). In older birds,  Farm 1, flock 3 (at 73 wk of age), the TG levels were 
significantly higher (ranging 21 to 23 mmol/L) than in younger hens (Farm 1 flock 1 at 29 wk of 
age). Glucose levels were found similar in birds of different flocks; there was a slight significant 
change in GLU levels in birds of the same flock over time. There were no significant changes 
between the values of the CHOL and TP levels measured in birds of different flocks and ages. 
 
The GGT and TG levels increased (P<0.001) in birds in Farm 3, flock 1 at 68 wk of age, and then 
both values significantly (P<0.001) decreased at 72 wk. This was associated with a decrease in egg 
production. In contrast, total plasma protein levels increased (P<0.001) in these hens. The TG levels 
in all young flocks on all Farms showed similar patterns. The concentration was increased over time 
and peaked at 35 weeks of age (18.1 mmol/L) and thereafter in older birds was found ranging 20 to 
23 mmol/L. There were no significant changes in RBCs, HGB, and HCT in hens of different flocks 
or ages on Farms 1, 2 and 3 (Table 5.6) except for a slight increase (P<0.05) in HCT in birds in 
Farm 1 flock 3 at 73 wk of age.  
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Table 5.6  Plasma metabolites and haematological profiles of birds (Farm 1, 2 and 3). 
 
Parameter Farm 1 Flock 1 (21 to 29 wk) 
21wk        25 wk       29 wk     P-value
1
 
Farm 2 Flock 1 (23 to 31 wk) 
23 wk         27 wk         31 wk   P-value 
Cholesterol  
(mmol/L) 
2.84 
±0.10 
3.30 
±0.04 
2.77 
±0.03 
0.255 2.70 
±0.10 
2.96 
±0.21 
2.48 
±0.03 
0.115 
Triglyceride  
(mmol/L)  
15.3 
±0.59 
16.7 
±0.21 
17.9 
±0.20 
0.005 15.2 
±0.54 
14.1 
±0.32 
18.1 
±0.22 
0.001 
Glucose  
(mmol/L) 
12.2 
±0.43 
14.9 
±0.05 
15.1 
±0.18 
0.000 12.5 
±0.18 
14.7 
±0.05 
15.1 
±0.19 
0.000 
Protein  
(g/L) 
43.7 
±3.52 
51.7 
±1.20 
47.8 
±0.80 
0.108 43.5 
±2.80 
50.6 
±2.10 
48.7 
±1.20 
0.102 
GGT  
(IU/L) 
33.7 
±3.76 
34.0 
±1.53 
32.2 
±1.64 
0.960 37.0 
±1.73 
32.7 
±2.33 
35.0 
±3.51 
0.542 
RBC  
(x10
12
/L) 
2.38 
±0.09 
2.47 
±0.06 
2.59 
±0.05 
0.147 2.41 
±0.25 
2.49 
±0.07 
2.51 
±0.11 
0.783 
Hb  
(g/L) 
131 
±3.17 
135 
±3.29 
135 
±2.88 
0.540 133 
±4.91 
134 
±3.08 
133 
±4.56 
0.965 
HCT 
(L/L) 
0.31 
±0.01 
0.30 
±0.01 
0.32 
±0.01 
0.805 0.29 
±0.01 
0.30 
±0.01 
0.30 
±0.01 
0.740 
Parameter Farm 1 Flock 3 (65 to 73 wk) 
65 wk          69 wk         73 wk P-value 
Farm 3 Flock 1 (64 to 72 wk) 
64 wk          68 wk        72 wk   P-value 
Cholesterol  
(mmol/L) 
2.65 
±0.01 
2.58 
±0.02 
3.09 
±0.03 
0.000 2.34 
±0.05 
3.20 
±0.02 
2.44 
±0.03 
0.000 
Triglyceride  
 (mmol/L)  
21.1 
±0.23 
21.0 
 ±0.33 
23.2 
±0.94 
0.073 23.5 
±0.57 
24.5 
±0.29 
20.1 
±0.29 
0.000 
Glucose 
(mmol/L) 
12.9 
±0.34 
14.5 
±0.28 
15.7 
±0.07 
0.002 13.4 
±0.07 
14.1 
±0.11 
13.0 
±0.10 
0.000 
Protein  
(g/L) 
57.0 
±1.20 
55.3 
±1.50 
56.0 
±2.00 
0.763 5.52 
±0.06 
5.24 
±0.12 
6.04 
±0.11 
0.000 
GGT 
(IU/L) 
45.0 
±1.53 
43.6 
±2.33 
46.0 
±2.65 
0.766 40.4 
±0.92 
44.1 
±0.93 
38.3 
±0.92 
0.001 
RBC 
(x10
6
/L) 
2.62 
±0.08 
2.52 
±0.05 
2.69 
±0.03 
0.156 2.28 
±0.03 
2.35 
±0.02 
2.39 
±0.05 
0.070 
Hb  
(g/L) 
139 
±3.77 
139 
±3.50 
148 
±0.80 
0.081 121 
±1.59 
126 
±1.95 
127 
±1.83 
0.093 
HCT  
(L/L) 
0.33 
±0.01 
0.32 
±0.01 
0.34 
±0.01 
0.048 27.4 
±0.39 
28.4 
±0.44 
28.7 
±0.54 
0.146 
1
Values in bold are significantly different;  
Each value is the average of  n=50 (Farm 1), n=30 (Farm 2), and n=48 (Farm 3).  
Only selected flocks are presented. 
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5.6  Discussion  
        
In this study, a questionnaire followed the monitoring of selected laying flocks, were used to study 
the epidemiology of FLHS in South East Queensland, Australia. The response rate to the 
questionnaire was 55%, and was considered satisfactory (Williams, 2003). The questionnaire 
provided important data on hen management practices, and also suggested that most egg producers 
are not aware of FLHS. However, due to the small number of participating farms and varying 
husbandry practices and procedures used on these farms, it was difficult to draw firm conclusions in 
relationship to management and the incidence of FLHS. The data from the intensive flock survey 
(on-farm systematic monitoring and sampling for 4 months) were used to evaluate and confirm the 
presence of FLHS in commercial layers flocks in Australia.  
 
The presence of FLHS in this epidemiological study was confirmed only after the post-mortem 
monitoring in three farms. Necropsies conducted in 7 flocks of different ages indicated that of all 
birds examined, 39.3% (or 256 out of 651 necropsied birds) died due to FLHS, indicating that 
FLHS was a significant cause of death of laying hens on the surveyed farms. These results are in 
agreement with previous Australian and overseas findings which have shown that FLHS is one of 
the main causes of death in caged flocks irrespective of mortality rate (Grimes, 1975; Lee et al., 
1975; Neill et al., 1975; Peckham, 1984; Rodenburg et al., 2005; Ugochukwu, 1983; Valkonen et 
al., 2008; Weitzenburger et al., 2005). It should be noted that not every dead bird was examined and 
in addition to this, only hens that were presented with large hematomas and massive liver 
haemorrhage were diagnosed as dying from FLHS. Therefore the actual prevalence of FLHS could 
be higher than reported in this study. It is well recognized that sample size required for such surveys 
depends on the prevalence of the syndrome studied. In the current study, to calculate the minimum 
number of birds necropsied from each flock at each sampling point, the occurrence rate was 
predicted to be as previously found by other in field investigations i.e., between 20% to 50% of 
dead birds (Butler, 1975; Couch, 1956; Dimitrov et al., 1980; Ugochukwu, 1983; Valkonen et al., 
2008; Weitzenburger et al., 2005). Therefore, a minimum sample size of 14 necropsied birds was 
found to be sufficient to detect FLHS in a flock with a population of >1000 birds, for a prevalence 
estimate of disease 20% or more (with a confidence level 95%) (Cannon, 1982). In this study over 
600 birds were necropsied and they represented over 40% of all birds that died in 3 farms during the 
epidemiological study (over 4 months), and from these birds ca. 40% revealed typical signs of 
FLHS. This level of occurrence is lower than the level found in the first study (when comparing 
housing systems), however is still very high in terms of the number of the birds examined (40% of 
dead birds) and the period of examination (3 times during a 4 month period), suggesting a much 
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higher prevalence during a full laying cycle. These data indicate that FLHS continues to be a 
disease with high prevalence in cages, most probably due to a restricted movement of hens in cages. 
Three experiments, (Greuel and Hartfiel, 1968; Hartfiel et al., 1972) investigated the effect of the 
housing system on the liver fat content, and concluded that the percentage of hens with a relatively 
high liver fat content decreased when hens were kept on the floor. Moreover, they indicated that a 
limited opportunity for hens to move in cages was one of the factors which increased liver fat 
content. 
 
The results of this study indicated that laying hens in multi-tier cages in a controlled environment 
shed (as exposed in Farm 1), are at the same risk of developing FLHS as hens kept in naturally 
controlled sheds (Farms 2 and 3). This is the first demonstration of a similar effect of a thermo-
neutral environmental temperature on the occurrence of FLHS in caged hens. Earlier studies that 
examined the effect of temperature on the occurrence of FLHS were conducted some 20 to 30 years 
ago, when controlled environment sheds were not widely used in the laying hen industry. In these 
studies, increased mortality due to FLHS was found at temperature extremes during hot weather 
(Couch, 1956; Greuel and Hartfiel, 1968; Ivy and Nesheim, 1973; Pearson and Butler, 1978a; 
Schexnailder and Griffith, 1973). In two trials, Griffith and Schexnailder (1970) found a substantial 
increase in the fat content of livers from hens housed in cages, during the summer months. 
According to these investigators the energy requirement of a hen, already lowered by the restriction 
of exercise in the cage, was further reduced by a high environmental temperature which discourages 
movement of birds and reduces heat loss (Meijering, 1979).  
 
Temperature is a factor that is related to type of housing, and apparently contributes to the 
development of FLHS. Interestingly, Wolford (1971) observed in his experiments that the liver fat 
content in birds housed at 17°C for 28 days was significantly lower than in hens housed at 26.7°C 
for the same period. Lee et al. (1975) however, did not see any effect of changing the environmental 
temperature from 22.2°C to 30.6°C or from 30.6°C to 22.2°C on total liver fat or liver wet weight. 
There is some information suggesting that daily fluctuations in temperature, perhaps affected by the 
season of the year, stimulates hens to over consume feed. Jensen et al. (1976a) observed more 
FLHS in warmer vs. cooler regions of Georgia, despite feed intake being reduced at high 
temperatures and increased in cold temperatures. The relationship between feed intake and hepatic 
lipid accumulation in laying hens is not straight forward, and is likely modulated by the rate of egg 
production and feed composition (Leeson, 2012). 
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The observations in the first study of this thesis, and current observations, are partly in agreement 
with previous investigators. One area of agreement is that housing system influences the prevalence 
of FLHS. As shown in the first study hens kept in cages exhibit a higher incidence of FLHS than 
those kept on the floor (barn and free-range system) in flocks with a similar strain of bird, diet and 
other husbandry practices. As regards the effect of temperature on the prevalence of FLHS, the first 
study and this study showed that hens kept in battery cages in an environmentally controlled 
temperature (23±0.5C) exhibit FLHS with the same frequency as hens kept in naturally ventilated 
sheds. As previously shown, keeping temperature controlled within the thermo-neutral zone does 
not decrease the incidence of FLHS (Lee et al., 1975). Other factors could have been involved. 
Most investigators agree that lack of exercise is a bigger contributor to FLHS. More specifically, 
this is related to the excess of energy produced and not spent, i.e. birds kept in battery cages have 
lower energy requirements. In addition, birds kept in cages at a thermo-neutral temperature require 
less energy, as they do not use the extra energy to activate mechanisms for maintaining body 
temperature. It is known that the body of an animal spends an important fraction of its energy to 
maintain core body temperature (Silva, 2006). It is thought that exposure to cold or heat induces 
stress and influences lipid metabolism in the fowl. Jaussi et al. (1962) demonstrated the role of both 
low- and high-temperatures as stress factors on the incidence of increased hepatic lipid deposition 
and FLHS, by injecting adrenocorticotropic hormone (ACTH) and producing a similar response in 
treated chickens.  
 
To sum up, hens under the influence of multiple factors such as restricted movement in cages 
(associated with an increase in BW), increased egg production (including increased levels of 
oestradiol and lipid metabolites, such as TG) nutritional factors and other stress factors (including 
temperature changes) are predisposed to FLHS. Low, thermo-neutral or high temperatures may 
contribute in different physio-pathological ways to increased hepatic lipid deposition and BW. In 
the current epidemiological study, heavier birds (the average BW of dead birds was 2008±107 g) in 
a flock were more likely to have the condition than the lighter birds. The greater BW reflects the 
effect of factors mentioned above including the lack of activity of caged birds. Liver weights were 
measured in this study, however due to the fact that some hens had large blood clots in the 
abdominal cavity and in some other birds the haemorrhage was subcapsular or in the form of big 
haematomas inside the liver, there were big discrepancies on liver weights, with livers weighing 
from 20 g to 85 g (data not shown).  
 
In this study, it was expected that blood parameters would be sufficient to identify anaemia caused 
by haemorrhage or haematoma of the liver of hens. Many investigators recommend measurements 
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of plasma enzymes to test for FLHS (Diaz et al., 1999; Pearson et al., 1978b; Walzem et al., 1993) 
and suggest that enzyme activities are indicative of liver damage in birds, in particular AST, LDH, 
and GDH. In this study, GGT was measured as it is a more sensitive and specific indicator of liver 
dysfunction in mammals and birds (Center, 2007; Lim et al., 2007). From studies in humans and 
animals it has been shown that there is a correlation between GGT and TG in patients with 
steatohepatitis (Lim et al., 2007; Sakugawa et al., 2004). In this study, GGT was significantly 
elevated on 2 occasions at 35 wk (birds in Farm 3 flock 2) and at 68 wk of age (birds in Farm 2). In 
both cases this increase correlated (P<0.05) with increased TG levels. 
 
Circulating levels of metabolites (CHOL, TG, and GLU) and TP are seen as biomarkers of energy 
or nutritional status and metabolic disorders (Bedogni et al., 2006; Brown et al., 2010). Circulating 
levels of TG were significantly increased in hens surveyed in this study, and were associated with 
increased egg production at this period of laying cycle. It is recognised that laying hens normally 
have increased circulating lipid metabolites in particular TG from 2-10 fold during egg production 
(Klasing, 1998), and develop hepatic steatosis to meet the requirements for yolk lipid synthesis and 
deposition (Hansen and Walzem, 1993). Data recorded in this survey demonstrated that very high 
levels of TG were measured in hens from 35 to 60 wk of age. In some cases this increase was 
associated with a slight rise in GLU concentrations. It appears that the diet and level of egg 
production influenced plasma metabolite levels. At 68 wk, birds in Farm 2 (fed a corn-based diet) 
had high concentrations of TG and GLU demonstrating that these birds had excess energy intake (at 
least more energy that they needed for egg production at this stage). It was not possible to follow 
the fate of flocks or birds sampled in this study, and determine if these birds could have been later 
prone to FLHS.  
 
It is pertinent to remember that death from FLHS occurs only in extreme cases following massive 
liver haemorrhage; therefore, it is likely that a significant number of hens within the flock were also 
suffering from ―sub-acute and chronic FLHS‖. This may have caused a drop in egg production, but 
little or no change in mortality. However, such hens may exhibit reproductive dysfunction (Chen et 
al., 2006). This is likely the result of chronic liver damage and impairment of the transport of 
triglycerides, phospholipids, and cholesterol from the liver to the ovary (Walzem et al., 1999), 
resulting in decreased yolk formation and egg production. This could have been the case with birds 
in Farm 1, where there was a drop in %HDP in hens from 46 to 54 wk of age, while the mortality 
rate was constant.  
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The results of this study demonstrated that the acute and chronic forms of FLHS are a significant 
source of losses in egg production for cage egg producers. It was assumed that on-farm management 
factors such as housing and different nutritional conditions could have contributed to excessive liver 
fat deposition and increased BW, presumably resulting in greater flock deaths due to FLHS.  
Monitoring flocks for increased BW and occurrence of FLHS (through systematic post-mortem 
examinations of dead hens) should be a priority and may assist in preventing FLHS. Furthermore, the 
development of a rapid, non-invasive technique (e.g. a body uniformity index for laying pullets) could 
help cage egg producers to identify birds predisposed to FLHS to the onset of egg laying and make 
important management decisions for their flocks while maximizing egg production and hen welfare.  
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6.1  Introduction  
  
In the preceding Chapters, it was shown that the housing system plays a major role in the 
occurrence of FLHS in laying hens. The occurrence of FLHS was found to be high in commercial 
cage layer operations ranging from 40 to 70% of dead necropsied birds. Recent USA reports (Mete 
et al., 2013; Trott et al., 2013), indicate that FLHS was the most common non-infectious cause of 
mortality in backyard laying hens. As previously demonstrated by other investigators and 
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discussed in Chapter 2, there are many factors involved in the pathogenesis of FLHS including 
nutrition, which seems to be a major predisposing factor in backyard hens.   
 
Despite FLHS causing significant economic losses, it is often overlooked and neglected by 
producers due to difficulties in detecting and preventing this metabolic disorder (Decuypere and 
Verstegen, 1999; Julian, 2005; Scheele, 1997). In Chapters 4 and 5 it was emphasised that post-
mortem of dead hens is the only way to monitor the presence of the FLHS in a flock, while BW 
records and blood tests could help to evaluate and track the risk of the condition developing in a 
commercial laying flock. However, a greater understanding of the pathogenesis and methods to 
detect the condition are required if the risk of FLHS developing in a flock is going to be reduced.  
 
The study of FLHS, as it occurs in flocks in the field (i.e. the initiation, progression and resolution 
of this disease), is very difficult as it occurs sporadically and over an extended period of time. An 
experimental model could assist greatly in investigating this disease and models have been 
attempted in the past as discussed below and in Chapter 2. Many of these models relied on 
manipulating the dietary energy (output/input) ratio, or elevation of circulating oestrogen levels, 
for a successful induction of FLHS. 
 
Fatty liver haemorrhagic syndrome has been  induced in immature female and male chickens 
(Polin and Wolford, 1977) and mature laying hens (Stake et al., 1981). Polin and Wolford (1977) 
either force-fed alone (amount of feed equal to 125% and 150% of ad libitum intake) or combined 
with hormonal treatments (three times a week for 21 days) in an attempt to induce FLHS in 
immature chickens. Force-feeding produced a gradient response in hepatic steatosis (as measured 
by percentage of fat in the liver, and the ratio of fat/fat-free liver dry weight), but did not 
reproduce FLHS. In contrast, intramuscular (i.m.) injections of β-estradiol-17-dipropionate (E2) at 
2 mg/kg BW, three times a week for 21 days, produced a gradient response in haemorrhagic score, 
and an increase in ad libitum feed intake, with no significant differences between sex or breed 
(Polin and Wolford, 1977). However, females of both breeds accumulated significantly more liver 
fat than males.  
 
Stake et al. (1981) used an endocrine (E2) model to study breed difference susceptibility to FLHS. 
Exogenous E2 was administered i.m. every 4 or 5 days (5.0 or 7.5 mg E2/kg BW) to induce FLHS 
in 9-month-old Rhode Island Red (RIR) and White Leghorn (WL) hens. The RIR hens exhibited 
ataxia and opisthotonus; 30% died from hepatic haemorrhage within 14 days.  No WL birds (that 
were similarly treated for 32 days) died or showed neurologic disorder, thereby indicating major 
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breed differences in response to exogenous E2. There were increases in liver lipid percentage, liver 
haemorrhage, and plasma volume due to E2 injections. Other reports have shown that exogenous 
E2 can also induce fatty liver in immature birds (Balnave, 1971; Chawak et al., 1997; Harms et al., 
1977; Klimis-Tavantzis et al., 1983; Pearson and Butler, 1978b).   
 
It appears from these studies that FLHS is more likely to be induced when mature laying hens are 
used. Moreover, as FLHS is usually observed in the latter half of egg production, it was decided to 
use laying hens after the onset of lay and before the peak of production. It is recognized that FLHS 
is commonly observed in high egg-producing birds, therefore the administration of exogenous 
oestrogen in the laying hen that has already started the production cycle should further stimulate 
lipid synthesis, and cause increased hepatic fat deposition. Moreover, a number of investigators 
administered oestrogen while feeding hens ad libitum or in combination with force feeding, to 
create a positive energy balance, which was seen as a necessity for FLHS to occur (Harms et al., 
1977; Pearson and Butler, 1978b; Polin and Wolford, 1977; Stake et al., 1981).  
 
In this thesis, the amount of the feed consumed by hens was seen as a factor that might be 
manipulated to either; enhance the incidence of FLHS (if given ad libitum), or reduce lipid 
synthesis and the incidence of the FLHS (if controlled or restricted). Therefore, the aims of this 
study were to: 
(i) Induce FLHS in laying hens by using exogenous E2;  
(ii) Manipulate the feed intake of the hens, and evaluate the effect of feed intake in the 
development of FLHS.  
 
6.2  Materials and methods  
  
6.2.1 Laying hens and housing conditions 
 
Experiments were carried out at the Gatton Layer Facility, University of Queensland.  One 
hundred and eight 30-week-old Hy-Line Brown laying hens were housed individually in stainless 
steel cages and kept in a controlled environment shed.  The temperature of the shed ranged from 
22ºC to 24ºC, and hens were exposed to a photoperiod of 16 hours of light and 8 hours of dark.  
Birds were fed a commercial layer (wheat-sorghum-soybean) diet that contained CP - 17.5%; ME 
- 11.5 MJ/kg; Ca - 4.1%; Available P - 0.40%; Na - 0.18%; Lysine - 0.85%, Methionine + 
Cysteine 0.77% (Appendix 2).  
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6.2.2 Experimental design: induction of FLHS in the laying hen 
 
In this study, the experimental protocol was based on the model proposed by Stake et al. (1981) to 
induce FLHS by  injecting exogenous E2.  Oestradiol (5mg/kg BW in 0.5ml corn oil) was injected 
every 4th day for 20 days (6 injections in total). The dose was delivered i.m. into the pectoral 
muscle and adjusted to initial BW. In addition to exogenous E2 administration, energy intake (i.e. 
total feed intake) of birds was manipulated to investigate the effect of ad libitum vs. restricted feed 
intake on the occurrence of FLHS. Hens in the feed-restriction treatment were given 10% less feed 
than the breeder‘s recommendation (HY-Line, 2008). It was anticipated that this level of 
restriction (10%) would reduce the amount of excessive energy (fat synthesis and deposition) in 
birds without disturbing the physiology of egg production and body weight maintenance. 
 
Hens were randomly allocated into six groups (18 hens each group), two untreated (one group had 
restricted feed intake), two groups injected with the E2 (one group had restricted feed intake), and 
two groups treated with oil only (one group had restricted feed intake). The treatment program and 
sampling was performed as indicated in Table 6.1.  At each sampling point, three hens per 
treatment were necropsied for liver macroscopic and microscopic evaluation. 
 
6.2.3 Blood tests  
 
Blood samples were taken from the wing vein using individual EDTA vacutainers and individual 
blood tubes. At each sampling point, 6 birds per treatment were bled. Whole blood was used to 
measure haematological parameters in an automated analyser (CELL-DYN® System 3700CS, 
Abbott Park, IL 60064), including the total number of red blood cells (RBC), haematocrit (HCT) 
and haemoglobin (HGB) concentrations, and the total number of white blood cells (WBC) and 
white blood cell count differentials (percentages).  
 
For other analyses, blood was centrifuged (1,500 rpm for 10 min) and plasma was stored at -20ºC. 
Blood concentrations for plasma metabolites were determined using commercial kits and a 
chemistry system (VetTest chemistry analyser, IDEXX Laboratories, Inc. USA). For detailed 
information on metabolite (CHOL, TRG, TP, and AST) testing see Chapter 3.3.2. In addition to 
metabolites, measurements of plasma fibrinogen levels were carried out. Plasma fibrinogen content 
was determined by the refractometer method (for details see Chapter 3.3.2). 
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Serum E2 concentrations were measured by radio-immunoassay (RIA), using coated tube 
technology (Spectria) from Orion Diagnostics as described in Chapter 3.3.1.  
 
Table 6.1  Summary of the treatments and hen sampling. 
Groups
1
  Treatment/ 
day 
Dose/form/route Sample taken 
/time
2
 
Feed 
intake
3
 
Performance 
records
4
 
EAL E2  
Day 1,5,10, 
15,21. 
5mg/0.5mL oil/kg 
BW, i.m. 
 
Blood, Liver; 
0h,24h,1wk, 
2wk,3wk,4wk  
Ad libitum HDP, FC 
Mortality/daily  
BW/weekly 
ERF E2  
Day 1,5, 10, 
15,21. 
5mg/0.5mL oil/kg 
BW, i.m. 
The same Restricted  The same 
OAL Oil  
Day 1,5,10, 
15,21. 
0mg/0.5mL oil/kg 
BW, i.m. 
The same Ad libitum The same 
ORF Oil 
Day 1,5,10, 
15,21. 
0mg/0.5mL oil/kg 
BW, i.m. 
 
The same Restricted  The same 
CAL Untreated - The same Ad libitum The same 
CRF Untreated - The same Restricted  The same 
 
1
EAL = oestrogen-treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); OAL = oil-treated 
(ad libitum feed intake); ORF = oil-treated (restricted feed intake); CAL = control (ad libitum feed intake); CRF = 
control (restricted feed intake);  
2
Last treatment with exogenous E2 was performed on day 21, but samples and records were taken also 1 week post-
treatment, on day 28. 
3
Feed was restricted by 10% of the daily feed intake recommended by breeder for birds of this age (30 to 35 wk of 
age).  
4
HDP = hen day production; FC = feed consumption; BW = body weight; i.m. = intramuscular. 
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6.2.4 Liver tests 
 
Necropsies were conducted at each time point of sampling, and when hens died during the 
experiment. The liver was removed weighed, and individually examined for the presence of 
haemorrhagic lesions. Haemorrhages were counted on both dorsal and ventral surfaces of the liver. 
Liver haemorrhages were graded on a scale from 0 to 5 (for details see Chapter 3.3.3. and Chapter 
5.3.3). Liver weight (g), and relative liver weights (liver to body weight ratios, g/100g body weight) 
were calculated and recorded. Liver samples were taken for the determination of total liver fat 
content, and histological examinations. The liver lipid content was determined by the method of 
Folch et al. (1957) as described in Chapter 3.3.5. 
 
Liver histology was conducted as described in Chapter 3.3.4. For each section of liver, randomly 
located areas were assessed using light microscopy (40x and 100x magnification). A digital camera 
connected to the microscope was used to take images. The histological slides were evaluated for the 
presence of intact and nucleated fat cells; the presence of vacuoles (a fat vacuole was considered to 
be any non-staining area of cytoplasm with a sharply defined border); inflammation, as evidenced 
by focal infiltration with leukocytes; and the presence of haemorrhage (determined according to the 
dilatation of arteries and veins, including focal infiltration of liver tissue with RBC). 
  
6.2.5 Laying hen performance      
 
Production and mortality records were used to calculate: egg day production, expressed as 
percentage of eggs produced per hen per day (hen day production, %HDP), and egg weights (g); 
mortality rates expressed as percentages of cumulative mortality from start of the experiment; body 
weights (BW g). In addition feed consumption (FC) g/bird/day was calculated for birds that were 
given an ad libitum diet.   
 
6.3  Statistical analysis 
 
For this study, a null-hypothesis was established saying that treatments (including both, E2 and 
restricted feed intake) will not cause any change in parameters measured in treated birds, so treated 
and untreated birds will have similar parameters over time. Data were collected at each sampling 
point, and values were subjected to two-way repeated measures ANOVA. 
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All analyses were performed using the General Linear Model (GLM) procedure of Statistical 
Analysis Software (SAS Institute Inc, 2001). For further interpretation of data, General Linear 
Model (GLM) procedures were used. When significant differences were found, comparisons among 
treatments were conducted by Duncan‘s multiple comparison tests. Statements of significance were 
based on P<0.05. Correlations between parameters were determined using Pearson correlation 
coefficients.  
 
6.4  Results 
 
6.4.1 Evaluation of the FLHS model 
 
Data on FLHS incidence (determined after the necropsy of euthanised birds, or birds that died 
during the experiment), mortality rate, liver haemorrhagic score and liver fat content of treated and 
control birds are presented in Table 6.2. 
 
Data on mortality and liver haemorrhagic score demonstrated that all birds (100%) treated with E2 
developed FLHS and presented different signs at different stages of the development of the 
condition. Birds treated with exogenous E2 and fed ad libitum developed advanced signs of FLHS 
(liver haemorrhagic score = 4-5, revealed in 87.5% of birds in this treatment/group). Three (or 
18.8%) birds in this treatment died due to liver haemorrhage or haematomas. Oestrogen-treated 
birds in the restricted-feed intake group developed FLHS in a similar way to E2-treated birds in the 
ad libitum fed group; however, the incidence of FLHS in the ad libitum fed group was higher 
(P<0.05; 87.5 % vs. 68.8%, respectively). The restricted feed intake group showed ca. 20% less 
incidence of FLHS than the ad libitum fed group. There were no mortalities in untreated or oil-
treated groups. All control groups had a low incidence of signs FLHS, in terms of haemorrhagic 
score (only 6.3 and 18.8 % of birds revealed signs of small haemorrhages or petechies in the liver) 
with control hens in the restricted feed intake group having the lower incidence of FLHS (only 
6.3%, and a liver haemorrhagic score 1).  
 
Data on other liver measurements indicated that treatment with E2 induced a significant (P<0.05) 
increase in liver weight, and liver fat content (Table 6.2). In particular the EAL-treated group 
showed an increase in fat content in the liver over 50%.  The liver weights to BW (g/100g) ratios 
were significantly (P<0.05) increased in E2-treated hens when compared to controls (2.9 vs. 2.1). 
 
.   
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Table 6.2 Effect of oestrogen injections and feed restriction on the incidence of FLHS, 
mortality, liver haemorrhagic score, liver weight and fat content, and relative liver 
weight of laying hens
1
. 
 
Treatments
2
 N of 
birds 
FLHS 
(%)
4
 
Haemorrhagic 
score
4
 
Liver 
weight
5
 
(g) 
 
Fat 
content
5
 
(%) 
Liver 
weight 
to BW 
ratio 
(g/100g) 
Mortality 
(%) 
CAL&OAL
3
 36 18.8
c
 
6.3
a
 
1-2 
3 
38.6±5.1
a
 
 
25.2±2.8
a
 
 
2.1
a 
 
0 
CRF&ORF
3
 36 6.3
a 
 
1
 
 
39.2±4.8
a
 
 
23.8±2.2
a
 
 
2.2
a 
0 
EAL 18 87.5
d
 
12.5
a,b
 
4-5
 
 
2-3 
53.0±6.0
b
 
 
51.4±5.3
c
 
 
2.9
b 
18.8 
ERF 18 68.8
c
 
18.8
 a,b
 
12.5
 a,b
 
4-5 
2-3 
1 
47.4±5.5
b
 
 
43.6±3.8
bc
 2.8
b 
6.3 
 
1
Data are presented for the whole experimental period; N of birds sacrificed at each sampling point was 3 
birds/treatment. At the end of the experimental period, all birds were sacrificed and underwent post-mortem 
examination. 
2
EAL = oestrogen-treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); OAL = oil-treated 
(ad libitum feed intake); ORF = oil-treated (restricted feed intake); CAL = control (ad libitum feed intake); CRF = 
control (restricted feed intake).  
3
There were no significant differences between untreated and oil-treated groups; therefore, data are pooled and 
presented together for control untreated and oil treated groups for both ad libitum and restricted feed intake birds; 
4
 Data on the occurrence of FLHS are divided to reflect haemorrhagic scores (next column) and so indicate the range 
and severity of the lesions 
5
Values for liver measurements are presented as mean ±SD (n=18). 
a,b,c,d 
Values within a column with different superscripts differ significantly (P<0.05).  
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6.4.2 Plasma E2 concentration  
 
The baseline concentrations of E2 were found to range between 350 and 500 pg/mL in all groups. 
In the present study plasma E2 concentrations were elevated by exogenous administration of 5 
mg/kg BW (Figure 6.1). The levels of E2 rose rapidly in EAL and ERF treated birds and were 2 to 
3 times higher than before treatment (baseline) or control birds measured at 24 h post injections 
(approx. 1500 and 900 pg/mL, respectively). The E2 concentrations peaked twice for EAL treated 
birds at 1wk and 3 wk after treatments started with the highest value reached at 3 wk approx. 2115 
pg/mL. The E2 concentration for ERF birds was significantly lower (P<0.05) than EAL birds, 
however, ERF birds showed a significant increase (P<0.05) in E2 concentrations when compared 
to E2 levels of control birds.  
 
Birds in the control group oil (ORF) had slightly lower levels of E2 than other controls however 
this difference was not significantly different (P>0.05) from the other controls; therefore data are 
presented together for all controls.   
 
EAL birds had their E2 concentrations elevated over the whole period of the treatment, and the 
levels decreased 10 days after last treatment and reached the baseline value (Figure 6.1). It should 
be noted that the E2 treatment did not always fit with blood sampling and E2 measurements; 
treatments were every 4-5 days, while blood sampling was taken weekly after the first treatment.   
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Figure 6.1 Effects of exogenous oestradiol on plasma oestradiol concentrations in treated and 
control birds
1,2,3
 
1
EAL = oestrogen-treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); 
OAL = oil-treated (ad libitum feed intake); ORF = oil-treated (restricted feed intake); CAL = control 
(ad libitum feed intake); CRF = control (restricted feed intake);  
2
There were no significant differences between untreated and oil-treated groups (for both diets, ad 
libitum; restricted feed intake) therefore, data are pooled and presented together for control untreated 
and oil treated groups (CAL, OAL, CRF and ORF birds); 
3
Values are presented as mean ±SD (n=6, for each time point); 
Significant differences between groups are represented by *P<0.05; ** P<0.01; ***P<0.001.  
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6.4.3 Peripheral leukocyte counts and fibrinogen concentration 
 
As shown in Table 6.3, at 24 hours, 1 wk, 2 wk and 3 wk post-treatment, E2-treated chickens of 
both groups (EAL and ERF) showed a significant (P<0.01) increase in peripheral white blood cells 
(WBC) or leukocytes, when compared to basal (at 0 h) levels and control hens (at 0 h and 24 h). 
At 2 wk post-treatments with E2, WBC counts rapidly increased (P<0.01) in E2-treated birds of 
EAL group and peaked with a value 64.8±4.6 x10
9
/L. The WBC counts stayed elevated for both 
E2 treated groups (EAL and ERF) in the following week (week 3) as well and were reduced at 
week 4 after the first treatment with E2 (or 1 week after the last treatment with E2). 
 
Plasma fibrinogen levels were also elevated (P<0.01) over time, predominantly in the first and 
second week post-E2 treatment in EAL and ERF hens. Fibrinogen levels peaked earlier than the 
WBC counts at week 1 (the value was approx. 3 times higher than the baseline, ca. 6g/L), and 
continued to be elevated on week 2 in both E2 treatment groups (EAL and ERF). Thereafter, 
plasma fibrinogen concentrations declined and were found significantly (P<0.05) lower than the 
values measured before treatments (or baseline levels).  
 
Correlation analyses showed that there was a low level of positive correlation between WBC 
counts with fibrinogen concentrations over time in E2 treated hens (Pearson‘s correlation r=0.20; 
P=0.014). The highest correlation was found at 2 wk (Pearson‘s correlation r=0.96; P=0.001). The 
regression line is shown in the scatter diagram (Figure 6.2) and expresses the relationship in the 
form of an equation which can help to predict the level of fibrinogen for a given WBC count in the 
case of high levels of E2. 
 
All control hens (untreated/oil/ad libitum or restricted feed intake) had slight but insignificant 
(P>0.05) changes of WBC and fibrinogen levels over time.  
 
As shown in Table 6.3 there were no significant differences (P>0.05) in RBC counts and HCT 
values among treated and untreated groups.  
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Table 6.3  Data on haematological parameters and plasma fibrinogen concentration of  
E2 treated and control hens. 
  
Treatment
1
 Time WBC
2 
(x10
9
/L) 
RBC
2 
(x10
12
/L) 
HCT
2 
(L/L) 
Fibrinogen
2
  
g/L 
CAL 0 h 16.5
 a
 2.4 0.30 2.3
a
 
CRF  16.6
 a 
 2.6 0.29 2.5
a
 
EAL  16.3
 a
 2.5 0.30 2.4
a
 
ERF  16.1
 a
 2.5 0.28 2.2
a
 
CAL 24 h 17.7
 a
 2.1 0.26 2.6
a
 
CRF  17.5
 a
 2.5 0.27 2.8
a
 
EAL  31.1
b
 2.2 0.26 4.5
b
 
ERF  25.7
 b
 2.3 0.27 4.8
b
 
CAL 1 wk 16.9
 a
 2.2 0.26 2.5
a
 
CRF  16.2
 a
 2.5 0.29 2.6
a
 
EAL  28.4
b
 2.7 0.27 5.5
b
 
ERF  25.2
 b
 2.3 0.27 5.8
b
 
CAL 2 wk 15.8
a
 2.0 0.25 2.4
a
 
CRF  16.6
a
 2.2 0.26 2.8
a
 
EAL  64.8
c
 2.3 0.24 5.2
b,c
 
ERF  43.2
c
 2.2 0.24 4.5
b
 
CAL 3 wk 18.0
a
 2.2 0.26 2.7
a
 
CRF  17.2
a
 2.4 0.30 3.0
a
 
EAL  55.9
c
 1.9 0.28 1.2
a
 
ERF  53.3
c
 2.0 0.25 1.0
a
 
CAL 4 wk 20.0
a
 2.2 0.29 2.3
a
 
CRF  18.2
a
 2.3 0.28 2.6
a
 
EAL  20.0
a
 3.0 0.26 1.7
a
 
ERF  20.2
a
 2.8 0.25 1.5
a
 
1
EAL = oestrogen-treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); OAL = oil-treated 
(ad libitum feed intake); ORF = oil-treated (restricted feed intake); CAL = control (ad libitum feed intake); CRF = 
control (restricted feed intake); WBC = white blood cells; HCT = haematocrit; 
2
Values are expressed as mean (n=6). Means with different superscripts (a-c) within a column are significantly 
different (P<0.05). 
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Figure 6.2 Linear regression of WBC counts with plasma fibrinogen in oestradiol treated and 
control birds at 2 wk after treatment started. 
Each data point represents the average of 6 measurements per treatment/group; 
WBC = white blood cells. 
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6.4.4 Plasma metabolic profile 
 
Figures 6.3, 6.4, 6.5 and 6.6 present data on plasma metabolites (CHOL, TG, TP and AST 
respectively) from E2 treated and control hens. As previously mentioned in the case that there were 
no significant differences between untreated and oil-treated groups (for both diets, ad libitum and 
restricted feed intake) data are pooled and presented together for control (untreated) and oil treated 
groups (CAL, OAL, and ORF birds) 
 
Hens treated with E2 showed increased (P<0.01) levels of plasma CHOL and TG at 24 h and week 
1, 2, and 3 after treatments (Figure 6.3 and Figure 6.4). In both E2 treated groups (EAL and ERF) 
plasma CHOL rose after 24 h and was elevated during the experimental period, however, ad 
libitum treated hens had higher (P<0.05) levels of CHOL than hens in restricted feed intake 
treatment. In terms of TG, all E2 treated birds had higher (P<0.01) plasma levels than controls, 
found in all measurement points after first treatment with E2. In all control birds there were no 
significant changes in plasma CHOL or TG levels in all measurement points.   
 
Measurements of plasma TP showed slight non-significant changes of TP concentrations in all 
birds. There were found a lower TP concentration in EAL and ERF groups at 1 wk after treatments 
with E2 (Figure 6. 5).  
 
For this study, both AST and GGT were measured in all birds to study changes in plasma liver 
enzyme concentrations of treated or untreated birds. However, changes in GGT concentrations 
were lower and insignificant (data not shown). The levels of plasma AST are shown in Figure 6.6 
revealing a significant decrease of AST levels in particular at 24h, 1 wk, and 3 wk after first 
treatment with E2 in both E2 treated groups, EAL and ERF. At week 3, levels of AST were found 
lower than in birds not treated with E2 however this decrease was not statistically significant. 
According to the schedule for E2 treatment this sampling point was planned 1 day before the next 
treatment with E2.  
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Figure 6.3  Plasma cholesterol (mmol/L) levels in oestradiol treated and untreated birds. 
    Each data point is average of 6 measurements. 
 
 
Figure 6.4  Plasma triglyceride (mmol/L) levels in oestradiol treated and untreated birds 
     
Each data point is average of 6 measurements. 
TG = Triglycerides. 
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Figure 6.5  Plasma total protein (g/L) levels in E2 treated and untreated birds. 
 
Each data point is average of 6 measurements; 
    TP = Total protein. 
 
 
 
 
Figure 6.6  Plasma AST (IU/L) levels in E2 treated and untreated birds. 
     
Each data point is average of 6 measurements; 
    AST = Aspartate aminotransferase. 
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6.4.5 Liver macroscopic and histological examination 
 
The liver tissue from birds euthanised at sampling points, or birds that were euthanised or found 
dead (during experimental period) were collected and examined. The majority of livers were pale, 
swollen and friable with different grades of haemorrhages and haematomas on both surfaces 
(dorsal and ventral) or in the edges of both lobes. In advanced cases (haemorrhage score 4 or 5), 
liver tissue was ruptured and small superficial or deep haematomas and or large blood coagula 
were found inside the abdominal cavity (Figure 6.7a,b and 6.8a,b). Hens with liver rupture died 
during the experiment; most deaths in E2-treated birds happened in the first or second week of 
treatment (see Table 6.2 for the mortality rates). Hens that had haematomas survived and were 
diagnosed with FLHS at necropsy after euthanasia (Figure 6.8). Data on liver tests (i.e. relative 
weights and fat content) showed that E2 treatment resulted in a significant (P<0.05) increase in 
liver relative weight and fat content of treated hens vs. controls (Table 6.2). 
 
Oestradiol treatment resulted in an increased infiltration of liver tissue and hepatocytes with fat. 
This can be seen macroscopically in Figure 6.7. Histologically, all livers had significant slight or 
moderate lipid accumulation (Figure 6.9 a, b). However, E2-treated birds demonstrated severe fat 
deposition, as indicated by the presence of small or large fat droplets in hepatocytes, or large 
vacuoles of fat filling the cytoplasm and distending hepatocytes (Figure 6.10 a, b). In addition to 
fat deposition, histological sections of E2-treated birds indicated focal inflammatory (heterophilic 
and/or lymphocytic/ mononuclear) infiltration, local haemorrhage and congestion of sinusoids, 
demonstrating an increased incidence of inflammation and haemorrhage Fig 6.11 a, b). Massive 
lipid infiltration, diffuse inflammatory infiltration and congestion were observed especially in the 
liver parenchyma of birds that macroscopically demonstrated severe lesions of FLHS.  
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            (a) 
 
 
    
(b) 
  
 Figure 6.7 Livers from oestradiol treated hens showing increased fat content, and haematomas 
and haemorrhage.  
 
Pictures presented here show livers removed from birds after first week of tretament with E2, 
showing an increased fat content (fat shown on the surface of the organ) and small haematomas (a) 
and haemorrhage or blood coagula in the abdominal cavity (b). 
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(a) 
 
 
       
(b) 
 
Figure 6.8 Livers from oestradiol treated hens showing superficial and deep haematoma. 
 
Pictures presented here show livers removed from birds at the end of the experiment (week 4) 
showing a superficial (a) and a deep haematoma ( b). It was suggested that these birds survived until 
experiemnt ended but stopped egg production in week 2.  
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(a) 
 
  
(b) 
 
Figure 6.9 Histological sections of livers from hens in the control group. 
Pictures showing normal structure of the tissue with some fat deposition (yellow arrows) in 
hepatocytes, and small fat vacuoles around the nucleus (microvesicular fatty change); 
H&E stain, using x200 (a) and x400 (b) magnification; portal triad = PT. 
PT 
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(a) 
 
 
(b) 
 
Figure 6.10 Histological sections of livers from oestradiol treated hens (after week 1). 
Yellow arrows showing fat vacuoles in hepatocytes (a & b) and fat droplets in the enlarged sinusoid 
(a); nucleus disappeared or displaced to periphery in hepatocytes (macrovesicular steatosis). Note 
focal infiltration with leukocytes (green arrow) near central vein (CV); 
H&E stain, using x400 magnification.  
CV 
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(a) 
 
 
(b) 
 
Figure 6.11 Histological sections from livers of oestradiol treated hens (after week 2). 
 
Extensive tissue infiltration with fat droplets (yellow arrow), leukocytes (green arrow), and 
erythrocytes (red arrow); the infiltration is most prominent near the central vein (a) and extends 
outward toward the portal tract. Hepatocytes are paler (a) and bigger (b) due to macrovesiculas or 
vacuolation; H&E stain, at x400 magnification. 
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6.4.6 Body Weight 
 
Body weights of birds in both ad libitum fed groups (CAL and EAL birds) increased after the first 
week of the experiment. However, the difference was not statistically significant (Figure 6.12). 
Hens in both restricted feed intake groups (CRF and ERF) had their BW reduced (P<0.01) in the 
second week of the experiment or when compared to their initial body weight or hens fed ad 
libitum. In the second week of treatments, BW of CRF and ERF birds continued to remain lower 
(without recovering), and continued to slightly reduce until the last week of the experiment (at 
week 4, i.e. 1 wk after the treatment was interrupted). At week 4, hens in restricted feed intake 
groups had lower BW (P<0.01) than all other hens (CAL vs. CRF, 1892 vs. 1687g). At week 4 
there was a slight increase in BW of CAL and EAL hens as compared to their initial BW, however 
this was statistically not significant (P=0.06). 
 
 
Figure 6.12 Body weights (g) of treated and control birds
1,2
  
1
CAL = control and ad libitum; CRF = control and feed restricted; EAL = oestrogen-treated and ad 
libitum; ERF = oestrogen-treated and feed restricted; 
2
Values are presented as mean ±SEM (initial number was n=16, thereafter the number was reduced 
in all groups as every week 3 hens per group were euthanised). There were no significant differences 
between untreated and oil-treated groups; therefore, data are pooled and presented together. 
Significant differences between groups are represented by *P<0.05. 
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6.4.7 Egg production 
 
As shown in Figure 6.13, hens had achieved their peak of production at 30-31 wk of age, and 
entered the experiment with the majority producing over 95%. Egg production was not affected 
after the first week of experiment, although the calculations of %HDP showed that there was a 
slight decrease (P>0.05) in the number (and %) of the eggs produced in the first week from all 
hens, untreated and treated hens. Hens in both restricted feed intake groups had a slight decrease in 
egg production at wk 1 and wk 2; however, only at week 3 and 4 did the %HDP decreased 
significantly (P<0.05) in CRF and ERF hens when compared to ad libitum fed hens. One week 
after the treatment was interrupted (at week 4), all hens treated with E2 (in the ad libitum and 
restricted feed intake diet groups) and untreated hens (in the restricted feed intake diet group) had 
reduced (P<0.05) %HDP when compared to initial %HDP at 30wk of age or hens in the ad libitum 
control group.  
 
 
 
Figure 6.13 Egg production (HDP) of treated and control birds
1,2
 
1
CAL = control (ad libitum feed intake); CRF = control (restricted feed intake); EAL = oestrogen-
treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); HDP=Hen day 
production. 
2
Values are presented as mean ±SEM (initial number was n=16, thereafter the number was reduced 
in all groups as every week 3 hens per group were euthanised). There were no significant differences 
between untreated and oil-treated groups; therefore, data are pooled and presented together. 
Significant differences between groups are represented by *P<0.05. 
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6.4.8  Egg weight 
 
Egg weight data of control and treated hens are shown in Figure 6.14. Hens entered the experiment 
with an average of egg weight of 57.8 g. There were slight changes (in both directions) in egg 
weights of hens after first and second week of the experiment; however none of differences was 
statistically significant. At Week 3 post-initial treatment with exogenous E2, egg weights of E2-
treated ad libitum diet hens were increased significantly (P<0.05) (Figure 6.14). At scheduled 
necropsy hens from EAL group had their ovaries full with large yolks (Figure 6.15) and their 
livers were very fatty and fragile. Egg weights from hens in the restricted feed regimen were 
slightly decreased during the experiment; there was a significant decrease in egg weights of these 
hens at Week 4 of the experiment.  
 
Correlation analyses between E2 levels and egg weights of E2 treated hens at wk 3 showed a high 
positive correlation (Pearson‘s correlation, r= 0.90; P<0.01).   
 
 
 
Figure 6.14 Effects of exogenous oestradiol on egg weights
1
 of treated and untreated birds. 
 
1
CAL = control (ad libitum feed intake); CRF = control (restricted feed intake); EAL = oestrogen-
treated (ad libitum feed intake); ERF = oestrogen-treated (restricted feed intake); 
2
Values are 
presented as mean ±SEM (initial number was n=16, thereafter the number was reduced in all groups 
as every week 3 hens per group were euthanised). There were no significant differences between 
untreated and oil-treated groups; therefore, data are pooled and presented together. Significant 
differences between groups are represented by *P<0.05 
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Figure 6.15 Yolks, an egg and liver from hens treated with oestradiol (EAL group).  
EAL = oestrogen-treated (ad libitum feed intake) group.  
These samples were taken at week 2 post-treatment in hens that were randomly euthanised for 
sampling. 
  
 
6.4.9  Feed intake of hens fed ad libitum 
 
There were no significant differences in the feed intake of hens in both groups fed ad libitum (E2 
treated or control hens). However, hens in CAL, EAL consumed on average 115 to 122 g/bird/day 
during the whole experimental period. 
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6.4.10  Ovary  
 
The ovary of hens was inspected for internal ovulations, internal oviposition, ovarian enlargement 
or regression and follicular atresia. There was an enlargement of the ova in EAL treated hens 
(Figure 6.16) compared to control hens, while hens in CRF and ERF showed a reduction of large 
yellow follicles. No internal ovulations were found in any of treated or untreated birds. 
 
     
 
Figure 6.16 The ovary of a laying hen showing the stroma (pool of undifferentiated 
follicles) and large yellow follicles.  
From a hen in the control group (a), and a hen from oestrogen-treated (ad libitum feed intake) group 
(b).  
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6.5  Discussion  
 
The laying hen model described by Stake et al. (1981) was employed in this study. It successfully 
induced FLHS under experimental conditions using modern laying hen genotypes. Stake et al. 
(1981) had shown significant breed differences in response to exogenous E2 injections with the 
response of White Leghorn hens mimicking clinical cases. In the model, two dosing regimens 
were used and in the current study, the lower oestrogen dose (5mg/kg BW) was applied and FLHS 
was induced in hens. In the adult bird, the rate of secretion of oestradiol by the ovary is of the 
order of 1–2.0 mg oestradiol/24 h (Hawkins et al., 1969), while the clearance rate for oestradiol 
has been calculated to be between 6.3 and 11 ng/min or 9 and 16 μg/day (Johnson and van 
Tienhoven, 1981; Tsang and Grunder, 1984). The current results demonstrate that a dose 5mg/kg 
BW of E2 (which is equivalent to 1.25 mg/kg BW/day) increased circulating concentrations of the 
hormone sufficiently above physiological values to induce the condition without the side effects 
noted by Stake et al. (1981) in Rhode Island Red hens. 
 
The successful application of the model allowed further investigation of the role of oestradiol in 
the condition. Many investigators had previously suggested that oestrogen, along with a positive 
energy balance, is necessary for the production of FLHS (Haghighi-Rad and Polin, 1982a; Harms 
et al., 1977; Pearson and Butler, 1978b; Polin and Wolford, 1977; Stake et al., 1981). The model 
also allowed the effect of feed intake (ad libitum vs. restricted feed intake) on the incidence and 
progression of FLHS to be studied. 
 
6.5.1  Oestradiol 
 
The disease was experimentally induced in laying hens of 30 weeks of age after injections of 
hormone oestradiol. The administration of exogenous E2 was associated with significant changes 
in the liver relative weights, and macroscopic (fat depositions, haemorrhages and haematomas) 
and microscopic (liver structure) alterations. The reproduction of the disease in the hen was 
associated with an increased mortality due to FLHS outbreak.  
 
The measurements of E2 concentrations demonstrated that E2 levels were significantly elevated 
(P<0.01) in treated hens, and were responsible for all significant differences in recorded 
parameters. In laying hens, baseline E2 increases 1 to 2 days after photostimulation and is 
maintained at a high level until egg production starts to decline (Etches and Cheng, 1981). At the 
same time as E2 elevation, hepatic lipogenesis is increased dramatically in hens in order to meet 
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the demand for vitellogenesis (Hansen and Walzem, 1993). Although the main products of de 
novo hepatic lipogenesis are triglycerides, the liver is also the major site of cholesterol and 
phospholipid synthesis (Chapter 2). These lipids, along with protein, are the main components of 
lipoproteins. In the laying hen, many factors, both external (e.g. nutritional and environmental 
factors) and internal (e.g. hormones and other mediators), may stimulate lipid metabolism and 
increase fat deposition in the liver and abdominal cavity. The increase in liver fat content is a 
characteristic of hens, and is related to special structural and physiological features participating in 
lipid absorption, synthesis, distribution and transport in to intra- and extrahepatic compartments, 
including the ovary (see Chapter 2). As emphasized in the literature review, dietary lipids are 
absorbed and secreted directly into the portal blood system, in the form of VLDL and are termed 
portomicrons. Lipogenesis that occurs mainly in the liver under the influence of E2 is particularly 
active in females producing eggs. Exogenous and endogenous lipids once secreted into the blood 
are transported by the blood to the ovary as components of lipoproteins. Fatty livers are normal for 
egg producing hens and occur when the increase in lipogenesis exceeds the capacity of synthesis 
and secretion of lipoproteins (Hermier, 1997).   
 
In this study, E2 level rose significantly in birds exposed to exogenous oestrogen, and peaked some 
3 to 4 times higher than untreated birds. Under the influence of E2, hens fed ad libitum 
experienced severe FLHS which was associated with an increase in mortality (approx. 20% of 
treated hens in this group vs. 0% of control ad libitum fed hens). Hens that did not die from FLHS 
were diagnosed with FLHS at necropsy and with ca. 88% of them having very high haemorrhagic 
score of 4 to 5. Oestrogen-induced hens from the restricted feed group also developed FLHS, but 
with a lower frequency in mortality (ca. 6.5% vs. 20%, for restricted feed vs. ad libitum hens, 
respectively) and haemorrhagic score of 4 to 5 (69% vs. 88% for restricted feed vs. ad libitum 
hens, respectively).  
 
6.5.2 Feed intake 
 
As expected, ad libitum fed hens demonstrated a higher incidence of FLHS than hens with a 
restricted feed intake. This was in agreement with previous studies (Haghighi-Rad and Polin, 
1982a; Harms et al., 1977; Lee et al., 1975; Pearson and Butler, 1978b; Stake et al., 1981) that 
birds with a greater feed intake are more at risk from FLHS than birds with a lower feed intake. 
Birds in control untreated groups did not develop FLHS and showed low haemorrhagic scores at 
necropsy. 
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In response to restricted feed intake, birds in CRF and ERF groups demonstrated a decline in BW 
at week 2, 3, and 4 after the restricted feed intake diet started. These birds also had a change in egg 
production (%HDP), which was significantly reduced in weeks 3 and 4 of the restricted feed 
intake regimen. With regard to egg weights, a significant decrease (P<0.05) was only seen in the 
CRF group at week 4, while egg weights of E2 treated ad libitum hens were significantly increased 
(P<0.05) in week 3. Reductions in BW and egg production have been previously described in hens 
given a restricted feed intake in experiments with fatty liver (Pearce, 1980; Sallmann and Schole, 
1973; Stake et al., 1981). Pearce (1980) demonstrated significant reductions in liver total lipid 
content compared with ad libitum fed control birds and also reductions of hepatic lipogenic 
enzyme activities. In the current study, only changes in relative liver weight and liver fat content 
were measured, and they were significantly increased in E2 treated hens (both ad libitum and 
restricted feed intake groups) when compared to untreated birds. Control (untreated) birds, both ad 
libitum and restricted feed intake groups, had insignificant differences in liver weights and liver fat 
content (Table 6.2).  
 
Overall, restriction of feed intake reduced the occurrence of FLHS of hens treated with E2, in 
terms of mortality and haemorrhagic score, and also affected their performance. The idea of 
reducing feed intake by 10 % of hens treated with E2 was to reduce the total energy intake or 
minimise the positive energy balance in hens without disturbing their physiology. In relationship 
to decreases in BW and egg production, it should be noted that hens fed ad libitum consumed ca. 
120 g/bird/day, suggesting that the feed intake of hens in CRF and ERF groups was reduced more 
than 10% or ca. 20 g/bird/day. Perhaps this is why hens in these groups had reduced BW, egg 
production and egg weight at weeks 3 and 4 after the treatments started. 
 
6.5.3 Hepatic responses 
 
Injections of E2 induced a significant increase in relative liver weight and liver fat content (Table 
6.2), presumably through the hormonal induction of hepatic lipogenesis. The histological 
examination of liver samples showed that all hens had some degree of hepatic fat infiltration 
(microvesicular fatty change). However, hens treated with E2 had consistent and severe infiltrations 
with fat and fat vacuolisations (macrovesicular fatty degeneration or steatosis). This is one of the 
most striking early events that had been observed after E2 exposure in the chicken. The current 
study was in accord with previous observations and demonstrated transient, massive accumulation 
of lipids (Figure 6.10b) in the cytoplasm of hepatocytes (Cherian and Goeger, 2004; Pearson and 
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Butler, 1978c; Walzem et al., 1993) in which a single, bulky fat vacuole distends the hepatocyte and 
pushes the nucleus and cytoplasm to the side.  
 
Interestingly, apart from large vacuoles in the liver parenchyma, histological examination revealed 
fat droplets in the liver sinusoids (Figure 6.10b). Sinusoids represent distensible vascular channels 
that carry mixed (from portal vein and hepatic artery) blood from the edges of the lobule to the 
central vein. The central vein empties into the hepatic vein, then blood is delivered to the inferior 
vena cava (Figure 6.17a) (Sturkie, 1986). The sinusoidal wall is formed by 4 different cells: 
fenestrated endothelial cells, Kupffer cells (liver-resident macrophages), fat-storing cells (Ito or 
stellate cells or lipocytes or Vitamin A storing) and pit cells (the natural killer cells of the liver) 
(Figure 6.17b). Sinusoidal endothelial cells permit hepatocytes to access nutrients and 
macromolecules in plasma, and are also responsible for endocytosis of molecules and particles such 
as lipoproteins (Tanaka et al., 2011; Wisse et al., 1996). Previous investigators have not 
demonstrated the presence of fat droplets in the sinusoids or blood vessels of the liver in the 
chicken.  
 
It is recognised that the absorption of exogenous fat in birds occurs directly via the portal blood 
system, as VLDL or portomicrons, which are rapidly taken up by the liver. Unlike mammals, the 
liver in birds is directly exposed to dietary fat, and is also the major site of lipogenesis 
(Bickerstaffe and Annison, 1970). One interesting characteristic of chicken liver structure is that 
the fenestra in the sinusoidal endothelium are smaller in size and lower, in number; therefore the 
endothelium is less porous, than in mammals. It has been suggested that this property prevents the 
hepatocytes from being swamped by dietary fat, but makes the chicken susceptible to diet-induced 
atherosclerosis (Fraser et al., 1986). As in women, oestrogen reduces atherosclerosis in chickens, 
mainly in the coronary arteries (Beaufrère, 2013; Petzinger and Bauer, 2013). The fenestrated 
endothelial cells act as a liver sieve by allowing macromolecules and chylomicrons to traverse 
through their fenestrations (sieve plates) to hepatocytes. Apparently, large particles that cannot 
pass the fenestrae in the sinusoidal capillary bed and cannot be also metabolized by the liver 
(Figure 6.9b) are trapped inside the sinusoids. These specific features of chicken liver structure 
will be discussed further in Chapter 7 in relation to a hen‘s predisposition to fat deposition and 
FLHS. 
  
120 
 
 
 
 
(a) 
 
 
 
 
(b) 
 
Figure 6.17 Schematic drawing of blood circulation in the liver and liver sinusoidal cells.  
(a) Source: http://www.siumed.edu/~dking2/erg/liver.htm; 
(b) Tanaka et al. (2011). 
 
121 
 
6.5.4 Haematology 
 
In this study haematological parameters were used to follow the progression of FLHS in the hen 
model. It was thought that these parameters (particularly the RBC and HCT) would help to predict 
any recent haematoma or haemorrhage in the liver or abdominal cavity of hens treated with E2. It 
is recognised that the HCT is one of the most precise methods of determining loss of blood or the 
degree of anaemia, while the RBC count is usually evaluated with HCT to confirm the presence of 
anaemia and differentiate it from excessive hydration. The HCT and RBC counts are usually 
decreased in haemorrhages and haematomas (Lumeij, 2008). In this study, there were no 
significant changes (P<0.05) in HCT and RBC values. This could have happened because birds 
usually have good tolerance of the loss of up to 10% of their circulating blood volume (Sturkie, 
1986). Like in other animals and humans, when birds lose a quantity of blood (under 10% of their 
circulating blood volume) they experience a physiological stress, yet the RBC counts and HCT 
generally remained only slightly depressed (Kovach et al., 1969).  
 
In the case of small internal haemorrhages and haematomas, a simultaneous release of RBC from 
reserves in the bone marrow, and rapid fluid replacement or relocation across compartments 
happens (Sturkie and Griminger, 1986). Even though many hens had haemorrhages and 
haematomas, this situation was not clinically exhibited in the blood parameters measured, as 
several homeostatic pathways may have compensated for the amount of blood lost in haematomas. 
In the case of liver capsule rupture and large haemorrhages in the abdominal cavity, it has been 
suggested that hens die suddenly (Julian, 2005) due to hypovolemic shock (within minutes) or 
signs of peritonitis (within 24 h). In addition to RBC, total WBC counts were recorded to monitor 
the general health and the immune response of hens.  
 
In this study, alteration of WBC counts and fibrinogen levels were found in hens treated with E2 
when compared to controls (Table 6.3). This is the first demonstration of increased WBC counts 
and fibrinogen in oestrogenised birds. As in mammals, the elevation of these parameters in birds 
demonstrates increased systemic inflammation and tissue repair (Latimer and Rakich, 2007). Hens 
treated with E2 had a significant increase in leukocytes 24 h post-treatments and this number 
continued to increase in week 1, 2 and 3. Simultaneously, there was an elevation of plasma 
fibrinogen which correlated to the WBC increase, with the exception that on week 3 fibrinogen 
levels decreased presumably due to liver damage impacting on fibrinogen synthesis in the 
hepatocytes (Brunt, 2010; Nagata et al., 2007). Fibrinogen is a moderate acute phase protein that 
circulates in the plasma at a concentration of 2 g/L to 4 g/L with a half-life of approximately 4 
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days, increasing in concentration in response to most forms of tissue injury, infection, or 
inflammation (Gruys et al., 2005; Mosesson et al., 2001). The ability of fibrinogen to participate in 
the inflammatory response depends on its specific interaction with leukocyte cell surface adhesion 
receptors, integrins (Mosesson et al., 2001; Ugarova and Yakubenko, 2001). In humans, changes 
in markers of inflammations including leukocytes and fibrinogen are seen as a response to low-
grade inflammation at local (leukocyte recruitment into the tissue) (Temelkova-Kurktschiev et al., 
2002), and systemic (Haukeland et al., 2006) levels. The discussion on the role of WBC and 
fibrinogen in the pathogenesis of FLHS is further discussed in Chapter 7. 
 
6.5.5 Clinical biochemistry 
 
In order to fully assess liver health, responses of plasma metabolites, CHOL, TG, TP, and AST, 
were measured (see Figures 6.3, 6.4, 6.5 and 6.6). The data show that E2 induced 
hypercholesterolemia and hypertriglyceridemia which were associated with severe impairment of 
liver histology (fat accumulation, inflammation and cell-vacuolisation) (Figures 6.8b, 6.9a,b and 
6.10a,b). Plasma AST and TP were also significantly affected in E2 treated birds (especially in 
restricted feed intake hens), probably reflecting the consequences of an increased deposition of TG 
and CHOL in the liver of birds temporarily impacting hepatic  protein synthesis (Limdi and Hyde, 
2003). It should be noted that, when a liver is partially damaged and hepatocytes are filled with fat 
droplets, swelling and necrosis may occur. However the mitotic activity in the remaining cells 
begins as early as 12 hours later, eventually restoring the liver to its normal weight (Bertalanffy et 
al., 1970; Michalopoulos, 2014; Sidorova, 1962). This remarkable capacity to regenerate after 
injury and the large reserve capacity of the liver tissue make it technically difficult to detect clinical 
changes and diagnose liver diseases. Many previous investigators have recommend measurements 
of plasma enzymes to test for FLHS (Diaz et al., 1999; Pearce, 1980; Walzem et al., 1993). 
However, as these investigators suggest, these tests are indicative of liver damage in birds, and do 
not specifically demonstrate the presence of liver damage due to FLHS. In this study both GGT and 
AST were measured, but only AST was significantly reduced in E2 treated hens, reflecting the 
situation was associated with a disordered metabolic state and liver dysfunction.  
 
This study confirmed the important involvement of oestrogens in lipid metabolism and the 
disturbance of the lipid metabolism due to elevation of E2 associated with an increase in positive 
energy balance. Most importantly, the results suggest that the inflammatory response is a 
contributor to the pathogenesis of FLHS. Further studies are required to explore the interaction of 
these pathways, especially the role of inflammation.  
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PATHOGENESIS OF FLHS   
 
7.1  Introduction …………………………………………………………………………….123 
7.2  Materials and methods …………………………………………………………….126 
7.2.1 Laying hens and housing conditions …………………………………….126 
7.2.2 Experimental design ………………………………………………………...126  
The justification for using E2 and LPS …………………………………….126 
Details of the E2 and LPS hen model.……………………………………...126 
7.2.3 Sampling and tests ………………………………………………………...128 
Blood samples ………………………………………………………………...128 
RNA extraction and real-time quantitative RT-PCR …………………….128 
Mortality rate and causes of mortality …………………………………….131 
Liver histology ………………………………………………………………...131  
Performance parameters …………………………………………………….131 
7.3  Statistical analysis …………………………………………………………………….131 
7.4  Results ………………………………………………………………………………...132 
7.4.1 Cytokine gene expression in the liver …………………………………….132 
7.4.2 Blood cell counts …………………………………………………………….133 
7.4.3 Fibrinogen …………………..………………………………………………...136 
7.4.4 Plasma metabolites and gamma glutamyl transferase levels ………...137 
7.4.5 Mortalities and necropsy results ………………………………………...139 
7.4.6 Liver histological examination …………………………………………….140 
7.4.7 Performance parameters …………………………………………………….144 
7.5  Discussion …………………………………………………………………………….145 
 
 
7.1  Introduction  
 
As discussed in the literature review, evidence has accrued in recent years showing that the 
dysfunction of metabolic processes and immune response pathways underlies many chronic 
metabolic diseases, including non-alcoholic fatty liver diseases (NAFLD) that occurs in man as a 
consequence of acquired or inherited overeating in the setting of reduced physical activity 
(Hotamisligil, 2006; Hotamisligil and Erbay, 2008; Osborn and Olefsky, 2012). It is also well 
established that obesity in humans is associated with a state of chronic low-grade inflammation 
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(metabolic inflammation) that is a major player in the link between metabolic syndrome and fatty 
liver disease (Cusi, 2012; Wisse, 2004). Fatty liver and FLHS are similar metabolic disorders that 
are associated with comparable factors such as diet, increased feed intake, and lack of exercise.   
 
Inflammation is known to be a defence mechanism triggered when innate immune cells detect 
infection or tissue injury (Newton and Dixit, 2012). Although inflammation itself is a very complex 
process and involves many cell types and molecules, a number of the participating molecules are 
multifunctional and contribute to the inflammatory response at different stages, such as, the 
initiation, the control during the progression, and its resolution (Serhan, 2011). The main function 
of inflammation is to resolve the infection or the injurious process, facilitate repair, and return to a 
relative state of homeostasis. The ideal inflammatory response is rapid and destructive (when 
necessary), yet specific and self-limiting (Barton, 2008). During the early inflammatory response, 
immediate pro-inflammatory mediators are released, which initiate and enhance the acute phase 
response (Gruys et al., 2005). The acute phase response results in a complex systemic reaction 
associated with the production of markers of inflammation: acute phase proteins (APP) or blood 
proteins, and immune cytokines (Cray et al., 2009). The APPs are primarily synthesized by 
hepatocytes and have defensive and repair functions to reduce pathologic damage, promote healing 
and restore homeostasis (Gruys et al., 2005). In addition, the immune cytokines secreted by a 
variety of cell types (polymorphonuclear leukocytes, fibroblasts, endothelial cells, monocytes, 
lymphocytes) play an essential role, not only in regulating inflammatory processes but also in 
modifying a variety of normal physiologic and metabolic processes (Schett et al., 2013). 
 
There is accumulating evidence indicating that adipose tissue is an endocrine organ capable of 
synthesizing a number of biologically active compounds that regulate metabolic homeostasis 
(Coelho et al., 2013). Both the adipocytes and inflammatory cells (that migrate in adipose tissue 
and/or liver during the acute phase response) secrete numerous pro-inflammatory cytokines. In 
particular, the intra‐abdominal WAT is strategically located to flood the liver with pro-
inflammatory cytokines via the portal circulation, and alter hepatic protein synthesis (Libby et al., 
2010). In addition, lipid droplets in hepatocytes, like adipocytes, are seen as inducible organelles 
with roles in cell signalling, regulation of lipid metabolism, membrane trafficking, and control of 
the synthesis and secretion of inflammatory mediators (Anderson and Borlak, 2008; Arisqueta et 
al., 2013; Bozza and Viola, 2010). Presumably, hepatocyte lipid droplets could be implicated in 
impairment of hepatic protein synthesis. Among the proteins of the acute phase response affected 
by inflammatory cytokines is fibrinogen. Fibrinogen is a clotting factor that provides a substrate for 
fibrin formation and thus is important in tissue repair. Moreover, fibrinogen plays a multifaceted 
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role in the immune and inflammatory response (Mosesson et al., 2001). It regulates leukocyte 
function in inflammation including cell adhesion, migration, cytokine and chemokine expression, 
degranulation, and other specialized processes (Flick et al., 2004; Ugarova and Yakubenko, 2001).  
 
As mentioned above, the role of the inflammatory response is to resolve infection and injury. 
Nevertheless, increasing evidence indicates that low-grade chronic inflammation may be the cause 
of several conditions and diseases associated with obesity, including type-2 diabetes, cardiovascular 
diseases, and fatty liver disease (Paschos and Tziomalos, 2012). In the previous chapter, it was 
demonstrated that hens treated with E2 showed an increased inflammatory response as demonstrated 
by changes in peripheral blood (elevated leukocyte numbers and fibrinogen levels) and structural 
alterations of liver tissue. This study suggested that, in addition to the metabolic pathways (altered 
metabolic profiles), the inflammatory and immune pathways were involved in the hen‘s response to 
elevated oestrogen levels.  
 
A question that arose from Chapter 6 was to what extent does inflammation (as a part of acute 
phase response) contribute to the progression (pathogenesis) of fatty livers, and most importantly to 
the precipitation of FLHS outbreaks (liver rupture and haemorrhage as an endpoint of this 
condition). Perhaps, in the field hens are exposed to an inflammatory insult, in addition to E2 to 
develop FLHS. Lipopolysaccharide (LPS) is an endotoxin (the major outer membrane constituent 
of gram-negative bacteria) and a potent inducer of inflammation (Kaisho and Akira, 2002). 
Challenging hens with LPS from Escherichia coli would induce low-level hepatic inflammation and 
mimic the challenges experienced by commercial laying hens. 
 
The aim of this study was to investigate the effect of challenging hens with E2 and LPS to allow 
examination of metabolic and inflammatory markers in a controlled manner. The objectives of this 
study were: 
 
i) To evaluate important markers of inflammation e.g., peripheral leukocyte, plasma 
fibrinogen levels, and mRNA expression levels of proinlammatory cytokines in 
hepatocytes, and examine the progression of liver injury (through necropsy and 
histological examination).  
ii) To establish a relationship between liver inflammation (i.e. the expression of mRNA 
proinflammatory cytokines levels in the hepatocytes) and the incidence of FLHS in hens 
treated with E2, LPS and E2&LPS. 
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7.2  Materials and Methods  
 
7.2.1 Laying hens and housing conditions 
 
In terms of birds, housing conditions and the diet this experiment was a repetition of the oestradiol 
hen model (see Chapter 6.2.1 for more details).  
 
7.2.2 Experimental design 
 
The justification for using E2 & LPS 
 
The rationale for using LPS as an inflammatory factor involved in the FLHS-hen model was based 
on the previous study (Chapter 6), where an increased inflammatory response was demonstrated in 
experiments with oestradiol. Moreover, studies with human and mouse models had confirmed that 
circulating endotoxin levels were elevated in patients with NAFLD (Harte et al., 2010). It was 
suggested that LPS, oxidative stress, cytokine production and other proinflammatory mediators 
each play roles in delivering a ‗second hit‘ during the transition from simple steatosis to NASH 
(Farrell and Larter, 2006). It is recognised that LPS facilitates a rapid reaction to infection via 
stimulation of toll-like receptors (TLRs), and activation of the innate immune pathways (i.e. it 
represents the first line of defence against gram-negative infections) (Kaisho and Akira, 2002). The 
liver is one of the LPS target organs (Pagani et al., 2003), and it has been also established that it is 
the clearance organ for LPS (Mimura et al., 1995) and inflammatory mediator production (Pagani et 
al., 2003).  
 
The hypothesis in the present study, was that hens treated with E2 and LPS will exhibit more rapid 
onset and greater inflammatory responses, and experience higher incidence of FLHS in terms of 
liver tissue alterations, than control hens or hens treated with E2 only. 
 
Details of the E2 and LPS hen model 
 
The E2 hen model was induced in 30-week-old Hi-sex laying hens (see Chapter 6). Birds were 
housed in a temperature-controlled shed with a 16 h light: 8 h dark cycle and had ad libitum access 
to water and food. Hens were randomly assigned to 6 treatments with 18 replicates for each 
treatment (n=18). All groups were fed a commercial layer diet during 3 weeks of experimentation 
(for diet ingredients see Appendix 2).  
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Birds treated with oestradiol were injected with exogenous E2, 5mg/kg body weight i.m. every 4 
days (day 1, 5, 9, and 13) (Table 7.1). For more details on E2 treatment see Chapter 6.2.2. For the 
LPS treatments, hens were injected intravenously (i.v.) with a single moderate dose of 8 mg/kg 
body weight of ultra-pure E. coli 0111:B4 strain LPS (InvivoGen, San Diego, CA, USA). 
Oestradiol was administered dissolved in 0.5 mL corn oil/kg BW, while for LPS injections 0.5 mL 
of PBS /kg BW was used. Birds in the control group were not treated, whereas birds in control-
treated groups were injected with 0.5 mL vehicle alone (oil or saline solution, respectively).  
 
 
Table 7.1 Summary of the treatments and samples collected for the E2&LPS hen model 
experiment. 
Groups
1
  Treatment 
/day 
Dose/route Samples 
/time
2
 
Performance 
records
3,4
 
Control Untreated Nothing Blood, Liver;  
0 h, 3h, 24 h,  
1 wk, 2 wk  
HDP% 
Mortality: daily  
BW: 24h, weekly 
Saline PBS 
Day 1 
0mg/0.5 mL  PBS/kg BW, i.v. The same The same 
Oil Oil 
Day 1,5,9,13 
0mg/0.5 mL  oil/kg BW, i.m. The same The same 
E2 E2  
Day 1,5,9,13 
5mg/0.5mL oil/kg BW, i.m. 
 
The same The same 
LPS LPS  
Day 1,5,9,13 
8mg/0.5mL PBS/kg BW, i.v. The same The same 
E2 & LPS E2&LPS 
LPS: Day 1  
E2:Day 1,5,9,13  
 
 
8 mg/0.5 mL PBS/kg BW, i.v. 
5mg/0.5 mL oil/kg BW, i.m. 
 
The same The same 
1
E2 = oestrogen-treated; LPS = LPS-treated; E2 & LPS-treated; Oil = corn-oil treated; Saline = PBS-treated;  
2
Last treatments were on day 13; samples and records were taken on day 14 or 2 wk after first treatment with E2 or 
LPS. 
3
Feed was provided ad libitum to all groups; 
4
%HDP= % hen day production; BW = body weight; i.m. = intramuscular; i.v. = intravenous.  
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7.2.3 Sampling and tests 
 
Blood samples were collected at 3 h, 24 h, and on day 7 and 14 post first treatments with E2 and 
LPS injections. At each sampling point, three hens per treatment were euthanised for necropsy 
records and liver samples. Other hens in the experiment were observed for their general health and 
welfare status; all hens were euthanised on day 14 of the experiment.  
 
Blood samples  
 
Blood samples were taken using individual EDTA vacuntainers and individual blood tubes from the 
wing vein. Each bird was appropriately restrained to ensure as little stress as possible on the bird. 
Whole blood was used to measure haematological parameters in an automated analyser (CELL-
DYN® System 3700CS, Abbott Park, IL 60064), including the total number of red blood cells 
(RBC), the total number of white blood cells (WBC) and percentages of white blood cell 
differential counts.  
 
For other analyses, blood was centrifuged (1,500 rpm for 10 min) and plasma was stored at -20ºC. 
Blood concentrations for plasma metabolites were determined for CHOL, TG, TP, and GGT using 
commercial kits and a chemistry system (VetTest chemistry analyser, IDEXX Laboratories, Inc. 
USA). For detailed information on chemical analyses see Chapter 3.3.2. In addition to these 
metabolites, measurements of plasma fibrinogen levels were carried out. Plasma fibrinogen content 
was determined by the heat precipitation method (Schalm, 1980) (see Chapter 3.2.2). 
 
RNA extraction and real-time quantitative RT-PCR 
 
The mRNA expression levels of IL-1β, IL-6, IL-18 were measured using real-time quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) assays. Three, 30 mg pieces of liver 
were immediately placed into RNA-Later and stored at –20°C prior to RNA purification. Total 
RNA was extracted from liver samples using an RNeasy plus mini kit (Qiagen, Doncaster, VIC 
Australia), following the manufacturer‘s directions. Isolated RNA was eluted in 50 ml RNase-free 
water, and stored at -80°C until use. The yield of total RNA was determined using absorption of 
light at 260 and 280 nm in a Nanodrop (ND-1000) spectrophotometer.  
 
Primers and probes for the house keeping gene (28S) and target genes (encoding IL-1β, IL-6, and 
IL-18) were designed, based upon sequences available from public databases, and synthesised by a 
commercial laboratory (OPERON Technologies, Cologne, Germany). All primers and probes tested 
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in this study are presented in Table 7.2. All probes were labelled with the fluorescent reporter dye 
5-carboxyfluorescein (FAM) at the 5` end and with the quencher N, N, N, N`-tetramethyl-6-
carboxyrhodamine (TAMRA) at the 3` end. Reverse transcription and PCR were performed in 
separate reactions as previously described (Shini et al., 2010). First, 2 μg of RNA were reverse-
transcribed into cDNA in a 20 μl RT reaction using SuperScript™ III First-Strand Synthesis System 
for RT-PCR (Invitrogen, Carlsbad, CA, USA) in a GeneAmp® PCR system 9700 (Applied 
Biosystems, Australia). After template denaturation at 65°C for 5 min, 10 μl of cDNA Synthesis 
Mix were added per tube and the program was continued at 55°C for 50 min, 85°C for 5 min and 
then held at 4°C until removal from the machine. The PCR was performed in a 10 μl reaction 
containing 2 μl of cDNA from the RT reaction, 5 μl TaqMan® Universal PCR Master Mix 
(Applied Biosystems, Australia), 2 μl primer (at 3 μmol) and 1 μl probe (at 1.5 μmol). Each PCR 
plate contained target genes and 28S rRNA in triplicate and a no-template negative control, 
containing 2μl water instead of cDNA. The real-time reactions were carried out on an ABI Prism 
7900HT Fast Real-Time PCR System (Applied Biosystems, Australia) with the following cycle 
profile: 95°C for 10 min, and 50 repeats cycles of 95°C for 15 s and then 60°C for 1 min.  
 
Quantification was based on the increased fluorescence detected by the 7900 Fast Sequence 
Detection System due to hydrolysis of the target-specific probes by the 50 nuclease activity of the 
rTth DNA polymerase during PCR amplification. Results are expressed in terms of the threshold 
cycle value (Ct), the cycle at which the change in the reporter dye passes a significance threshold 
(Rn). To account for variation in sampling and RNA preparation, the Ct values for cytokine-specific 
product for each sample were standardised using the Ct value of 28S rRNA product for the same 
sample. To normalise RNA levels between samples within an experiment, the mean Ct value for 
28S rRNA-specific product was calculated by pooling values from all samples in that experiment. 
Tube-to-tube variations in 28S rRNA Ct values about the experimental mean were calculated. The 
slope of the 28S rRNA log10 dilution series regression line was used to calculate differences in 
input total RNA. Using the slopes of the respective cytokine and chemokine or 28S rRNA log10 
dilution series regression lines, the difference in input total RNA, as represented by the 28S rRNA, 
was then used to adjust cytokine-specific Ct values, as follows:  
 
Corrected Ct value = Ct (Nt – Ct`) S/S` 
where: Ct = mean sample Ct;  Nt = mean experimental 28S;  Ct` = mean 28S of sample;  
S = cytokine slope, and S` = 28S slope; 
 
Results are expressed as differences (n-fold) between treated samples and controls. 
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Table 7.2 Primer and probe sequences for qRT-PCR. 
Target 
RNA 
Probe/ 
Primer
1
 
 Sequence  Accession 
number 
28S P   
F  
R  
5-(FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)-3 
5-GGCGAAGCCAGAGGAAACT-3 
5-GACGACCGATTTGCACGTC-3 
 
X59733 
IL-1b  
 
P 
F  
R 
5-(FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA)-3 
5-GCTCTACATGTCGTGTGTGATGAG-3 
5-TGTCGATGTCCCGCATGA (FAM)-3 
 
AJ245728 
IL-6 P  
F  
R 
5-(FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-
(TAMRA)-3 
5-GCTCGCCGGCTTCGA-3 
5-GGTAGGTCTGAAAGGCGAACAG-3 
 
AJ250838 
 
IL-18 P  
F  
R 
5-(FAM)-TCTTTACCAGCGTCCTACCTTGCGACA -
(TAMRA)-3 
5-GCCCTCCTCCTGGTTTCAG-3 
5-TGGCACCGCAGCTCATT-3 
AJ009800 
1
P, probe; F, forward primer; R, reverse primer. 
  
131 
 
Mortality rate and causes of mortality 
 
Necropsies were conducted at each sampling point or when hens were found dead or in distress and 
immediately euthanised. 
 
Liver histology 
 
The liver was removed, weighed and individually examined for the presence of haemorrhagic 
lesions (for details see Chapter 5.3.3). Liver samples were taken for mRNA extraction and 
histology slides. As described in Chapter 3.3.4, liver samples (small pieces) were fixed in 10% 
formalin and embedded in paraffin. Sections measuring 5µm were cut and stained with H&E. Liver 
slides were examined blind by two independent observers. 
 
Performance parameters  
 
Egg production and mortality records were taken as per experimental design (see Table 7.1), and 
%HDP and mortality were calculated as per Chapter 3.2.3 and Chapter 4.2.3, respectively. Body 
weights were recorded at day 1 time 0 h and then on days 7 and 14.  
 
7.3  Statistics 
 
All biochemical analyses and blood cell counting were done in duplicate for each time point. The 
mean values (±SEM) of plasma metabolites, WBC counts and performance parameters of controls 
and treated chickens were determined by one-way ANOVA for repeated measures (SAS Institute 
Inc, 2001). Differences were further separated using Duncan‘s multiple range test and considered 
significant at P<0.05. Correlations between different significant measures were determined using 
Pearson's correlation coefficient. 
 
For cytokine mRNA expression, statistical analyses were performed using Microsoft Office Excel 
2010 v14.0 (Microsoft Corporation). PCR tests were repeated two times and each sample was 
assayed in triplicate. Data from two repeated experiments were pooled for presentation and 
statistical analysis. The mean and standard error of the mean (mean ± SEM) for all cytokines were 
calculated for each group (controls and treatments). For statistical purposes, an unpaired t-test was 
used to compare two means (control vs. E2 treatment; control vs. LPS treatment and E2 vs. LPS 
treatment) and determine the P value. A 99% confidence interval for the true difference between the 
means was set, and the values were considered significant at P < 0.01.  
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7.4  Results 
As demonstrated in Chapter 6, the E2   model induced FLHS in laying hens and this was 
exacerbated by a challenge with LPS (see section 7.4.5 below).  
7.4.1  Cytokine gene expression in the liver 
 
Data on mRNA expression of targeted cytokines (IL-1β, IL-6, and IL-18) from hepatocytes are 
presented at 3h and 24 h after first treatment with E2, LPS and E2 & LPS (Figure 7.1). These two 
sampling points are relevant in terms of acute changes post LPS and E2 administrations, and were 
expected to reflect changes in mRNA expressions of selected inflammatory cytokines. Figure 7.1 
shows the standardised data for cytokine levels expressed as fold changes in mRNA levels 
compared to basal mRNA levels. The mean mRNA levels of IL-1β and IL-6 of each 
group/treatment pooled together increased by 3 to 58 folds compared with basal levels (P<0.01) at 3 
h following treatments with E2 and LPS. Both, IL-1β and IL-6 mRNA expression were 
significantly (P<0.01) elevated in E2, LPS and E2 & LPS hens (Appendix 5, Table 6).  
 
The expression of IL-6 mRNA in hepatocytes in all treated groups was elevated (P<0.01) from 6 to 
56 folds as compared to baseline and controls. The highest fold change was found in LPS and E2 & 
LPS treated birds at 3 h post-treatments when compared to controls. At 24 h later IL-6 gene 
expression was slightly decreased, however was still significantly elevated approximately by 20 
folds. When compared to E2 treatments all LPS and E2 & LPS birds demonstrated higher (P<0.01) 
levels of IL-6 and IL-1β. The expression of mRNA for IL-6 and IL-1β in E2 treated birds was 
moderate but still significantly (P<0.01) up-regulated from 3 to 12 folds at 3h and 24 h after 
treatments with E2, respectively.  
 
The mRNA levels for IL-1β were better expressed at 24 h in all treated birds (E2, LPS and E2 & 
LPS). At 3 h and 24 h, mRNA levels for IL-1β were highly (P<0.01) up-regulated in E2 & LPS 
treated birds when compared to other treatments (E2 and LPS). The expression of IL-18 mRNA in 
the liver tissue was lower than IL-1β and IL-6 mRNAs in all treated birds. At 3 h and 24 h post 
treatment with E2 the mRNA levels for IL-18 were found minimal to undetectable in E2 treated 
birds. In LPS-treated birds at 3h and 24h the expression of mRNA IL-18 was significantly (P<0.01) 
elevated (<5 folds). 
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Figure 7.1 Cytokine mRNA expression profiles from real-time qRT-PCR analyses of 
hepatocytes of treated birds compared to baseline levels and controls at 3 h and 24 h 
post-treatments. 
 
E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; 
All Ct values were corrected using the housekeeping gene 28S, and time point 0 was used as the 
calibrator. Values are expressed as mean ± SEM fold change relative to control (data is pooled for 
all controls: not treated, corn-oil treated and PBS-treated birds). Error bars show SEM from 
triplicate samples (n=16) from two separate qRT-PCR experiments (P<0.01, unpaired t-test). 
 
 
7.4.2 Blood cell counts 
 
Data on blood parameters (WBC and RBC counts, and percentages of heterophils and lymphocytes 
and H/L ratios) are presented in Table 7.3.  
 
At 3 h post-treatments (with E2, LPS and E2 & LPS), WBC counts were significantly increased 
(P<0.05) in E2 and LPS treated birds when compared to controls but not E2 & LPS treated birds. As 
shown in Table 7.3, from the differential counts (%) of heterophils and lymphocytes and H/L ratios, 
the increase in leukocytes included both, heterophils and lymphocytes. Other WBC types did not 
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show any significant change in percentages (data not shown), while thrombocytes percentages were 
measured inconsistently therefore were not included in the study.  
 
At 24 h post-treatments, hens exposed to LPS had a numerical increase in WBC but at this time the 
increase was in favour of heterophils. There was a significant (P<0.05) increase in heterophil 
percentages and H/L when compared to controls and measurements at 3 h (1.42 vs. 0.48 or 0.43, 
respectively). Similarly, leukocyte numbers were significantly raised (P<0.01) in birds treated with 
E2 & LPS, while birds treated with only E2 continued to have elevated WBC numbers.  
 
Birds treated with E2 or E2 & LPS demonstrated high numbers of leukocytes at week 1 and 2 post-
treatments. At week 1 this increase in leukocytes included mainly heterophil numbers, but at week 
2 the increase was proportional therefore the H/L ratio was decreased and was found to be slightly 
significantly different (P<0.05) from LPS treated birds but similar to values at 3 h (Table 7.3). One 
week after treatments started, WBC of birds treated with LPS were still elevated (approx. 
32x10
9
/L), but decreased significantly (P<0.01) and reached the level of the control birds (approx. 
18.6 x10
9
/L) at week 2.    
 
Data on RBC counts on treated and untreated birds are presented in Table 7. 3. As shown in the 
results, the average of RBC counts was more consistent in all birds (untreated and treated). There 
was a slight but significant increase (P<0.05) in RBC counts in control birds at 24 h and in E2 
treated birds at week 2 compared to LPS treated birds at 3 h and at week 1. 
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Table 7.3 Changes in blood cell counts (WBC and RBC), heterophil and lymphocyte 
percentages and H/L ratios in control and treated laying hens
1,2 
Treatment Time  WBC
2 
(x10
9
/L) 
Heterophils 
(%) 
Lymphocytes 
(%) 
H/L 
ratio 
RBC
2 
(x10
12
/L) 
CONT 
E2 
LPS 
E2 & LPS 
3 h 
 
18.0
a 
29.6
a 
61.9
a 
0.48
a
 2.5
a,b
 
25.7
b 
28.0
a 
62.2
a 
0.45
a
 2.3
a
 
27.0
b 
28.2
a 
65.4
a 
0.43
a
 2.1
a 
21.7
a,b 
26.7
a 
64.3
a 
0.42
a
 2.2
a
 
       
CONT 
E2 
LPS 
E2 & LPS  
24 h 
 
17.5
a 
25.6
a 
63.1
a 
0.41
a
 2.6
b 
28.2
b 
29.0
a 
64.1
a 
0.45
a
 2.2
a
 
35.8
b,c 
53.6
c 
37.8
b 
1.42
c
 2.3
a
 
43.8
b,c 
55.6
c 
36.2
b 
1.54
c
 2.2
a
 
       
CONT 
E2 
LPS 
E2 & LPS 
1 wk 
 
18.7
a 
22.6
a 
66.1
a 
0.34
a
 2.4
a,b
 
42.7
b,c 
35.9
b 
54.4
a,b 
0.66
b 
2.3
a
 
31.9
b 
48.8
b,c 
38.0
b 
1.28
c
 2.0
a 
34.8
b,c 
51.6
c 
42.9
b 
1.20
c
 2.5
a,b
 
       
CONT 
E2 
LPS 
E2 & LPS 
2 wk 
 
15.9
a 
29.4
a 
59.4
a 
0.49
a
 2.2
a
 
52.3
c 
36.1
b 
55.5
a,b 
0.65
b
 2.6
b 
18.6
a 
22.0
a 
66.5
a 
0.33
a
 2.4
a,b
 
35.5
b,c 
30.3
b 
58.2
a 
0.52
b 
2.2
a
 
1
E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; CONT = data is pooled for all controls 
(not treated, corn-oil treated and PBS-treated birds); WBC=White blood cells; RBC=Red blood cells; 
2
Values are expressed as mean (n=6). Means with different superscripts (a-c) within a column are significantly 
different (P <0.05). 
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7.4.3 Fibrinogen 
 
As shown in Figure 7.2, at 3 h plasma fibrinogen levels in LPS and E2 & LPS treated birds were 
slightly elevated (P<0.05) when compared to control birds (3.8 and 3.6 g/L vs. 2.0 g/L, 
respectively). At 24 h there was a high response in fibrinogen levels in all treated birds (E2, LPS 
and E2 & LPS), surprisingly in E2 treated hens the value of fibrinogen concentration was higher 
than in LPS treated hens (5 g/L vs. 4.1 g/L, respectively). Fibrinogen concentrations rose earlier in 
LPS treated birds compared to E2 treated birds. However, as shown in Figure 7.2, elevated 
concentrations of fibrinogen remained high in weeks 1 and 2 post-treatments with E2, while in 
LPS treated birds, fibrinogen levels were reduced to control values after the first week of 
treatments. As in the first experiment with E2 (Chapter 6), fibrinogen levels correlated with WBC 
levels in E2 treated birds. Thereafter, plasma fibrinogen concentrations declined and were found 
lower in LPS treated birds than the values of control birds, however this difference was 
statistically not significant.  
 
 
Figure 7.2  Plasma fibrinogen concentrations (g/L) in treated and untreated birds. 
E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; control = data is pooled 
for all controls (not treated, corn-oil treated and PBS-treated birds);
 
Values are expressed as mean 
±SEM (n=6). 
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7.4.4  Plasma metabolites and gamma glutamyl transferase levels  
 
Plasma concentration for TG and GGT for treated (E2, LPS, and E2 & LPS) and untreated birds, are 
presented in Figure 7.3 and 7.4, respectively. Other metabolites (AST, CHOL, TP, and GLU) are 
presented in Appendix 8, Table 7. Data from control groups are pooled and presented together for 
control (untreated) and oil and saline treated groups. 
 
As demonstrated in the E2 hen model experiment, hens treated with E2 showed again increased 
(P<0.01) levels of plasma lipids especially TG (Figure 7.3); CHOL was less elevated than TG in 
E2 treated birds (Appendix 8, table 7). In both E2 treated groups plasma TG rose significantly 24 h 
after first treatment, and then continued to be increased at week 1 post-treatments. Birds treated 
with LPS indicated a significant decrease (P<0.05) in plasma lipids, especially at 24 h post 
treatments when compared to control birds. For this study, both GGT and AST levels were 
measured, as both enzymes could indicate liver damage. Data are presented here for GGT 
concentrations (Figure 7.4), which demonstrate a slight significant increase (P<0.05) of the levels 
in particular within 3 h after first treatments with E2 and LPS. Plasma concentrations for TP, and 
GLU did not show any significant changes in all birds over time (Appendix 8, Table 7). All 
control birds had insignificant changes in plasma metabolites at all measurement points.   
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Figure 7.3  Plasma concentrations of TG (IU/L) in treated and untreated birds.  
 E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; control = data is pooled 
for all controls (not treated, corn-oil treated and PBS-treated birds); TG = Triglycerides; Values are 
expressed as mean ±SEM (n=6).
 
 
 
Figure 7.4  Plasma concentrations of GGT (IU/L) in treated and untreated birds. 
E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; control = data is pooled 
for all controls (not treated, corn-oil treated and PBS-treated birds); GGT=gamma glutamyl 
transferase;
 
Values are expressed as mean ±SEM (n=6). 
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7.4.5 Mortality and necropsy results 
 
Data on mortality and liver haemorrhagic score demonstrated that all birds (100%) treated with E2 
and E2&LPS developed FLHS (Table 7.4). Birds treated with E2&LPS showed and more severe 
signs of FLHS (after first week of treatments all necropsied birds had liver haemorrhagic score = 
4-5). However, the mortality rate was higher (P<0.05) in E2 birds than in E2&LPS treated birds. 
There were no mortalities in control-untreated and LPS-treated birds. All control groups had a low 
incidence of FLHS, in terms of haemorrhagic score (one bird had liver haemorrhagic score 1-2).  
 
Table 7.4 Effect of oestrogen injections, and a single LPS injection on mortality, the incidence of 
FLHS, and liver haemorrhagic of laying hens
1
. 
 
Treatments
2
 Number  
of birds 
FLHS4 
(%) 
Haemorrhagic score4 Mortality  
(%) 
Controls
3
 54 5.5
a
 1-2 0 
 
E2 
 
18 
 
66.7
c 
33.3
b
 
 
4-5
 
2-3 
 
 
11
b
 
LPS 18 5.5
a
 
11.1
a
 
2-3 
1
 
 
0 
E2&LPS 18 88.9
d
 
11.1
a
 
4-5
 
 
2-3 
5.5
a
 
1
Data are reported for the whole experimental period; N of birds sacrificed at each sampling point was 3 
birds/treatment. At the end of the experimental period, all birds were sacrificed and underwent post-mortem 
examination. 
2
Controls = untreated; E2 = oestrogen-treated; LPS = LPS-treated; E2 & LPS-treated;  
3
There were no significant differences between untreated and oil-treated and saline-treated groups; therefore, data are 
pooled and presented together; 
4
 Data on the occurrence of FLHS are divided to reflect haemorrhagic scores (next column) and so indicate the range 
and severity of the lesions 
 
a,b,c,d 
Values within a column with different superscripts differ significantly (P<0.05). 
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7.4.6 Liver histological examination 
 
The liver tissue from hens treated with E2, LPS, and E2 and LPS had significant histological 
changes when compared to samples from control hens (Figures 7.5, 7.6, 7.7), including the most 
extensive fat deposition (in terms of cells with 50 to 75% vacuolisation) and WBC and RBC 
infiltration in the areas surrounding blood vessels or into liver parenchyma. Large vacuoles 
containing fat distended many hepatocytes (Figure 7.6a,b) or totally replaced their cytoplasm and 
atrophied their nucleus (Figure 7.7a,b). The pathological evaluation indicated other abnormalities 
associated with lipid droplets found in the sinusoidal endothelial cells (Figure 7.7a), Disse space 
(which is located between the sinusoidal membrane and plasma membrane of the liver cell) (Figure 
7.6a), perisinusoidal stellate cells or in the spaces of arterioles, venules (see also Figure 6.14). In 
particular, histological slides from both E2, and E2 & LPS treated hens revealed major areas of 
mononuclear aggregations, and increased incidence of sinusoidal congestions and petechial 
haemorrhages. These results corroborate with previous observations from the E2 hen model. 
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(a) 
 
 
(b) 
Figure 7.5 Histological sections showing livers from control hens (a) and LPS treated hens (b). 
Note normal portal triad and hepatocyte fat infiltration (a), (yellow arrow); and inflammatory cell 
infiltration (green arrow) in the periportal area surrounding portal vein & artery and the bile duct (b);  
H&E stain, using x400 magnification. 
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(a) 
 
 
(b) 
Figure 7.6 Histological sections showing periportal inflammation in livers from E2 & LPS 
treated hens. 
Note moderate periportal inflammation (green arrow) and fat infiltration (yellow arrow);  
H&E stain, using x400 magnification. 
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(a) 
 
(b) 
Figure 7.7 Histological sections showing inflammation and hemorrhages in livers from LPS & 
E2 treated hens. 
Note severe parenchymal and sinusoidal fat (yellow arrow), leukocyte (green arrow), RBC (red 
arrow) infiltration and sinusoidal dilation, congestion and telangiectasias (a & b); 
H&E stain, using x400 magnification.  
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7.4.7 Performance parameters 
 
Egg weight, body weight and relative organ (liver and spleen ) weights did not significantly change 
in response to treatments (Table 7.5) but there was a slight increase (not statistically significant 
P>0.05) in relative liver weight of E2 treated hens at wk 1 and 2, and in relative spleen weight in 
LPS treated hens when compared to control hens.   
 
Table 7.5 Egg weight, body weight (g), and relative liver weight (g/100g BW) and relative 
spleen weight (g/100g BW) in treated and untreated birds. 
Treatments Time of 
measurements 
Egg weight  
(g) 
SEM BW 
(g) 
SEM Relative LW 
(g/100g BW)  
Relative SW 
(g/100g BW)   
Control 0 h 59.1 0.2 1793 40 NA NA 
E2 59.0 0.2 1802 29 NA NA 
LPS 59.0 2.2 1775 34 NA NA 
E2 & LPS 59.3 0.1 1765 31 NA NA 
Control 24 h NA NA 1794 42 2.72 0.10 
E2 NA NA 1803 28 2.75 0.11 
LPS NA NA 1768 34 2.80 0.12 
E2 & LPS NA NA 1748 28 3.01 0.12 
Control 1 wk 61.3 0.6 1805 38 2.37 0.11 
E2 61.1 0.9 1803 31 2.88 0.13 
LPS 58.6 2.2 1768 38 3.02 0.13 
E2 & LPS 58.7 0.6 1739 27 3.62 0.13 
Control 2 wk 61.3 0.7 1816 34 2.52 0.10 
E2 61.2 1.0 1801 31 3.24 0.13 
LPS 59.5 1.7 1813 27 2.99 0.12 
E2 & LPS 61.7 1.0 1751 28 3.44 0.13 
BW = body weight; LW = Liver weight; SW=spleen weight; NA=data not available; 
E2 = oestrogen-treated; LPS = LPS-treated; E2&LPS = E2- and LPS-treated; control = data is pooled for all controls 
(not treated, corn-oil treated and PBS-treated birds);
 
Values are expressed as mean of all birds in experiment for egg 
weights and body weights and n=3 for relative LW and SW. 
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7.6  Discussion 
 
In this study, an E2 & LPS hen model was employed to investigate the involvement of 
inflammatory response in the pathogenesis of FLHS. The evaluation of the physiological and 
metabolic responses was undertaken along with the inflammatory markers of plasma and liver to 
study the disease as it develops in treated hens. The hepatic mRNA levels of the genes that encode 
the key regulators of the hepatic inflammation (IL-1β, IL-6 and IL-18) (Braunersreuther et al., 
2012) were evaluated to explore their expression in hepatocytes during the inflammatory responses 
in hens treated with E2, LPS or both E2 & LPS. The goal of this study was to understand the 
involvement of inflammatory response in the pathogenesis of FLHS in laying hens; therefore the 
discussion here will focus on the inflammatory parameters evaluated in this study. 
 
There is a large number of cytokines that are involved in the regulation of endocrine-metabolic and 
immune responses that are produced by leukocytes, hepatocytes and adipose tissue. Cytokines 
targeted in this study (IL-1β, IL-6, and IL-18)  are of interest because they are involved in the 
generation of systemic and local responses to infection and injury by generating fever, activating 
lymphocytes and by promoting leukocyte infiltration at sites of infection or injury (Finotto et al., 
2004).  Interleukin -6 (IL-6) stimulates the acute-phase reaction, which enhances the innate immune 
system and protects against tissue damage (El-Kadre and Tinoco, 2013; Gruys et al., 2005).  
 
Both IL-1β and IL-18 are related cytokines that were recognized early on for their ability to cause a 
wide variety of biological effects associated with infection, inflammation, and autoimmunity 
(Dinarello, 2006; Finotto et al., 2004). Both IL-1β and IL-18 are members of the same structural 
family; IL-1β regulates systemic and local responses to infection, injury and immunological 
challenge by generating fever, activating lymphocytes and promoting leukocyte transmigration into 
sites of injury or infection (Dinarello, 2006), while IL-18 is essential to host defences against severe 
infections, in particular, the clearance of intracellular bacteria, fungi and protozoa (Nakanishi et al., 
2001). IL-18 should be seen as a unique cytokine that enhances innate immunity and both Th1- and 
Th2-driven immune responses. 
 
In this study, the expression of IL-1β, IL-6, and IL-18 mRNA in hepatocytes of laying hens were 
quantified using real-time qRT-PCR. As presented in the results (Figure 7.1), the expression of both 
IL-1β, IL-6 were highly upregulated in both E2 and LPS treated hens, with IL-6 responding 
stronger in the acute phase response (3 h post-treatments) and IL-1β being more expressed at a later 
stage (at 24 h). It is recognised that cytokines crosstalk on multiple levels. Cellular signalling 
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studies have shown that IL-1β counteracts signal transduction of IL-6-type cytokines at different 
levels: it affects IL-6-induced gene expression by acting on target gene promoters (Radtke et al., 
2010). This mechanism explains observations in the current study that indicated a down-regulation 
of the IL-6 mRNA expression while levels of IL-1β mRNA were highly up-regulated. Moreover, it 
has been suggested that IL-6 has anti-inflammatory properties. IL-6 appears to be the primary 
inducer of the hepatocyte-derived acute-phase proteins, many of which have anti-inflammatory 
properties (Barton, 1997). 
 
In terms of the treatments, LPS is known to lead to an increased inflammatory response and up-
regulation of IL-6, IL-1β mRNA expression in hepatocytes. The administration of E2 only 
moderately stimulated the expression of IL-6, IL-1β, but the combination of E2 with LPS caused a 
higher and stronger response than (E2 alone) and longer than LPS alone, thus reinforcing the 
hypothesis that the inflammatory response (induced by a bacterial toxin) is involved in triggering 
liver injury in the context of hepatic steatosis. 
 
Lipopolysaccharide is a molecule that induces local and systemic inflammation and is associated 
with progression of liver injury (Harte et al., 2010). Bacterial LPS (endotoxin) has been implicated 
in the pathogenesis of acute liver disease through its induction of the pro-inflammatory cytokines. 
Evidence suggests that endotoxin-induced cytokines are important mediators of hepatic 
steatohepatitis. In relation to NAFLD, it has been shown that saturated fatty acids represent an 
endogenous danger in the form of a first hit, thereby inducing sensitization to LPS-induced 
inflammasome activation and inflammatory injury (Bieghs and Trautwein, 2013).  
 
Many studies have supported a possible role for endotoxin in metabolic diseases. In humans, it has 
been confirmed that intestinal permeability and small intestinal bacterial overgrowth are increased 
in NAFLD patients and that these factors are associated with the severity of hepatic steatosis (Miele 
et al., 2009). In FLHS in laying hens, this is a new area that could be explored to determine how the 
gut microflora could influence the progression of hepatic lipidosis and an outbreak of FLHS in 
individuals with increased metabolism (BW and egg production). Recent studies show that 
intestinal flora function much like a metabolic ―organ,‖ influencing nutrient acquisition, energy 
homeostasis, and, ultimately, the control of body weight (Frazier et al., 2011). An increased gut 
permeability, low-grade endotoxemia, and fatty liver are observed in animal models of obesity 
caused by either high-fat or high-fructose feeding. The role of the gut microbiota and metabolic 
endotoxemia-induced inflammation in the development of FLHS needs to be explored further. It 
seems that feed (or nutrition) including lipids and other molecules of lipid precursors, microflora, 
147 
 
and the physiology of intestinal membranes and special structural features of the liver are major 
players of the inflammatory response starting in the gut and affecting the first and most visited 
organ, the liver. 
 
Other markers of liver inflammation that were evaluated in this study were peripheral and local 
(liver tissue) leukocyte response through WBC counts and liver histology. Data on leucocyte counts 
and percentages supported the hypothesis that a general inflammatory and immune response caused 
an increase in total leukocyte counts and triggered their movement towards liver tissue, most 
probably due to release of hepatic cytokines (in the case of E2 injections) or LPS circulation in the 
liver. One inflammatory molecule that has not previously mentioned in the pathology of FLHS is 
fibrinogen.  
 
Fibrinogen can be used as a general clinical biomarker of inflammation, including cases of liver 
inflammation and damage. Measurement of the fibrinogen concentration is not a specific test, as it 
may identify the inflammation or infection but would not identify the source of inflammation within 
the body. However, elevated levels of fibrinogen 2 to 10 times higher than normal values could 
indicate the development of cellular and molecular processes involved in the coagulation, 
pathogenesis of inflammation-related diseases or infectious diseases (Levi et al., 2003). Fibrinogen 
is an inflammatory molecule that was altered in the experiments with E2 (Chapter 6 and 7) and E2 
& LPS (Chapter 7). Elevated plasma levels of fibrinogen, indicating chronic subclinical 
inflammation, have been associated with metabolic diseases such as NAFLD (Bhatia et al., 2012). 
The low-grade chronic inflammatory state results in several deleterious pathophysiological 
processes including abnormal glucose, fatty acid and lipoprotein metabolism, increased oxidative 
stress, deranged cytokine profile, hypercoaguability, endothelial dysfunction, and accelerated 
progression of atherosclerosis (Bhatia et al., 2012). 
  
Fibrinogen is considered to be a moderate APP (Cray et al., 2009). It is a slow reacting positive 
acute phase reactant with a possible delay of some days after infection (Gruys et al., 2005). 
Compared to other acute phase proteins, fibrinogen levels in humans can be lower but it can persist 
for a longer time than C-reactive protein and serum amyloid A (see Figure 7.8) (Gabay and 
Kushner, 1999).  
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Figure 7.8  Acute phase proteins and the systemic inflammatory response  
    Modified by Gabay and Kushner (1999). 
 
This makes fibrinogen testing a valuable marker that could help in the detection of low-grade 
(subacute) inflammation which is now seen as a critical component of the metabolic syndrome 
(Wisse, 2004). The stimulation of fibrinogen synthesis during acute-phase reaction is mediated by 
cytokines, and in particular IL-6 has a prominent role in the enhancement of fibrinogen synthesis by 
directly up-regulating fibrinogen gene expression (Caso et al., 2009). In the current study the 
evaluation of mRNA expression of IL-6 demonstrated an earlier up-regulation of IL-6 (at 3 h post-
treatments with LPS and E2 & LPS) than the fibrinogen levels. Increased levels of fibrinogen 
followed the IL-6 up-regulation and peaked at 24 h post-treatments. These data demonstrate the 
importance of acute phase response and involvement of IL-6 and fibrinogen as a protective 
molecules that participate in the resolution of inflammation and tissue repair (Liaskou et al., 2012).   
 
What causes hepatic inflammation, and how can inflammation be controlled and prevented, so that 
fatty livers do not have haemorrhage events? These are some questions that have yet to be 
answered. It is very important, therefore, to develop new biomarkers for the detection of birds 
predisposed to FLHS.  
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8.1  Introduction  
 
Advances in genetic selection, nutrition, and other management practices have contributed to the 
creation of the ―modern laying hen‖ with improved egg production characteristics, and a liver 
which must accommodate increased metabolic demands. The liver is the major site of synthesis of 
lipids and the majority of proteins, including enzymes, hormones, blood proteins, clotting factors, 
inflammatory and immune molecules are also synthetised in the hepatocytes (see Chapter 2). When 
hepatic lipogenesis exceeds the capacity of lipid secretion and metabolism, triglycerides accumulate 
in the liver, causing a fatty liver. High producing laying hens have a fatty liver because of the 
demands of yolk synthesis. In some situations, this phenomenon can develop into liver damage, 
liver capsule rupture, haemorrhage and death of the bird, or FLHS. It appears that the balance 
between hepatic synthesis and secretion of lipids is therefore a key point in the regulation of hepatic 
and extrahepatic fat deposition in the laying hen. As described in Chapter 2, despite its obvious 
importance, the aetiology of FLHS has not been well-defined and the pathogenesis is poorly 
understood.  
 
In this thesis, investigations under field and experimental conditions were undertaken in an attempt 
to better define the occurrence, aetiology and pathogenesis of this metabolic disorder and open new 
possibilities for its control and prevention in commercial laying birds. 
 
  
150 
 
8.2  Is FLHS still a problem for birds in cages?  
 
The results of the first study, conducted in the layer facility at the Gatton Campus, University of 
Queensland, showed that housing system did not have any significant effect on hen egg production 
and mortality rates; however it influenced the BW, and especially affected causes of mortality in 
hens. The most common cause of death in hens kept in cages was FLHS with 74% of hens dying 
from this condition. The majority of hens kept in free range died from cannibalism (77%) and 
cachexia (14%), while hens in barns had problems such as cannibalism (59%), reproductive tract 
infections (10%) and cachexia.  This study is in accord with previous studies that concluded that 
FLHS is a disease that mainly affects hens kept in cages (Butler, 1976; Couch, 1956; Hansen and 
Walzem, 1993; Julian, 2005; Leeson, 2007; Neill et al., 1975; Peckham, 1984; Ringer and 
Sheppard, 1963; Simonsen, 1978; Weitzenburger et al., 2005). Data presented in this thesis also 
demonstrated that hens in cages had significantly increased body weights. This presumably 
reflected a positive energy balance induced from a lack of exercise due to restricted space in cages. 
It appears that monitoring BW throughout the laying cycle may be a helpful diagnostic tool to 
predict FLHS in a laying flock.  
 
8.2.1 What about Queensland? 
 
The initial ―field‖ investigation in a research facility demonstrated the possible significance of 
FLHS in caged layers and prompted a more intensive investigation of FLHS in commercial flocks. 
An epidemiological study was undertaken and involved a questionnaire followed by monitoring of 
selected laying flocks in South Eastern Queensland. The results suggested that the majority of egg 
producers were not aware of FLHS despite about 40% of birds dying from FLHS. These results 
indicate that FLHS remains a significant cause of death of laying hens in Queensland and 
presumably Australia. It may be that due to the limited number of necropsies carried out and 
undetected subacute cases, the actual prevalence of FLHS could be higher than reported in this 
study. Nevertheless, this investigation indicates that FLHS continues to be a disease with a high 
prevalence in cages, most probably due to housing conditions associated with restricted movements 
of hens in cages, which predisposes to accumulation of fat in the liver and hepatic rupture.  
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8.2.2 Temperature and FLHS 
 
The results of the second study revealed that laying hens, in multi-tier cages in a controlled 
environment (thermo-neutral) shed are at the same risk of developing FLHS as hens kept in 
naturally ventilated sheds. This is in contrast to most previous studies that found more FLHS deaths 
at temperature extremes during hot weather (Couch, 1956; Greuel and Hartfiel, 1968; Ivy and 
Nesheim, 1973; Pearson and Butler, 1978a; Schexnailder and Griffith, 1973). Whether the 
increased incidence of FLHS is a response to temperature per se, or the response to a stressor, has 
not been examined. Given the current results and those of Lee et al. (1975) who observed that 
keeping temperature controlled in the thermo-neutral zone does not decrease the incidence of FLHS 
suggests that stress rather than ambient temperature is the important factor. Nevertheless, ambient 
temperature is related to the energy balance, i.e. birds kept in battery cages have lower energy 
requirements, and  if maintained at thermo-neutral temperatures require even less energy, as they do 
not need the extra energy to activate mechanisms for maintaining body temperature (Silva, 2006). 
The exposure of birds to cold or heat seems to induce stress and influence lipid metabolism in the 
chicken.  
 
8.2.3 Other predisposing factors for FLHS 
 
Other factors could have been involved in the aetiology of FLHS. Most investigators agree that lack 
of exercise is a contributor to FLHS. Commercial laying hens are under the influence of multiple 
factors that affect their physiology such as restricted movement (associated with increased BW), 
increased egg production (and levels of oestradiol) and other nutritional and stress factors 
(including temperature changes) which predispose hens to FLHS. The epidemiological study 
conducted in this thesis involved measurements of blood parameters so that the hen‘s clinical 
biochemical responses could be explored. Circulating levels of metabolites (CHOL, TG, and GLU 
and TP) are biomarkers of energy and metabolic responses (Bedogni et al., 2006; Brown et al., 
2010).  
 
Circulating levels of TG were significantly increased in hens surveyed in this study, and were 
associated with increased egg production. It is recognised that laying hens normally have increased 
circulating lipid metabolites in particular TG from 2-10 fold during egg production (Klasing, 1998), 
and develop hepatic steatosis to meet the requirements for yolk lipid synthesis (Hansen and 
Walzem, 1993). Data from the current study revealed that higher levels of TG in hens from 35 to 60 
wk of age. In some cases, this increase was associated with a slight rise in GLU concentrations. It 
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appeared that the diet and level of egg production influenced plasma metabolite levels. It was 
concluded that results of this study demonstrated that the acute and chronic forms of FLHS are a 
significant source of losses in egg production for cage egg producers. Factors such as housing and 
nutrition contribute to increased BW and liver fat deposition, resulting in increased flock deaths from 
FLHS.  
 
8.3 An E2 laying hen model to study the aetiopathogenesis of FLHS  
 
Previous studies (see Chapter 2) have implicated oestrogen as a factor in the production of FLHS 
along with the necessity for the hen to be in a positive energy balance, to facilitate hepatic fat 
accumulation and the development of FLHS. This suggests that manipulation of these factors may 
allow the experimental induction of the condition and the development of a reproducible model to 
study this disease. Moreover, a model would allow the determination of molecular and cellular 
factors that influence fat accumulation and inflammatory processes in the avian liver. A similar 
approach has been adopted to allow the examination of obesity and fatty liver pathogenesis in 
humans (see Chapter 2). These studies suggest that liver is the first organ to be affected when 
adipose tissue becomes dysfunctional and inflamed, initially undergoing a pro-inflammatory state 
followed by inflammatory processes. 
 
In Chapter 6 it was demonstrated that the FLHS model developed by Stake et al., (1981) was 
applicable to the modern layer; this allowed an investigation of the effect of the amount of feed 
consumed on the occurrence of FLHS. The administration of exogenous E2 caused the disease in 
adult (30 wk old) laying hens and was associated with significant changes in liver relative weights, 
and macroscopic (fat depositions, haemorrhages and haematomas) and microscopic (liver structure) 
alterations. 
The measurements of E2 concentrations in hens demonstrated that E2 levels were significantly 
elevated (P<0.01), and were responsible for all significant changes observed. Fatty livers are 
normal for egg producing hens and occur when the increase in lipogenesis exceeds the capacity of 
synthesis and secretion of lipoproteins (Hermier, 1997). However, the degree to which this occurs 
in laying hens is modulated by many factors, both external (e.g. nutritional and environmental 
factors) and internal (e.g. hormones and other mediators) to the bird.  
 
Under the influence of E2 hens in the E2-treated and ad libitum fed group experienced severe 
FLHS which was associated with an increase in mortality. Hens that did not die from FLHS were 
diagnosed with FLHS at necropsy. As expected, ad libitum fed hens demonstrated a higher 
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incidence of FLHS than hens fed a restricted feed intake diet, showing that birds with a higher 
feed intake, i.e. energy balance, are more at risk from FLHS than birds with a lower feed intake. In 
response to restricted feed intake, birds in CRF and ERF groups demonstrated a decreased BW 
and egg production. Decreased BW and egg production have been described in hens given a 
restricted feed intake diet. Overall, restricted feed intake diet given to hens treated with E2 reduced 
the occurrence of FLHS, in terms of mortality and haemorrhagic score, but also affected their 
performance.  
 
Treatment with E2 induced significant liver tissue alterations, as demonstrated histologically.. 
Normally, livers from laying hens can have some fat infiltration (microvesicular fatty change). 
However, hens treated with E2 had consistent and severe infiltrations with fat and fat vacuolisations 
(macrovesicular fatty degeneration or steatosis). This was one of the most striking early features 
observed in E2 treated hens. This study revealed transient and massive accumulation of lipids 
(Figure 6.11b) in the cytoplasm of hepatocytes in which a single fat vacuole distended the 
hepatocyte and pushed the nucleus and cytoplasm to the side. Further histological examination of 
the slides exposed fat droplets in the liver sinusoids (Figure 6.10b). This has not been previously 
reported.  
 
In this study haematological parameters were used to follow the progression of FLHS in the hen 
model. Like in other animals and humans, when birds lose a quantity of blood (under 10% of their 
circulating blood volume) they experience a physiological stress, yet the RBC counts and HCT 
remain only slightly depressed (Kovach et al., 1969). Therefore, in the case of small internal 
haemorrhages and haematomas a simultaneous release of RBC from reserves in the bone marrow, 
and rapid fluid replacement or relocation across compartments occurs to maintain homeostasis  
(Sturkie and Griminger, 1986). In this study, RBC counts and HCT were not significantly altered, 
most probably due to this redistribution of the RBC and fluids which decreased the possibility to 
detect any changes.  
 
The WBC counts and fibrinogen levels were altered in hens treated with E2 when compared to 
controls (Table 6.3). This is the first demonstration of increased WBC counts and fibrinogen in 
oestrogenised birds. Hens treated with E2 had a significant increase in leukocytes 24 h post-
treatments and this number continued to increase in weeks 1, 2 and 3. Simultaneously, there was 
an elevation of plasma fibrinogen which correlated with WBC increases. Fibrinogen is considered 
a moderate acute phase protein that circulates in the plasma in response to most forms of tissue 
injury, infection, or inflammation (Gruys et al., 2005; Mosesson et al., 2001).  
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8.5 Is inflammation involved in the pathogenesis of FLHS?  
 
In studies (Chapter 6) using the E2 hen model there were indications that inflammation was 
involved in the aetiology of FLHS. To explore this possibility an E2& LPS hen model was 
employed (Chapter 7) and this permitted evaluation of inflammatory markers including gene 
expression levels of important inflammatory cytokines in hepatocytes. The cytokines targeted in 
this study (IL-1β, IL-6, and IL-18)  are of interest because they are involved in the generation of 
systemic and local responses to infection and injury by generating fever, activating lymphocytes 
and by promoting leukocyte infiltration at sites of infection or injury (Finotto et al., 2004). As 
discussed in Chapter 7 the dynamics of the expression of the different cytokines was consistent with 
an inflammatory LPS challenge. This challenge when coupled with E2 injections increased the 
severity of hepatic lesions. In addition, the changes in the circulating concentrations of fibrinogen (a 
marker of liver inflammation) (Levi et al., 2003) were consistent with cytokine modulation 
following an hepatic inflammatory insult (Caso et al., 2009). 
 
It is known that an inflammatory response can be induced by bacterial toxins (LPS) which trigger 
liver inflammation (Kaisho and Akira, 2002) inducing local and systemic inflammation which is 
associated with progression of liver injury (Harte et al., 2010). Bacterial LPS has been implicated in 
the pathogenesis of acute liver disease through its induction of the pro-inflammatory cytokines. 
Many studies have supported a possible role for endotoxin in metabolic diseases. In laying hens this 
is an area that has received little attention and should be explored. Perhaps a gut microbiota induced 
metabolic endotoxemia and resulting inflammation is involved in the development of FLHS.  
 
Although it was not possible to separate out the relative effects of E2 and LPS from the current 
studies, the results suggest a role for inflammation in the pathogenesis of FLHS. May be in the field 
where commercial laying hens have high circulating concentrations of oestrogen, sporadic 
exposures to inflammatory challenge is sufficient to precipitate FLHS in birds with pre-existing 
fatty livers. 
 
8.6  Implications of the study 
 
Studies conducted in this thesis indicate that FLHS is a significant disease of caged layer hens in 
Queensland and impacts on hen health and welfare. Significant economic losses to producers occur 
because egg production drops and mortality increases. The results arising from this research pose as 
many questions as it answers. From this research and the literature, FLHS is a single disease with 
multiple aetiologies and this has a number of implications for both industry and further research.  
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With regard to industry: 
 
 Egg producers should be made aware of the presence of this syndrome in laying flocks and 
its significant impact on egg production and hen mortality  
 Egg producers should be advised of the importance of monitoring their flocks for FLHS by 
systematic necropsy of dead hens. Monitoring BW, especially in high producing flocks and 
heavy layer strains, may assist in identifying flocks predisposed to FLHS.  
 
From a research perspective, the apparent role of both inflammation and elevated circulating 
oestrogen concentrations in inducing FLHS is a useful step in understanding the pathogenesis of 
this condition. This model should prove useful in further studies of the disease, including;   
 The development of non-invasive techniques to detect FLHS in commercial laying flocks. 
This will assist egg producers to detect FLHS and make important management decisions in 
relation to this metabolic disease while maximising egg production efficiency  
 Further exploration of the interactions between metabolism, inflammation and 
endocrinology in the pathogenesis of FLHS, especially the effects of inflammatory factors 
on liver cells and the occurrence of the condition. This would help explain why only some 
laying hens develop FLHS while all have fatty livers.  
 
Finally, it will not be possible to develop strategies to reduce the incidence of FLHS until the 
factors that predispose birds to the condition are fully understood.    
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Appendices 
 
Appendix 1 
 
Diet specifications (feed analysis for Farm 1, 2, and 3) 
  
CONFIDENTIAL 
 
 
Table 1 Farm 1 feed analysis 
 
Analysis 
Volume % 100.0 Na % 0.139 
Protein %  17.30 K % 0.531 
Fat % 3.91 Cl % 0.174 
Fibre % 2.40 Methionine % 0.319 
ME_POUL MJ MJ/kg 11.40 METH + CYST% 0.611 
Calcium % 3.91 Linoleic 1.207 
Phosphorus % 0.66 Choline 878 
AV. Phosphorus % 0.38 Soy+FF 10.9 
CAL:PHOS 5.95   
 
 
 
Table 2  Farm 2 feed analysis 
  
Nutrient Name Amount Units 
PROTEIN 19.0  % 
Fibre 4.3  % 
FAT 5.6 % 
CALCIUM  3.82 % 
PHOSPHORUS 0.83 % 
M.E.POULTRY MJ 11.6  MJ/kg 
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Table 3 Farm 2 Production formula: Layer 120 
 
Nutrient Name Amount Units 
PROTEIN 16.69 % 
FAT 6.143 % 
CALCIUM 3.800 % 
AVAIL. PHOSPHORUS 0.450 % 
PHYTATE PHOSPHORUS  0.280 % 
METHIONINE 0.435 % 
METHIONINE + CYSTINE 0.700   % 
M.E.POULTRY-MJ  11.50  MJ/kg 
CHOLINE 1,300   mg/kg 
DIGEST LYSINE  0.669   % 
SODIUM  0.180   % 
POTASSIUM  0.664 % 
CHLORIDE 0.200  % 
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Table 4 Comparison of laying nutrient levels as recommended by breeders until 44 wk of 
age (Australian ingredients) and provided in the diets used in farms surveyed 
 
Nutrients Hy-
Line
2
  
 
Farm 1  
(farm-mixed) 
Farm 2 
(farm-
mixed) 
ISA 
Brown
2
  
Farm 3 
(commercial) 
Sorghum, 
wheat and 
soybean based 
meal  
Corn 
based 
meal (100 
g) 
 Sorghum, wheat, 
soybean, and meat 
based meal 
Metabolisable 
Energy (MJ/kg)
 2
 
11.7 11.4 11.6 11.5-
11.8 
11.5 
Protein (g/kg)
 2
 16.5 17.3 19.0 17.7 16.7 
Fibre  2.50 4.30   
Fat (g/kg)  3.91 5.60  6.14 
Calcium (g/kg) 3.50 3.90 3.82 4.1-4.3 3.80 
Av. Phosphorus 
(g/kg) 
0.44 0.38 0.48 0.38 0.48 
Methionine (%) 0.44 0.32  0.41 0.44 
Methionine + 
Cystein (%) 
0.74 0.61  0.71 0.70 
Digest. Lysine (%) 0.84 0.80    0.67   
1
Brown-egg-layers at 110 g of feed per hen daily 
2
ISA Brown at 110 g of feed per hen daily from 28 wks to the end of lay;  
3
Energy required per hen per day in relation to BW (average of 1750 g) and rate of egg production (80%) 
4
Derived with corn-soybean meal diet 
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Appendix 2 
 
Table 5 Composition of laying hen diet used for trial at Gatton Layer facility 
 
Analysis 
Volume % 100.0 CAL:PHOS  5.95 Threonine 0.59 
Protein %  17.30 CAL:AVPHOS 10.29 Leucine 1.47 
Fat % 3.91 Na % 0.14 Isoleucine 0.68 
Fiber % 2.49 K % 0.53 Tryptophan 0.18 
ME_PO Kcal kcal/kg 270.97 Cl % 0.174 Avlys_poult 0.67 
ME_POUL MJ MJ/kg 11.39 Na + K_Cl meq/kg 147.96 Linoleic 1.21 
Calcium % 3.91 LYSINE % 0.78 Choline 878.42 
Phosphorus % 0.66 METHIONONE % 0.32 Legumes 0.0 
AV Phos % 0.38 METH + CYST% 0.61 Soy+FF 10.93 
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Appendix 3  
Necropsy record sheet 
 
Owner’s identification:     
Bird identification: 
Breed/Age: 
Weight: 
Date/Time of possible death: 
Cause of death: found dead/killed/injured etc. 
Relevant clinical signs prior to death: 
 
Date of examination:                                      Preservation of body:  fresh/frozen 
 
1.  External examination  
 
Normal 
(Yes/No) 
Describe abnormalities 
Skin   
Feather/Comb condition   
External parasites   
Eyes/Ears/Nose   
Beak/Oral cavity   
Foot condition   
General carcass 
condition 
  
 
 
2.  Examination of the 
organs/tissues/contents 
 
Normal 
(Yes/No) 
Describe abnormalities 
Subcutaneous   
Musculoskeletal   
Peritoneal / Pleural cavities   
Oesophagus   
Crop   
Proventriculus   
Gizzard   
Intestine   
Cloaca   
Liver / Pancreas   
Spleen   
Thymus (if present)   
Bursa (if present)   
Air sacs/Lungs/Trachea   
Heart/circulatory   
Nervous system   
Genital/Ovary/Oviduct   
Kidney/ureter/adrenal gland   
Other   
3. Further records 
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a. Sample collection: Yes / No 
i. Organ 
ii. Tissue 
iii. Content (fluid) 
iv. Culture (swabs) 
 
b. Smear preparation: 
 
c. Pictures: 
 
d. Other:  
 
4. Ancillary diagnostics: 
a. Histopathology  (  ) 
b. Toxicology   (  ) 
c. Cytology   (  ) 
d. Parasitology   (  ) 
e. Microbiology   (  ) 
f. Virology   (  ) 
g. Other    (  ) 
 
5. Disposal arrangements: 
 
6. Tentative diagnosis/comments: 
 
7. Examiner: 
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Appendix 4 
 
Questionnaire used to survey farmers in Queensland 
 
Questionnaire 
 
Fatty Liver Haemorrhagic Syndrome (FLHS) Survey 
 
Farm Name/Address:  
 
Your participation in this survey will be much appreciated and ensure results which will benefit 
your organisation and the industry as a whole.  Please be assured that you will not be identified 
individually in the survey outcomes.  Your confidentiality is respected. 
For further information please contact: A. Shini 07 5460 1159 or email a.shini@uq.edu.au.  
Please return the questionnaire as an email attachment, or fax (07) 5460 1444, or send by mail 
to: A. Shini, School of Animal Studies, University of Queensland, Gatton QLD 4343. 
 
1. GENERAL 
 
a) Length of time poultry farm has been operational:  _______years 
 
b) Average number of caged layers each year / laying cycle: _________ 
 
c) Housed in (number of sheds) ________________  
 
d) N of flocks currently ________ Age of flock _________________ 
 
  
If flocks have different age: 
1: 
2: 
3: 
 
2. HOUSING 
 
a) Cage type _____________________________________________________;  
 
 With environmentally controlled ventilation   naturally ventilated   no ventilation    
 
 Size of cages  _______________ 
 
 Number of hens per cage  ________ 
 
 
b) Shed temperature  ____-____°C 
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3. FEED AND FEED INGREDIENTS/ANALYSIS 
 
What kind of feed is used?: Commercial  Self-prepared  
 
a) Feed Formulation Information 
Please fill in ingredients/feed analysis or attach a list of the diet: 
 
Feed Type Pre-Lay Diet Phase 1 Layer 
Diet 
Phase 2 Layer 
Diet 
Phase 3 Layer 
Diet 
Age (week)     
Energy (MJ/KG) or 
(Kcal/kg) 
    
Protein (%)     
Fat (%)     
Fibre (%)     
Calcium (g/kg)     
Avail. Phosphorus 
(g/kg) 
    
Ca:P      
Methionine     
Methionine + 
Cystein  
    
Other     
 
b) Are there any other chemical components in the feed? yes  no    
 
c) If yes, what? ____________________________________________________________ 
 
4. HENS AND PERFORMANCE 
 
a) What breed and/or strain do you currently use for your flock? __________________ 
 
b) Are hens reared on farm?   yes   no    
 
 If yes, how are hens reared?  Floor  Cage (Wire)  Barn  
 
c) At what age are pullets placed in cages? _____________________________________ 
 
d) At what age do you dispose of hens? ________________________________________ 
e) Are hens replaced on an ‘all in, all out’ basis? _________________________________ 
 
f) Do you use a lighting regime?  yes  no    If yes, what is it? __________________ 
 
g) What is your average rate of production? _____________________________________ 
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h) What is your rate of production at peak? ______________________________________ 
 
i) What is your rate of production at this time of laying cycle? ________________________ 
 
j) What is your average rate of mortality?  _______________________________________ 
 
k) What is your average rate of mortality at this time of laying cycle? __________________ 
 
 
5. MANAGEMENT 
 
a) Are birds beak trimmed? yes  no   If yes, at what age? ______________________ 
 
b) Do you undertake a regular weighing programme? yes  no   If yes, how often?  
 
c) Do you undertake a regular worming/external parasite eradication programme? 
   
yes  no   If yes, how often?  weekly  monthly  tri-monthly  yearly  as required 
 
d) Against which diseases are your flocks vaccinated? (please tick) 
 
IBV (infectious bronchitis)  
ILT (infectious laryngotracheitis)  
Marek’s disease  
Newcastle disease  
Fowl pox  
Coccidiosis  
Infectious coryza  
MG (Mycoplasma gallisepticum)  
MS (Mycoplasma synoviae)  
AE (avian encephalomyelitis)  
EDS (inactivated egg drop syndrome)  
Fowl cholera  
Other  
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What were the main causes of mortality (birds found dead and culled) on your farm (if known)? 
Disease Number of  
mortalities 
Age (weeks) 
Fowl cholera   
Marek’s disease   
Salmonella sp.   
Tracheitis (Mycoplasma sp)   
Coccidiosis   
Spotty liver   
Fatty liver haemorrhagic syndrome   
Egg peritonitis   
Ingluvitis (inflammation of the crop)   
Salpingitis (inflammation of the oviduct)   
Prolapse/protrusion   
Cannibalism   
Physical injury (i.e. Broken leg)   
Heat Stress   
Other   
Unknown   
e) Who determines the cause of mortality?  
Person Percentage of time 
Owner/Manager  
Veterinarian  
Pathology Lab  
 
Thank you for your cooperation! 
  
186 
 
Appendix 5 
 
Table 6 Statistical analysis showing results from unpaired Student t test (p-value)  
Cytokine Treatment Difference  
from control 
SE (difference) T (statistic) P 
IL-1β CONT 3 h         
  E2 1.094 0.4129 0.2283 0.831 
  LPS 1.884 0.3348 3.2381 0.032 
  CONT 24 h         
 E2 3.086 0.4287 7.1989 0.002 
  LPS 4.842 0.2424 19.9738 0.000 
  LPS & E2 1.379 0.1848 7.4637 0.002 
IL-6 CONT 3 h         
  E2 5.483 0.6857 7.9958 0.001 
  LPS 5.182 0.5574 9.2965 0.001 
  CONT 24 h         
 E2 2.775 0.0670 41.3842 0.000 
  LPS 1.019 0.1742 5.8478 0.004 
  LPS & E2 3.483 0.0535 65.1614 0.000 
IL-18 CONT 3 h         
  E2 1.286 3.6318 0.3542 0.741 
  LPS 2.039 2.9579 0.6895 0.528 
  CONT 24 h         
 E2 -1.090 3.1212 0.3492 0.745 
  LPS 2.076 3.3374 0.6222 0.568 
  LPS & E2 2.481 3.6205 0.6854 0.531 
 
1
E2 = oestrogen-treated; LPS = LPS-treated; E2 & LPS-treated; Oil = corn-oil treated; Saline = PBS-treated; CONT = 
control (no treatment); P evaluating the hypothesis that the difference is zero 
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Appendix 6 
 
 
a) E2 treated ad libitum fed birds  
 
 
b) E2 treated restricted feed intake birds  
 
Figure 2 Distribution of individual values of oestradiol for birds administered with exogenous 
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Appendix 8 
 
Table 7 Plasma concentration of GGT, CHOL, GLU, and TP in treated and control hens  
 
 GGT U/L CHOL mmol/L GLU mmol/L TP g/L 
Control 3 h 23.7 2.7 10.5 55.1 
Control 24 h 25.2 2.5 11.6 47.9 
Control 1 wk 24.5 2.8 11.3 56.3 
E2 3 h 33.7 4.6 10.3 54.7 
E2 24 h 30.5 3.8 10.7 51.6 
E2 1 wk 28.8 3.7 11.6 57.3 
LPS 3 h 34.3 2.8 11.2 49.0 
LPS 24 h 25.3 1.8 11.7 50.8 
LPS 1 wk 26.2 1.8 11.5 56.0 
E2&LPS 3 h 30.8 3.4 10.9 45.0 
E2&LPS 24 h 27.2 3.5 10.5 48.3 
E2&LPS 1 wk 28.5 3.7 10.2 45.7 
 
